Pathology In Depth

Library › Lower GI non-neoplastic pathology: colitis, inflammatory bowel disease and IBD dysplasia, ischemic and drug injury, appendix and anal non-neoplastic lesions, and pediatric GI disorders

Lower GI non-neoplastic pathology: colitis, inflammatory bowel disease and IBD dysplasia, ischemic and drug injury, appendix and anal non-neoplastic lesions, and pediatric GI disorders

Last reviewed 2026-11-17 by a board-certified pathologist. 218 references.

Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides

Definition. Acute self-limited (infectious) colitis is active colitis with preserved crypt architecture and without basal plasmacytosis. Its main differential is the first presentation of inflammatory bowel disease (IBD), in which chronicity features can appear within the first weeks of symptoms (Surawicz et al. 1994; Villanacci et al. 2021b). Interpretation of colonic biopsies is based on the normal segmental histology of the colon and depends on correct sampling, orientation and site labeling (Villanacci et al. 2021a).

Related page: Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD (ulcerative colitis, Crohn disease, IBD-unclassified and activity scores) Related page: Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis (microscopic, ischemic, drug-induced and radiation colitis) Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (CMV, adenovirus, Giardia, Cryptosporidium, Strongyloides, Histoplasma, Cryptococcus and tuberculosis in biopsies; Whipple disease; amyloid and mastocytosis) Related page: Esophagitis and Non-Neoplastic Diseases of the Esophagus (CMV and HSV inclusion morphology) Related page: Gastritis, Gastropathies and Non-Neoplastic Gastric Polyps (Candida, Aspergillus and Mucorales hyphal morphology) Related page: Colorectal Cancer Staging, CAP Reporting, Biomarkers and Neoadjuvant Response (lymph node harvest in colectomy specimens) Related page: Neuroendocrine, Mesenchymal and Lymphoid Tumors of the Esophagus, Stomach and Small Intestine (metastases to the GI tract and the immunohistochemistry of origin) Related page: Gram-Positive Bacteria and Anaerobes: Staphylococci, Streptococci, Enterococci, Gram-Positive Rods and Clostridioides difficile (Clostridioides difficile testing) Related page: Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods (enteric pathogens and Shiga toxin-producing Escherichia coli detection) Related page: Mycobacteria, Nocardia, Spirochetes, Mycoplasma, Chlamydia and Other Intracellular Bacteria (mycobacteria and spirochetes in the laboratory) Related page: DIC, Thrombotic Microangiopathy and Viscoelastic Testing (STEC-associated hemolytic uremic syndrome) Related page: Cytomorphology of Anal Cytology Samples (Entamoeba in anal cytology)

Normal colonic and ileal mucosa in endoscopic biopsies

Compartment Normal finding Sources
Crypt architecture Flat surface; straight, parallel, evenly sized and regularly spaced crypts whose bases reach the muscularis mucosae Villanacci et al. 2021a
Crypt density Average 7–8 crypts per mm of mucosal length; lower in the cecum and distal rectum Villanacci et al. 2021a
Sites of physiologic irregularity Ileocecal valve, mucosa near the appendiceal orifice and mucosa over lymphoid follicles Villanacci et al. 2021a
Paneth cells Present in the right and transverse colon; Paneth cells in the left colon are metaplastic and indicate chronic crypt injury Villanacci et al. 2021a; DeRoche et al. 2014
Lamina propria cellularity Lymphocytes and plasma cells most abundant in the cecum, denser near the surface than near the muscularis mucosae ("top-heavy"); the lower rectum has the lowest density Villanacci et al. 2021a
Eosinophils Normally present throughout the right colon; rare in the left colon and rectum, with individual variation Villanacci et al. 2021a; Villanacci et al. 2021b
Lymphoid tissue Primary and secondary lymphoid follicles, sometimes extending into the submucosa Villanacci et al. 2021a
Proliferative compartment Mitoses common in the lower third of crypts; occasional apoptosis in the upper and middle thirds Villanacci et al. 2021a
Terminal ileum Villus to crypt height ratio 2:1 or more; villous irregularity over lymphoid follicles Villanacci et al. 2021a
Preparation and endoscopic artifacts Edema, pseudo-detachment of surface epithelium and occasional surface neutrophils from bowel preparation; hemorrhagic foci and pseudolipomatosis from endoscopic trauma (pseudolipomatosis is described in Diverticular Disease, Mucosal Prolapse and Other Structural Colonic Disorders, Appendicitis, and Non-Neoplastic Anal and Perianal Lesions) Villanacci et al. 2021a

Biopsy sampling and handling for suspected IBD

  • Sampling at diagnosis. At least two biopsies are taken from the terminal ileum and from each colonic segment (cecum, ascending, transverse, descending and sigmoid colon, and rectum), including endoscopically normal mucosa. Biopsies are taken before treatment because drugs alter the morphology. Esophageal, gastric and duodenal biopsies are added when upper tract involvement is suspected (Villanacci et al. 2021a).
  • Sampling during follow-up. The minimum is two biopsies from each segment with significant lesions and two from the rectum. A discordance between the initial diagnosis and the clinical course leads to complete resampling and review of the previous biopsies (Villanacci et al. 2021a). Dysplasia surveillance sampling is described in IBD-Associated Dysplasia: Conventional and Non-Conventional Dysplasia, Reporting and Surveillance.
  • Site labeling and orientation. Biopsies are placed in separate vials for each site, or on a cellulose acetate strip in proximal-to-distal order. They are fixed at once in 10% buffered formalin and embedded with a 90° rotation to obtain cross-sections perpendicular to the muscularis mucosae (Villanacci et al. 2021a).
  • Levels and stains. Step sections at two or three levels, each with five or more sections, are recommended because lesions such as granulomas are focal. H&E is sufficient for the diagnosis of IBD (Villanacci et al. 2021a).
  • Guideline status. The 2025 ECCO-ESGAR-ESP-IBUS guideline, a joint project of ECCO, the European Society of Gastrointestinal and Abdominal Radiology, the European Society of Pathology and the International Bowel Ultrasonography Group, covers the requirements for initial diagnosis, monitoring and cancer surveillance (Kucharzik et al. 2025). The previous European histopathology standard was the 2013 ECCO and European Society of Pathology consensus (Magro et al. 2013).

Resection specimens from patients with IBD

  • Gross examination. Small bowel segments or right hemicolectomies (usually Crohn disease) and total colectomies (usually ulcerative colitis) are opened along the antimesenteric border. Mucosal changes, pseudopolyps, erosions and ulcers, fistulas, wall thickness, serosal findings and any elevated lesion or mass are recorded (Villanacci et al. 2021a).
  • Sampling. Sections include the resection margins, lymph nodes, terminal ileum, ileocecal valve and appendix. Serial sections from both affected and normal-appearing mucosa improve diagnostic yield, and the site of each block is recorded. The size of the mesentery and any mesenteric lesion are described (Villanacci et al. 2021a).
  • Crohn disease resections. Positive resection margins, granulomas and plexitis in the index specimen predicted postoperative recurrence in a meta-analysis and are recorded in the report (Tandon et al. 2021). Lymph node harvest is covered in Colorectal Cancer Staging, CAP Reporting, Biomarkers and Neoadjuvant Response.

Special stains, immunohistochemistry and molecular tests in colonic biopsies

Stain or test Target or use in the colon Sources
Masson trichrome Thickened subepithelial collagen band in collagenous colitis Villanacci et al. 2021b
CD3 immunohistochemistry Increased intraepithelial T lymphocytes in lymphocytic colitis Villanacci et al. 2021b
Warthin-Starry or Dieterle silver stain Spirochetes forming the surface fringe of intestinal spirochetosis Tsinganou and Gebbers 2010
Treponema pallidum or Borrelia burgdorferi immunohistochemistry Cross-reacting labeling of intestinal spirochetes Villanacci et al. 2021b; Tsinganou and Gebbers 2010
PAS Entamoeba histolytica trophozoites; Histoplasma yeasts Gao et al. 2025; Villanacci et al. 2021b
Grocott methenamine silver (GMS) Histoplasma capsulatum yeasts within macrophages Villanacci et al. 2021b
Ziehl-Neelsen Acid-fast mycobacteria Villanacci et al. 2021b
CMV immunohistochemistry Cytomegalovirus; sensitivity reaches 93%, higher than H&E Villanacci et al. 2021a
PCR on formalin-fixed tissue Campylobacter jejuni (mapA), pathogenic Yersinia species and Mucorales Schneider et al. 2006; Lamps et al. 2001; Addasi et al. 2023
E. coli O157:H7 immunoperoxidase Organisms in archival sections of hemorrhagic colitis Su et al. 1998
p53 immunohistochemistry Adjunct for dysplasia in IBD, covered in IBD-Associated Dysplasia: Conventional and Non-Conventional Dysplasia, Reporting and Surveillance East et al. 2025

Acute self-limited colitis compared with first-presentation IBD

Feature Acute self-limited (infectious) colitis Idiopathic IBD at presentation Sources
Crypt architecture Normal Diffusely abnormal, with distortion and atrophy Surawicz et al. 1994
Lamina propria Acute inflammation, sometimes mixed with chronic cells; edema and congestion Mixed inflammation with basal plasmacytosis, basal lymphoid aggregates and basal lymphoid hyperplasia Surawicz et al. 1994; Villanacci et al. 2021b
Basal plasmacytosis 6% of infectious colitis 63% of first-episode ulcerative colitis Villanacci et al. 2021a
Granulomas and giant cells Non-caseating granulomas and isolated giant cells occur with some infections, including Yersinia and tuberculosis Isolated basal giant cells and epithelioid granulomas Surawicz and Belic 1984; Villanacci et al. 2021a
Epithelium Cryptitis without architectural change Villous surface, goblet cell mucin depletion and reactive epithelial hyperplasia Surawicz and Belic 1984; Surawicz et al. 1994
Timing of chronic changes Crypt architecture remains normal Present as early as 7 days after onset; biopsies taken after the first 4 days remain discriminating Surawicz et al. 1994
  • Discriminating features. Distorted crypt architecture, increased round cells and neutrophils in the lamina propria, a villous surface, epithelioid granulomas, crypt atrophy, basal lymphoid aggregates and basally located isolated giant cells each predicted IBD with a probability of 87%–100%. One or more was present in 79% of IBD biopsies, and the diagnosis of acute self-limited colitis was based on the absence of these features (Surawicz and Belic 1984).
  • Reproducibility. Isolated basal giant cells, surface erosions and epithelioid granulomas were the most reliable early features of IBD, with 6% interobserver disagreement. Crypt distortion, crypt atrophy, basal lymphoid aggregates and dense lymphocytic infiltrates predicted IBD in 76%–86% but had 16%–29% interobserver disagreement (Allison et al. 1987).
  • Earliest IBD feature. Focal or diffuse basal plasmacytosis is the earliest feature of ulcerative colitis with the highest predictive value and was present in 38% of patients within 2 weeks of presentation (Villanacci et al. 2021a).
  • Stage of acute self-limited colitis at biopsy. In the peak stage, within 0–4 days of the onset of bloody diarrhea, biopsies show mucosal edema, cryptitis, crypt ulcers and crypt abscesses. At resolution, 6–9 days after onset, regenerative features appear with residual focal cryptitis. Later rectal biopsies may be nondiagnostic or may be confused with Crohn disease because focal cryptitis persists. Crypt distortion and basal plasmacytosis were the two most useful criteria separating ulcerative colitis from acute self-limited colitis (Kumar et al. 1982).

Focal active colitis: definition, causes and outcome

Focal active colitis (FAC) is focal neutrophilic crypt injury (cryptitis or crypt abscesses) without chronic architectural change in a colorectal biopsy from a patient without known IBD (Greenson et al. 1997; Soubra and Nasser 2026).

Study Patients Later IBD Other final diagnoses Sources
Retrospective, adults 49 (42 with follow-up) None Acute self-limited colitis-like illness 19, incidental FAC 11, irritable bowel syndrome 6, antibiotic-associated colitis 4, ischemic colitis 2; 20 immunosuppressed and 19 taking NSAIDs Greenson et al. 1997
Retrospective, adults 31 Crohn disease 4 (13%) Infectious-type colitis most common; incidental FAC 9 (29%); ischemic colitis 3 (10%) Volk et al. 1998
Prospective, adults 90 14 (15.6%), mostly Crohn disease, 2 ulcerative colitis Drugs, especially NSAIDs, 24%; probable infection 19% Shetty et al. 2011
Retrospective, adults 419 2.15% Irritable bowel syndrome 33.2%, infectious colitis 11.2%, drug-induced colitis 8.6%, diverticular disease 4.5%, no cause 25.3% Soubra and Nasser 2026
Retrospective, children 29 with follow-up Crohn disease 8 (27.6%); ulcerative colitis 1 Infectious-type colitis 9 (31%), idiopathic FAC 8 (27.6%), allergic colitis 2 Xin et al. 2003
Retrospective, children 68 16 (24%); 6 of 54 (11%) after cases with terminal ileal inflammation were excluded IBD associated with terminal ileal inflammation, crypt abscesses and elevated serum inflammatory markers; no amount or pattern of inflammation predicted IBD Osmond et al. 2018
  • Campylobacter in FAC. Campylobacter jejuni DNA was found by PCR in 21 of 110 FAC biopsies (19%). Fourteen of these patients had diarrhea, 3 had bleeding and 3 had incidental FAC at screening colonoscopy (Schneider et al. 2006).
  • Sodium phosphate bowel preparation. After oral sodium phosphate preparation, aphthoid ulcers unexplained by other diagnoses were found in 18 of 687 consecutive colonoscopies (2.6%), with FAC or neutrophils over lymphoid follicles on biopsy. FAC was present in 11 of 316 endoscopically normal patients who had biopsies (3.5%). In 8 patients with rectosigmoid aphthoid ulcers, re-examination 7–56 days later showed no abnormality. Crypt apoptotic bodies (1.2 compared with 0.5 per 10 crypts) and the MIB-1 labeling index were higher after sodium phosphate than on re-examination without it (Driman and Preiksaitis 1998).
  • Histologic predictors. No histologic feature of FAC predicted the final diagnosis in adults, including mild crypt distortion or slight basal plasmacytosis (Greenson et al. 1997; Volk et al. 1998; Soubra and Nasser 2026). Basal FAC, a subtype with neutrophilic injury at the crypt bases, was associated with drugs (Shetty et al. 2011).
  • Age. Across these series, IBD followed FAC in 24%–31% of children and in 0%–15.6% of adults. Without terminal ileal inflammation, the pediatric rate was 11%, similar to adults (Xin et al. 2003; Osmond et al. 2018; Greenson et al. 1997; Shetty et al. 2011).

Specific bacterial enterocolitides

Organism Distribution and endoscopy Histologic findings Ancillary detection Sources
Salmonella Simulated ulcerative colitis clinically and radiologically in 7 of 8 patients Mild cases: mucosal edema and focal inflammation. Severe cases: neutrophils in the walls of degenerating crypts, with mucosal microthrombi in one case; one resection showed mucosal necrosis, hemorrhage and microthrombi extending into submucosal venules, resembling acute ischemic colitis Culture and molecular detection in Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods McGovern and Slavutin 1979; Andrews and Putra 2025
Shigella Rectosigmoid involved in all 33 patients; lesions extended to the splenic flexure in 18 (55%) and pancolitis was present in 5 (15%); continuous and diffuse disease decreasing in intensity proximally; aphthoid erosions in 5; proximal extension with diarrhea of 4 or more days Inflammation milder in proximal than in distal biopsies; features of chronicity can occur Culture and molecular detection in Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods Speelman et al. 1984; Andrews and Putra 2025
Campylobacter jejuni Colonoscopy abnormal in 10 of 21 PCR-positive patients (erythema, ulcers, colitis or hemorrhage) Focal active colitis with focal cryptitis and preserved crypt architecture mapA PCR on fixed biopsies Schneider et al. 2006
Yersinia enterocolitica and Y. pseudotuberculosis Appendicitis, ileocolitis and mesenteric adenitis Epithelioid granulomas with lymphoid cuffing, transmural inflammation with lymphoid aggregates, mucosal ulceration and cryptitis; intramural non-caseating granulomas, often with stellate abscesses, usually in the terminal ileum; mimics Crohn disease PCR positive in 10 of 40 granulomatous appendices (25%) Lamps et al. 2001; Villanacci et al. 2021b
E. coli O157:H7 (Shiga toxin-producing) Hemorrhagic colitis resembling ischemic colitis; right colon most severely affected Extreme submucosal edema, fibrin deposition and hemorrhage; patchy mucosal ulceration, mucosal hemorrhage, neutrophils and microvascular thrombi; pseudomembranes a minor feature; regenerative mucosa and submucosal plasma cells in advanced lesions Immunoperoxidase positive in 2 of 2 culture-proven cases and in 3 of 11 cases of ischemic colitis Kelly et al. 1990; Su et al. 1998
Intestinal spirochetes (Brachyspira aalborgi, B. pilosicoli) Mucosa often endoscopically normal; proximal colon to rectum and appendix Basophilic fringe 3–6 μm thick on the intercryptal surface epithelium ("false brush border") Warthin-Starry or Dieterle silver stain; Borrelia or Treponema immunohistochemistry; PCR and FISH on fixed tissue Tsinganou and Gebbers 2010; Villanacci et al. 2021b
Klebsiella oxytoca (cytotoxin-producing) Antibiotic-associated hemorrhagic colitis without C. difficile: 6 of 22 C. difficile-negative patients with suspected antibiotic-associated colitis had colonoscopic findings of hemorrhagic colitis, 5 of the 6 grew K. oxytoca, and all 5 were taking penicillins Infection of rats given amoxicillin-clavulanate reproduced a right-sided hemorrhagic colitis Stool culture; every isolate produced cytotoxin; carriage in 1.6% of 385 healthy subjects Högenauer et al. 2006
Treponema pallidum, Chlamydia trachomatis and herpes simplex virus (proctitis) Endoscopic and histologic resemblance to IBD in sexually active patients; herpes simplex virus proctitis is confined to the distal rectum, with friable mucosa, diffuse ulceration and vesicles Chronicity generally mild Herpes simplex virus by PCR of rectal mucosal swabs Andrews and Putra 2025; Hall et al. 2024
  • Syphilitic and lymphogranuloma venereum (LGV) proctocolitis. In 10 HIV-positive patients with serologically confirmed syphilis, LGV or both, every specimen showed an intense lymphohistiocytic infiltrate with prominent plasma cells and lymphoid aggregates, only mild to moderate acute inflammation, minimal basal plasmacytosis and crypt distortion, and rare granulomas and Paneth cell metaplasia. Mass lesions occurred only with syphilis. Spirochetes were shown by T. pallidum immunohistochemistry in 1 specimen and by silver stains in none of 3. Initial impressions included condyloma acuminatum, IBD and malignancy, and symptoms and imaging abnormalities resolved after STI therapy in all 6 patients with follow-up (Arnold et al. 2013).
  • LGV compared with Crohn disease. In 28 autopsy cases of LGV, the bowel showed follicular lymphohistiocytic and plasma cell infiltrates in the submucosa, muscularis propria and serosa, neuromatous hyperplasia of the submucosal and myenteric plexuses, and fibrotic wall thickening. The rectum was uniformly involved, with deep ulceration and fissuring, and the proximal colon was generally spared of severe chronic inflammation. This distal, left-sided predominance differs from the usual right-sided predominance with rectal sparing of Crohn colitis (de la Monte and Hutchins 1985).
  • Chronicity in infection. Salmonella, Shigella and Entamoeba histolytica infections can show architectural distortion, pyloric metaplasia and Paneth cell hyperplasia that mimic IBD. Necrotizing granulomas raise the possibility of Mycobacterium tuberculosis, Yersinia or Actinomyces infection (Andrews and Putra 2025). Mycobacterium is identified by Ziehl-Neelsen stain or PCR in caseating granulomas with multinucleated giant cells (Villanacci et al. 2021b). Tuberculosis and Crohn disease in colonoscopic biopsies are compared in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.
  • Ischemic-like infection. Enterohemorrhagic E. coli and Clostridium perfringens can produce an ischemic-like pattern with hemorrhage, acute inflammation, marked edema, crypt withering, lamina propria hyalinization and mucosal necrosis (Villanacci et al. 2021b).
  • Schistosomiasis. PAS-positive schistosome eggs, sometimes calcified, are contained in microgranulomas with fibrotic submucosal thickening and lymphoid hyperplasia (Villanacci et al. 2021b).
  • Spirochetosis in context. Colonization is most frequent in men who have sex with men and in people with HIV infection. Spirochetes usually attach to the surface epithelium without invasion; invasion beyond the surface epithelium may correlate with symptoms (Tsinganou and Gebbers 2010).
  • Superimposed infection in IBD. Cytomegalovirus and C. difficile are the most frequent infections complicating IBD. Pseudomembranes are usually absent in C. difficile infection superimposed on IBD, so stool testing is used for detection. Testing for Neisseria gonorrhoeae, herpes simplex virus, Chlamydia trachomatis and Treponema pallidum is considered in patients with IBD and severe rectal symptoms (Villanacci et al. 2021a).
  • Laboratory detection. Culture, antigen and molecular detection of enteric bacteria are covered in Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods, and spirochetes in Mycobacteria, Nocardia, Spirochetes, Mycoplasma, Chlamydia and Other Intracellular Bacteria.

Pseudomembranous colitis and Clostridioides difficile

  • Organism. Clostridioides difficile is a gram-positive anaerobic bacillus. Mucosal injury ranges from mild inflammation to deep injury that resembles ischemia (Villanacci et al. 2021b).
  • Pseudomembranes. Mushroom-shaped pseudomembranes of fibrin, mucus, neutrophils and necrotic epithelial debris overlie injured mucosa. The underlying crypts show cryptitis, crypt abscesses and dilatation without basal plasmacytosis (Villanacci et al. 2021b). In biopsies the lesion appears as a volcano-like eruption of fibrin and inflammatory cells (Westerhoff 2022).
  • Spectrum in rectal biopsies. Three basic histologic patterns were described in 29 cases, ranging from a non-diagnostic proctitis to changes indistinguishable from acute ischemia. Capillary microthrombosis was proposed as a cause of the later mucosal necrosis (Price and Davies 1977).
  • Diagnosis. Histology suggests the diagnosis, and confirmation requires isolation of the organism and detection of its toxin. Pseudomembranes can be absent, particularly in patients receiving immunosuppressive agents (Villanacci et al. 2021b). Testing algorithms are covered in Gram-Positive Bacteria and Anaerobes: Staphylococci, Streptococci, Enterococci, Gram-Positive Rods and Clostridioides difficile.
  • Differential. Pseudomembranes also occur in severe ischemic colitis and in drug injury with a pseudomembranous pattern, and enterohemorrhagic E. coli produces an ischemic-like pattern (Villanacci et al. 2021b); these are compared in Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis.

Amebic colitis

  • Endoscopy. Classic amebic colitis shows discrete "flask-shaped" ulcers with intervening normal mucosa in the cecum and ascending colon (Li et al. 2026). The ileocecal region (9 of 12 patients) and rectum (5 of 12) were the commonest sites (Gao et al. 2025). Eight of 10 patients with multisegmental disease had more severe ileocecal than distal lesions, a gradient opposite to that of ulcerative colitis. Eight of 13 patients with amebic colitis (61.5%) were first diagnosed as having ulcerative colitis before biopsy confirmation (Li et al. 2026).
  • Trophozoites. Entamoeba histolytica trophozoites are present in the inflammatory exudate and necrotic debris as round, eosinophilic or foamy bodies with ingested erythrocytes, and resemble histiocytes containing phagocytosed red cells (Villanacci et al. 2021b; Li et al. 2026; Gao et al. 2025). PAS staining confirms the organisms (Gao et al. 2025).
  • Background mucosa. Acute and chronic inflammation with ulceration, sometimes with eosinophils, cryptitis and granulation tissue, is typical (Gao et al. 2025). Crypt distortion was recorded in 1 of 13 amebic colitis biopsies (7.7%) and in 9 of 21 ulcerative colitis biopsies (42.9%), and surface necrosis in 92.3% and 66.7%, respectively (Li et al. 2026).
  • Chronic pattern. Trophozoites can be found in biopsies showing chronic active colitis with crypt distortion and basal lymphoplasmacytosis. Stool studies can miss the organisms, and immunosuppressive therapy for presumed IBD can cause fulminant amebic colitis with perforation (DeRoche et al. 2014).

Fungal and cytomegalovirus colitis

Infection Colonic presentation Histologic and laboratory findings Sources
Histoplasma capsulatum Colon and ileum are the commonest GI sites, attributed to their lymphoid tissue; the colon was the most affected GI site in 212 published cases, with or without HIV infection; cecal and ileal ulcers were the commonest findings Yeasts in lamina propria macrophages (GMS, PAS), with morphology in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies. Intracellular Candida glabrata mimics Histoplasma but has variably sized yeasts, more frequent buds, no halo and Gram positivity, and is more often extracellular Ekeng et al. 2023; Villanacci et al. 2021b; Westerhoff 2022
Mucorales (gastrointestinal mucormycosis) Stomach 57.5%, colon 32.3%, small intestine 7%; hemorrhagic, edematous mucosa mimicking ischemia, sharply demarcated necrotic ulcers, thrombosis of adjacent vessels and black eschar Broad (3–25 μm), thin-walled, aseptate, folded or twisted hyphae with irregular branching; Mucorales PCR on fixed tissue adds yield Addasi et al. 2023
Candida and Aspergillus Only in immunocompromised patients; the colon accounts for 20% of GI candidiasis and is the third GI site after the esophagus and stomach; aspergillosis is often accompanied by lung involvement; mucosal flecks resembling pseudomembranous colitis, ulcers and infarcts Candida: budding yeasts, pseudohyphae and occasional septate hyphae, with transmural infarcts and angioinvasion in some cases. Aspergillus: septate hyphae with parallel walls and acute-angle branching; angioinvasion with fibrin thrombi and hyphae radiating from vessels Westerhoff 2022
Cytomegalovirus Tropism for inflamed tissue; tested in severe colitis refractory to immunosuppression and in biopsies with granulation tissue and large ulcers Cytomegalic endothelial cells and fibroblasts in granulation tissue, 2–4 times normal size, with amphophilic intranuclear inclusions, a clear halo and small cytoplasmic inclusions; immunohistochemistry reaches 93% sensitivity Villanacci et al. 2021a
  • CMV in IBD. CMV reactivation is more frequent in ulcerative colitis (10%–56.7%) than in Crohn disease (0%–29.6%). Five or more inclusions define a high-density group. High density predicted benefit from antiviral therapy; low density did not. Ganglion cells and necrotic or apoptotic cells can mimic inclusions, and sampling error causes false-negative biopsies (Villanacci et al. 2021a).
  • CMV in steroid-refractory ulcerative colitis. Immunohistochemistry detected CMV in 10 of 40 patients with steroid-refractory ulcerative colitis (25%), in 1 of 40 with severe nonrefractory ulcerative colitis (2.5%) and in none of 40 noncolitis controls. Inclusions were identified on H&E in only 2 of the 40 refractory patients at first review (Kambham et al. 2004).
  • Linked morphology. CMV and HSV inclusion morphology is described in Esophagitis and Non-Neoplastic Diseases of the Esophagus, and Cryptococcus, Strongyloides and adenovirus in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.

Differential diagnosis of active colitis in biopsies: infection, IBD, ischemia and drugs

Feature Acute self-limited (infectious) colitis IBD Ischemic colitis Drug-induced active colitis
Crypt architecture Preserved Distorted, branched and atrophic in established disease Atrophic crypts lined by small cells with eosinophilic cytoplasm Ranges from normal to IBD-like distortion
Lamina propria Edema, congestion and neutrophils; no basal plasmacytosis Basal plasmacytosis and transmucosal mixed inflammation Hemorrhage and hyalinization; inflammation mild relative to epithelial injury Eosinophils often prominent
Epithelial injury Cryptitis and crypt abscesses Cryptitis, crypt abscesses, erosion and ulceration Coagulative necrosis, microthrombi and pseudomembranes Apoptosis, intraepithelial lymphocytes or pseudomembranes, depending on the drug
Distribution Diffuse, patchy or focal Continuous from the rectum (ulcerative colitis) or segmental (Crohn disease) Segmental Variable by agent (Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis)
Key confirmation Stool studies Clinical, endoscopic and histologic correlation Clinical setting and vascular risk factors Drug history and its timing
Sources Villanacci et al. 2021b; DeRoche et al. 2014 Villanacci et al. 2021a; DeRoche et al. 2014 Villanacci et al. 2021b; DeRoche et al. 2014 Villanacci et al. 2021b; DeRoche et al. 2014; Andrews and Putra 2025

Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD

Definition. Ulcerative colitis is a chronic inflammatory disease of the colorectal mucosa that begins in the rectum and extends proximally in continuity. Crohn disease is a segmental, transmural inflammatory disease that can involve any part of the gastrointestinal tract, with granulomas unrelated to crypt injury among its features of highest diagnostic value (Villanacci et al. 2021a; DeRoche et al. 2014). The diagnosis integrates clinical, endoscopic, radiologic, laboratory and histologic findings, and no single feature is diagnostic (Villanacci et al. 2021a).

Related page: Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides (normal colon, biopsy handling, acute self-limited colitis, infections and CMV in IBD) Related page: IBD-Associated Dysplasia: Conventional and Non-Conventional Dysplasia, Reporting and Surveillance (dysplasia and carcinoma in IBD) Related page: Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis (drug-induced, ischemic, radiation and microscopic colitis) Related page: Diverticular Disease, Mucosal Prolapse and Other Structural Colonic Disorders, Appendicitis, and Non-Neoplastic Anal and Perianal Lesions (diverticular disease, anal fistulas and the appendix) Related page: Gastritis, Gastropathies and Non-Neoplastic Gastric Polyps (Crohn gastritis) Related page: Gastric Dysplasia, Gastric Carcinoma, Gastroesophageal Biomarkers and Small Intestinal Adenocarcinoma (small intestinal adenocarcinoma in Crohn disease) Related page: Cholestatic and Biliary Liver Disease: Primary Biliary Cholangitis, Primary and IgG4-Related Sclerosing Cholangitis, Pediatric Cholestasis, Ductal Plate Malformations and Hepatic Cysts (primary sclerosing cholangitis and its IBD association) Related page: Laboratory Evaluation of Inborn Errors of Immunity and Secondary Immunodeficiency (chronic granulomatous disease, IPEX and other inborn errors of immunity) Related page: Liver, Kidney and Gastrointestinal Function Tests (fecal calprotectin) Related page: ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (atypical pANCA and its antigen) Related page: Granulomatous, Vasculitic, Neutrophilic and Eosinophilic Dermatoses: Sarcoidosis, Granuloma Annulare, Cutaneous Vasculitis and Vasculopathy, Sweet Syndrome, Pyoderma Gangrenosum and Wells Syndrome (metastatic Crohn disease and pyoderma gangrenosum) Related page: Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis (erythema nodosum in IBD)

Ulcerative colitis: distribution and diagnostic histology

  • Distribution. Inflammation is diffuse and continuous from the rectum proximally, with decreasing severity and a sharp transition to uninvolved mucosa. The bowel wall has normal thickness, and fat wrapping, strictures and fistulas are absent (Villanacci et al. 2021a; DeRoche et al. 2014).
  • Chronicity. Crypt distortion (non-parallel crypts of varying diameter), crypt branching, crypt atrophy, basal plasmacytosis and Paneth cell metaplasia in the left colon define chronic injury. Branching is abnormal when more than 10% of crypts, or more than two crypts in a well-oriented biopsy with at least 2 mm of muscularis mucosae, are branched. Crypt atrophy is a widened space between the crypt bases and the muscularis mucosae (Villanacci et al. 2021a). Pyloric gland metaplasia is rare in ulcerative colitis (DeRoche et al. 2014).
  • Frequency of architectural change. Crypt distortion with branching and atrophy is present in 57%–100% of patients and increases with disease duration (Villanacci et al. 2021a).
  • Activity. Activity is neutrophil-mediated epithelial injury: cryptitis, crypt abscesses, surface infiltration, erosion and ulceration (DeRoche et al. 2014).
  • Semiquantitative activity. Mild activity is neutrophilic injury in fewer than 50% of crypts, moderate activity involves more than 50% of crypts, and severe activity shows erosion or ulceration (DeRoche et al. 2014).
  • Eosinophils. Eosinophils accompanying basal plasmacytosis (more than three at the base and lateral aspect of crypts) favor ulcerative colitis at first biopsy. More than 60 eosinophils per 10 high-power fields in the left colon at diagnosis can predict non-response to medical therapy (Villanacci et al. 2021a).
  • Quiescent colitis. Architectural abnormalities persist without active inflammation: crypt atrophy, irregularity and shortening, thickening of the muscularis mucosae and Paneth cell or pyloric metaplasia (DeRoche et al. 2014).
  • Pretreatment diagnosis. Diffuse, uniform chronic active colitis with rectal involvement and no granulomas in the first set of biopsies supports ulcerative colitis once other causes are excluded (DeRoche et al. 2014).

Atypical patterns of ulcerative colitis

Pattern Frequency or setting Interpretation Sources
Rectal sparing in children 30% of pediatric ulcerative colitis at presentation (relative or absolute) Compatible with ulcerative colitis DeRoche et al. 2014; Villanacci et al. 2021a
Patchy inflammation in children 21% of pediatric ulcerative colitis Compatible with ulcerative colitis DeRoche et al. 2014
Treated ulcerative colitis Rectal sparing in 44% of treated patients; complete restoration of rectal mucosa in 34%–44% Disease distribution is not used to subtype IBD after treatment Villanacci et al. 2021a; DeRoche et al. 2014
Rectal sparing in biopsies compared with colectomy 30% on biopsy; 5.4% in colectomy specimens, all relative Colectomy assesses the rectum more accurately DeRoche et al. 2014
Cecal or appendiceal patch Patchy right-sided inflammation in 9% of left-sided ulcerative colitis; appendiceal inflammation in subtotal or left-sided colitis Compatible with ulcerative colitis DeRoche et al. 2014
Backwash ileitis About 17%–20% of ulcerative colitis, mostly with pancolitis (94%) and severe colonic activity (65%) Mild patchy neutrophilic ileitis, cryptitis and mild villous blunting; no effect on pouch complications DeRoche et al. 2014; Villanacci et al. 2021a
Upper GI inflammation Superficial plasmacytosis, focal gastritis and basal mixed inflammation; diffuse chronic active duodenitis Nonspecific; without granulomas it does not establish Crohn disease; duodenal intraepithelial lymphocytosis with or without partial villous atrophy also occurs DeRoche et al. 2014
Fulminant colitis Rectal sparing in 13% of adults; linear or fissuring ulcers and focal transmural inflammation beneath deep ulcers Compatible with fulminant ulcerative colitis Villanacci et al. 2021a; DeRoche et al. 2014
  • Fulminant colitis. Fulminant colitis is severe acute colitis with systemic toxicity, and 89% of cases are IBD. In this setting, granulomas and transmural lymphoid aggregates away from ulcers are the two most specific indicators of Crohn disease (DeRoche et al. 2014).
  • Crypt rupture granulomas. Loose microgranulomas of pale foamy histiocytes and giant cells adjacent to damaged crypts or eroded surfaces are a reaction to extravasated mucin and occur in ulcerative colitis. Deeper levels can show the association with a ruptured crypt. Well-formed epithelioid granulomas away from epithelial injury support Crohn disease when other causes are excluded. Isolated giant cells in the lamina propria away from epithelial injury carry the same weight (DeRoche et al. 2014). In 29 biopsies with giant cells or granulomas on a background suggesting ulcerative colitis, 10 were classed as ulcerative colitis on histology. The 9 with a concordant clinical diagnosis had only crypt-associated giant cells or granulomas, and the tenth, with a solitary free-standing granuloma, had perianal disease suggesting Crohn disease (Mahadeva et al. 2002).

Crohn disease: distribution, gross and microscopic features

  • Location. About one third of patients have colonic disease, one third ileocolic disease and one third small bowel disease, and the location usually does not change over time. Upper GI involvement is reported in 35%–75% (Villanacci et al. 2021a).
  • Gross findings. Diseased segments are separated abruptly by uninvolved bowel (skip lesions). The earliest lesions are aphthous ulcers over lymphoid follicles along the mesenteric margin. Coalescing serpiginous or linear ulcers with edematous mucosa between them produce a cobblestone pattern. Fat wrapping (creeping fat) extends toward the antimesenteric surface, mainly in the small bowel. Transmural inflammation with fibrosis and fibromuscular proliferation thickens and stiffens the wall. Fistulas are more frequent in the small bowel, and free perforation is exceptional (Villanacci et al. 2021a).
  • Biopsy features. The features of highest diagnostic value are discontinuous chronic inflammation, focal crypt distortion and granulomas unrelated to crypt injury. Inflammation is focal, of variable density and not confined to the superficial mucosa. Crypt distortion is less pronounced than in ulcerative colitis (Villanacci et al. 2021a).
  • Granuloma definition. An epithelioid granuloma is a discrete collection of at least five epithelioid cells, with or without multinucleated giant cells, unrelated to crypt injury (Villanacci et al. 2021a).
  • Granuloma frequency. Granulomas were present in 53.8% of children with Crohn disease in one series and are more frequent in children than in adults (Nambu et al. 2022; Villanacci et al. 2021a). In 282 fully investigated children with Crohn disease, granulomas were found in 61% of untreated and 24.5% of treated patients. Upper tract and terminal ileal biopsies were essential to identify 42% of patients with granulomas, and their presence at diagnosis was associated with perianal disease (De Matos et al. 2008). Upper GI non-necrotizing granulomas are found in more than half of untreated pediatric patients, most often in the stomach (Andrews and Putra 2025).
  • Ileal findings. Irregular villous architecture is the most frequent ileal change. Early lesions are focal neutrophils and eosinophils in the surface epithelium over a normal villous background. Pyloric gland metaplasia, a marker of ulceration and repair, is found in 2%–27% of ileal biopsies and more often in resections (Villanacci et al. 2021a).
  • Neural and mural changes. Neural hypertrophy can be present. Ganglionitis and transmural nodular lymphoid inflammation are reported in resection specimens (Villanacci et al. 2021a).
  • Resection specimens. Transmural inflammation, subserosal lymphoid aggregates, fissures or sinus-like tracts, granulomas, enteric nervous system abnormalities and muscularis mucosae thickening or atrophy with pyloric metaplasia were more frequent in Crohn disease than in other resected bowel. The combination of transmural inflammation, chronic inflammatory change and architectural abnormality had a sensitivity of 92.4% and a specificity of 97.7% (Fu et al. 2024). Recurrence predictors at the margin are covered in Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides.
  • Ulcerative colitis-like Crohn disease. Crohn disease limited to the colonic mucosa, without fissuring ulcers, transmural lymphoid aggregates, sinuses or fistulas, is recognized only by segmental disease, creeping fat, absolute skip lesions, granulomas in the colectomy specimen or perianal disease. In colectomy specimens, relative rectal sparing and segmental sparing of up to one section are allowed in ulcerative colitis if the colitis is otherwise diffuse and superficial, without transmural inflammation or granulomas (DeRoche et al. 2014).
  • Perianal and upper GI disease. Skin tags, anal fissures and perianal fistulas are among the most helpful clinical findings for Crohn disease (Villanacci et al. 2021a). In 75 patients with Crohn disease, focally enhanced gastritis without Helicobacter pylori (focal CD3-positive lymphocytes and CD68-positive histiocytes, with granulocytes in 80%) was found in antral biopsies of 48% and body biopsies of 24%. Focally enhanced gastritis or granulomas were present in 76% of H. pylori-negative patients with Crohn disease and in 0.8% of controls (Oberhuber et al. 1997). In children, focally enhanced gastritis is found in 54%–55% with Crohn disease and 21%–30% with ulcerative colitis, and lymphocytic esophagitis in up to 28% and 7%, respectively (Andrews and Putra 2025). Crohn gastritis is covered in Gastritis, Gastropathies and Non-Neoplastic Gastric Polyps.

Ulcerative colitis compared with Crohn disease

Feature Ulcerative colitis Crohn disease Sources
Distribution Continuous from the rectum; decreasing severity proximally Segmental with skip lesions; any part of the GI tract Villanacci et al. 2021a
Rectum Involved, particularly in untreated adults Variable; colitis with rectal involvement is common in children Villanacci et al. 2021a; DeRoche et al. 2014
Terminal ileum Normal or mild backwash ileitis with pancolitis Commonly involved, with linear ulcers, cobblestoning, stenosis and pyloric metaplasia DeRoche et al. 2014; Villanacci et al. 2021a; Andrews and Putra 2025
Depth Mucosa, except near deep ulcers in fulminant colitis Transmural, with lymphoid aggregates in the muscularis propria and subserosa DeRoche et al. 2014; Fu et al. 2024
Crypt architecture Diffuse, uniform distortion Focal, less pronounced distortion Villanacci et al. 2021a
Lamina propria inflammation Diffuse, with basal plasmacytosis, heaviest in the rectum Focal and discontinuous within and between biopsies Villanacci et al. 2021a
Crypt abscesses 41% 19% Villanacci et al. 2021a
Granulomas Only crypt rupture or foreign body type Epithelioid granulomas unrelated to crypt injury DeRoche et al. 2014; Villanacci et al. 2021a
Fissures, sinuses and fistulas Absent, except fissuring ulcers in fulminant colitis Present DeRoche et al. 2014; Fu et al. 2024
Creeping fat and strictures Absent Present DeRoche et al. 2014; Villanacci et al. 2021a

IBD-unclassified and indeterminate colitis

  • Indeterminate colitis. The Montreal Working Party reserved "indeterminate colitis" for colectomy specimens (Andrews and Putra 2025). The term describes colectomy specimens in which a definitive diagnosis of ulcerative colitis or Crohn disease is not possible. It is a provisional diagnosis, and about 80% of cases in one series were classified as ulcerative colitis or Crohn disease within 8 years. Patients without pathologic or clinical stigmata of Crohn disease remain candidates for ileal pouch-anal anastomosis (IPAA) (DeRoche et al. 2014).
  • Origin of the term. "Colitis indeterminate" was introduced for 30 colectomy specimens, nearly all resected urgently for fulminant disease. Fissuring ulceration, transmural inflammation and preserved goblet cells, accepted criteria of Crohn disease, were found in cases later proved to be ulcerative colitis, and biopsies from a quiescent phase resolved many of the difficulties (Price 1978).
  • IBD-unclassified (IBDU). IBDU is the label when endoscopic and histologic assessment cannot distinguish Crohn colitis from ulcerative colitis; it is diagnosed on clinical and endoscopic findings, including biopsies (Lamb et al. 2019; Andrews and Putra 2025). It is the term for biopsies (Villanacci et al. 2021a).
  • Frequency. About 5%–15% of patients with IBD cannot be classified as ulcerative colitis or Crohn disease, usually because of insufficient data or overlapping features, and IBDU is more common in children than in adults (Villanacci et al. 2021a; Lamb et al. 2019).
  • Pediatric classification. The revised Porto criteria define typical and atypical ulcerative colitis, treat atypical phenotypes as ulcerative colitis and use multiple criteria to diagnose IBDU (Levine et al. 2014). The PIBD-classes algorithm scores 23 features, many histologic, in three classes (incompatible with, rarely found in and uncommon in ulcerative colitis); a simplified 19-feature version was introduced in 2020. Pediatric IBDU is reclassified more often as Crohn disease than as ulcerative colitis, and most patients retain the IBDU diagnosis (Andrews and Putra 2025).

IBD mimics: infection, diversion, diverticular, drug, ischemic and pouch changes

Mimic Distinguishing findings Sources
Infectious colitis Acute colitis pattern without crypt distortion; Salmonella, Shigella and Entamoeba histolytica can produce chronicity features; detailed in Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides DeRoche et al. 2014; Andrews and Putra 2025
Diversion colitis Bowel excluded from the fecal stream; dense superficial lymphoplasmacytic infiltrate with prominent lymphoid follicular hyperplasia; regenerative, mucin-depleted glands; occasional granulomas; architectural distortion is not a feature; the diagnosis requires a surgical history Villanacci et al. 2021b
Segmental colitis associated with diverticulosis (SCAD) Chronic inflammation of the interdiverticular mucosa of the involved segment, usually sigmoid; lesions on fold crests with sparing of diverticular orifices; rectum spared by definition and proximal colon usually spared; ulcerative colitis-like pattern (crypt distortion, crypt abscesses, basal plasmacytosis) or Crohn-like pattern (granulomas and deep lymphoid follicles); a small subset progresses to ulcerative colitis; the course is more benign and self-limiting than that of IBD Villanacci et al. 2021b; DeRoche et al. 2014; Piscopo and Ellul 2020
Drug and ischemic injury (mycophenolate, NSAIDs, chronic ischemia) IBD-like crypt distortion can occur; apoptosis, eosinophils or hyalinized lamina propria favor these causes; detailed in Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis DeRoche et al. 2014
Cord colitis syndrome Culture-negative, antibiotic-responsive chronic active colitis after cord blood stem cell transplantation; basal plasmacytosis and architectural distortion usually not prominent DeRoche et al. 2014
Monogenic IBD and immunodeficiency Apoptotic, eosinophil-rich, lymphocytic or granulomatous patterns in very young children Andrews and Putra 2025
  • Pouch biopsies. Chronic changes (architectural distortion, villous atrophy, crypt hyperplasia and mononuclear infiltrates) are present in up to 87% of biopsies from healthy ileal pouches, while neutrophils are rare. Pouchitis is active inflammation of the pouch mucosa with neutrophilic infiltrates, cryptitis, crypt abscesses and ulcers, often patchy and more prominent in the lower and posterior pouch, and infection, particularly CMV, is considered. Deep lymphoid aggregates and Crohn-like complications do not refute ulcerative colitis; Crohn disease is diagnosed after IPAA only when review of the colectomy specimen shows typical features. Ulcers in the afferent limb proximal to the pouch often represent recurrent Crohn disease but also occur in patients with ulcerative colitis taking NSAIDs, and mucosal prolapse features occur, often in the anterior wall. Pouch specimens removed for failure show deep lymphoid aggregates and granulation tissue-lined fistulous tracts (Villanacci et al. 2021a).
  • Pouchitis Disease Activity Index. The index quantifies clinical findings with endoscopic and histologic features of acute inflammation. All 10 patients with clinical pouchitis met its criteria, compared with 1 of 10 under earlier scoring systems, and no asymptomatic patient qualified (Sandborn et al. 1994).
  • Pyloric gland metaplasia in the pouch. Pyloric gland metaplasia was found in 40.1% and 24.0% of two pouch cohorts. Its sensitivity and specificity for chronic antibiotic-refractory pouchitis or Crohn disease of the pouch were 70.7% and 92.5% in the first cohort and 39.0% and 86.4% in the validation cohort (Kariv et al. 2010).
  • Diversion colitis mechanism. The excluded rectosigmoid contained negligible short-chain fatty acids. In 4 patients, irrigation with short-chain fatty acids resolved symptoms and endoscopic inflammation in 4–6 weeks, and histologic inflammation resolved more slowly and less completely. The colitis persists until the segment is reanastomosed and can lead to stricture (Harig et al. 1989).
  • IPAA and Crohn disease. IPAA is contraindicated in Crohn disease because of high rates of severe complications and pouch failure (DeRoche et al. 2014).

Histologic activity indices in ulcerative colitis

Index Components and grades Threshold used for histologic remission or activity Sources
Geboes score Six grades, each subgraded: 0 structural change only; 1 chronic inflammation; 2 lamina propria neutrophils; 3 neutrophils in epithelium; 4 crypt destruction; 5 erosions or ulcers Below 2.0 for histologic healing; above 3.1 (neutrophils in epithelium involving more than 5% of crypts) for activity Geboes et al. 2000; Jucan et al. 2023; Pavel et al. 2024
Simplified Geboes score Only variables linked to active inflammation 3.1 or more for active microscopic disease Jauregui-Amezaga et al. 2017
Nancy index Three items (ulceration, acute inflammatory infiltrate, chronic inflammatory infiltrate); grade 4 ulceration; grade 3 moderate or severe neutrophilic infiltrate without ulceration; grade 2 few neutrophils without ulceration; grade 1 moderate or severe chronic inflammation without neutrophils or ulceration; grade 0 little or no chronic inflammation Remission 0; histologic response 1 or less Marchal-Bressenot et al. 2017; Villanacci et al. 2021a; Jucan et al. 2023; Pavel et al. 2024
Robarts Histopathology Index (RHI) Chronic inflammatory infiltrate, lamina propria neutrophils, neutrophils in the epithelium, and erosion or ulceration Remission 3 or less, with lamina propria and epithelial neutrophil subscores of 0 and no erosion or ulceration; one review uses below 3 for remission and below 9 for response Mosli et al. 2017; Jucan et al. 2023; Pavel et al. 2024
  • Reproducibility. Initial interobserver kappa values for the Geboes score were 0.20–0.42 and rose to 0.59–0.70 after a pictorial scale was introduced. Agreement for neutrophils in the epithelium was 0.903–1.000, and epithelial neutrophils correlated with crypt destruction and ulceration (Geboes et al. 2000). The Nancy index had an intrareader intraclass correlation coefficient of 0.88 (Marchal-Bressenot et al. 2017). The RHI was developed from the most reliable items of the Geboes and modified Riley scores (Mosli et al. 2017).
  • Correlation between indices. The Geboes score correlated strongly with the RHI (0.81) and with the Nancy index (0.88) (Akiyama et al. 2024).
  • Histologic activity in endoscopic remission. Active microscopic disease was found in 25% of patients in complete endoscopic remission (Mayo 0) and in 84% with mild endoscopic lesions (Mayo 1) (Jauregui-Amezaga et al. 2017). In a meta-analysis of 757 patients in endoscopic remission, histologic remission was associated with a 63% lower risk of clinical relapse (Akiyama et al. 2024).
  • Basal plasmacytosis and relapse. In patients with normal endoscopy, basal plasmacytosis with a Geboes score above 3.1 predicted relapse within 12 months (37% compared with 9%) (Pavel et al. 2024).
  • ECCO position paper (2020). The ECCO position paper on ulcerative colitis histopathology recommends the RHI or the Nancy index for randomized trials and the Nancy index for observational studies and clinical practice. It sets absence of intraepithelial neutrophils, erosion and ulceration as the minimum definition of histological remission (Magro et al. 2020).

Treatment targets: STRIDE-III with the previous STRIDE-II rule

  • STRIDE-III (2026). Targets are grouped into three categories. Actionable targets are clinical response and remission, C-reactive protein normalization, fecal calprotectin within the target range and endoscopic remission. Adjunctive targets are urgency, histologic remission in ulcerative colitis, transmural remission in Crohn disease and growth; they guide treatment optimization and tighter monitoring without necessarily requiring a change in therapeutic class. Patient-centered targets are disability, fatigue and quality of life (Turner et al. 2026).
  • Previous rule, STRIDE-II (2021). Long-term targets were clinical remission and endoscopic healing, with absence of disability, restoration of quality of life and normal growth in children. Short-term targets were symptomatic relief and normalization of serum and fecal markers. Histologic healing in ulcerative colitis and transmural healing in Crohn disease were not formal targets and were to be assessed as measures of the depth of remission (Turner et al. 2021).

Montreal classification and the Paris pediatric modification

Category Montreal classification (2006) Paris modification for children (2011) Sources
Age at diagnosis, Crohn disease A1 below 17 years; A2 17–40 years; A3 over 40 years A1a 0 to under 10 years; A1b 10 to under 17 years; A2 17–40 years; A3 over 40 years Lamb et al. 2019; Levine et al. 2011
Location, Crohn disease L1 terminal ileal, with or without limited cecal disease; L2 colonic; L3 ileocolonic; L4 upper GI disease (proximal to the terminal ileum), which can coexist with L1–L3 L4a proximal to the ligament of Treitz; L4b from the ligament of Treitz to above the distal ileum Lamb et al. 2019; Levine et al. 2011
Behavior, Crohn disease B1 non-stricturing, non-penetrating; B2 stricturing; B3 penetrating; "p" added for perianal disease (abscesses, ulcers or fistulas); skin tags and fissures do not count as perianal disease Stenosing and penetrating disease can both be recorded in the same patient (B2B3) Lamb et al. 2019; Levine et al. 2011
Growth No growth category G1 growth failure at any time; G0 never Levine et al. 2011
Extent, ulcerative colitis E1 proctitis, distal to the rectosigmoid junction; E2 left-sided, distal to the splenic flexure; E3 extensive, proximal to the splenic flexure E4 added for extent proximal to the hepatic flexure Lamb et al. 2019; Levine et al. 2011
Severity, ulcerative colitis S0 clinical remission; S1 mild; S2 moderate; S3 severe S0 never severe; S1 ever severe (PUCAI 65 or more) Lamb et al. 2019; Levine et al. 2011
  • Use of extent in pathology reports. Disease extent can progress or regress after diagnosis, and classification stays at the maximal extent. Endoscopy can underestimate the true extent, particularly in quiescent ulcerative colitis, so extent is confirmed by mapping biopsies (Lamb et al. 2019).

Pediatric and very early onset IBD

  • Pediatric presentation. About 10%–15% of IBD is diagnosed before 18 years of age. Children with untreated ulcerative colitis often have extensive colitis with less severe inflammation, less epithelial injury and less architectural distortion than adults. Crypt architecture can be nearly normal in children with early ulcerative colitis, so preserved architecture does not exclude IBD in this age group. Pediatric Crohn disease involves the ileum less often at onset and often presents as colitis with rectal involvement; focal inflammation that varies between and within biopsies favors Crohn disease (Villanacci et al. 2021a).
  • New-onset ulcerative colitis in children compared with adults. Of 73 children with untreated ulcerative colitis, 21% had patchy chronicity, 23% relative and 3% absolute rectal sparing, and 8% little or no crypt architectural distortion in rectal biopsies. None of these features was seen in 38 adults (Glickman et al. 2004).
  • Pediatric workup. The revised Porto criteria recommend upper GI endoscopy and ileocolonoscopy for every child with suspected IBD (Levine et al. 2014).
  • Age categories. Very early onset IBD (VEO-IBD) is diagnosed before 6 years of age, infantile IBD before 2 years and neonatal IBD within the first 28 days of life (Andrews and Putra 2025).
  • Monogenic IBD. Presumed monogenic causes were found in 7.8% of Canadian children diagnosed before 6 years and in 2.3% of those diagnosed at 6–18 years. Inheritance is most often autosomal recessive (Andrews and Putra 2025).
Gene or disorder Share of monogenic IBD Histologic clues Sources
IL10, IL10RA and IL10RB (IL-10 and IL-10 receptor deficiency) More than 15%, the largest group Crohn-like disease with fistulas, perianal disease and folliculitis; multifocal colonic ulcers and pear-shaped intramural abscesses; no characteristic histologic finding in a systematic review Andrews and Putra 2025; Nambu et al. 2022
XIAP (X-linked inhibitor of apoptosis deficiency) Up to 9% Severe pancolitis with crypt abscesses and epithelial apoptosis; granulomas in 47.1% of reported cases; hemophagocytic lymphohistiocytosis is the leading cause of death Andrews and Putra 2025; Nambu et al. 2022
CYBB and other chronic granulomatous disease genes 9% for CYBB Granulomas in 72.7% of reported cases, more confluent than in Crohn disease; pigment-laden lamina propria macrophages in 54.5%; TNF inhibitors can cause life-threatening infection Andrews and Putra 2025; Nambu et al. 2022
LRBA (with secondary CTLA4 deficiency; IPEX-like) 4% Lymphocytic pattern with surface and crypt intraepithelial lymphocytes, or chronic active colitis; villous blunting in 47.6% of IPEX-like cases Andrews and Putra 2025; Nambu et al. 2022
TTC7A 4% Epithelial apoptosis in 96.7% with neutrophils and depleted lymphocytes; multiple intestinal atresias and combined immunodeficiency Andrews and Putra 2025; Nambu et al. 2022
FOXP3 (IPEX) Eight cases with histologic descriptions in a systematic review Villous blunting in 50%; apoptotic and lymphocytic patterns Nambu et al. 2022; Andrews and Putra 2025
  • Pattern-based approach. VEO-IBD biopsies are grouped into chronic active enteritis, apoptosis or epithelial injury, eosinophil-rich, lymphocytic and granulomatous patterns. Apoptosis out of proportion to inflammation raises the possibility of an immune dysregulation disorder, and lymphocyte or plasma cell depletion raises the possibility of common variable immunodeficiency, severe combined immunodeficiency or X-linked lymphoproliferative disease (Andrews and Putra 2025).
  • Granulomas in young children. Granulomas are not more frequent in very early onset IBD than in older pediatric IBD, and a granuloma in a young child prompts molecular testing for chronic granulomatous disease and XIAP deficiency (Nambu et al. 2022). Laboratory testing for inborn errors of immunity is covered in Laboratory Evaluation of Inborn Errors of Immunity and Secondary Immunodeficiency.

Epidemiology, smoking and susceptibility genes in IBD

  • Prevalence and incidence. The highest reported prevalences are in Europe (ulcerative colitis 505 per 100,000 in Norway; Crohn disease 322 per 100,000 in Germany) and North America (ulcerative colitis 286 per 100,000 in the USA; Crohn disease 319 per 100,000 in Canada). IBD prevalence exceeds 0.3% in North America, Oceania and many European countries. Incidence is stable or falling in most North American and European studies and has risen since 1990 in newly industrialized countries such as Brazil and Taiwan (Ng et al. 2017).
  • Smoking. Current smoking is associated with Crohn disease (odds ratio 1.76) and protects against ulcerative colitis (odds ratio 0.58). Former smoking is associated with ulcerative colitis (odds ratio 1.79) (Mahid et al. 2006).
Gene or finding Data Sources
NOD2 (CARD15), chromosome 16 (IBD1 locus) A frameshift variant (3020insC) predicted to truncate NOD2 is associated with Crohn disease; mutant NOD2 fails to activate NF-κB in response to bacterial lipopolysaccharide Ogura et al. 2001
NOD2 genotype and phenotype R702W, G908R and 1007fs form 32%, 18% and 31% of Crohn disease mutations; 93% of mutations are in the distal third of the gene; none is associated with ulcerative colitis. Half of patients with Crohn disease carry at least one mutation and 17% carry two. Compared with patients without a mutation, those with two mutations had younger onset (16.9 compared with 19.8 years), more stricturing disease (53% compared with 28%) and less colonic involvement (43% compared with 62%) Lesage et al. 2002
IL23R, chromosome 1p31 The uncommon coding variant p.Arg381Gln (rs11209026) strongly protects against Crohn disease; other IL23R variants are associated with Crohn disease and ulcerative colitis Duerr et al. 2006
Genome-wide loci 163 IBD loci, most shared by Crohn disease and ulcerative colitis; overlap with ankylosing spondylitis, psoriasis and susceptibility to mycobacterial infection Jostins et al. 2012

Serologic and fecal markers

  • pANCA. Perinuclear ANCA is found in 60%–70% of ulcerative colitis, 10%–15% of Crohn disease and fewer than 5% of non-IBD colitis (Villanacci et al. 2021a). Atypical pANCA and its antigen are covered in ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System.
  • ASCA. IgG anti-Saccharomyces cerevisiae antibodies are found in 60%–70% of Crohn disease, 10%–15% of ulcerative colitis and fewer than 5% of non-IBD colitis. No single validated serologic antibody exists for the diagnosis of IBD (Villanacci et al. 2021a).
  • Fecal calprotectin. Calprotectin is used to separate IBD from functional bowel disease and to monitor activity, but it is also raised by enteric infection, drugs and neoplasms (Villanacci et al. 2021a). Thresholds are covered in Liver, Kidney and Gastrointestinal Function Tests.
  • Stool culture. Every evaluation for suspected IBD includes a stool culture (Villanacci et al. 2021a).

Complications and associations of IBD: PSC, superimposed infection, toxic megacolon and carcinoma

IBD-Associated Dysplasia: Conventional and Non-Conventional Dysplasia, Reporting and Surveillance

Definition. Dysplasia in inflammatory bowel disease (IBD) is unequivocal neoplastic epithelium confined within the basement membrane in which it arose. It is both a marker of synchronous carcinoma and a precursor of carcinoma, and it is the best predictor of neoplastic progression in colitis (DeRoche et al. 2014; Villanacci et al. 2021). Colitis-associated dysplasia arises only in mucosa affected by chronic inflammation and is often multifocal (Villanacci et al. 2021).

Related page: Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD (diagnosis of ulcerative colitis and Crohn disease, activity indices and PSC-IBD) Related page: Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides (biopsy handling and site labeling) Related page: Colorectal Adenomas, Serrated Polyps and Other Colorectal Polyps (sporadic adenomas, serrated lesions and post-inflammatory polyps) Related page: Colorectal Adenocarcinoma: Histologic Subtypes, Grade, Tumor Budding and the Malignant Polyp (low-grade tubuloglandular adenocarcinoma and other carcinoma subtypes) Related page: Colorectal Cancer Staging, CAP Reporting, Biomarkers and Neoadjuvant Response (staging of colorectal carcinoma) Related page: Cholestatic and Biliary Liver Disease: Primary Biliary Cholangitis, Primary and IgG4-Related Sclerosing Cholangitis, Pediatric Cholestasis, Ductal Plate Malformations and Hepatic Cysts (primary sclerosing cholangitis and the start of colonoscopic surveillance in children with PSC) Related page: Gastric Dysplasia, Gastric Carcinoma, Gastroesophageal Biomarkers and Small Intestinal Adenocarcinoma (small intestinal adenocarcinoma in Crohn disease)

Dysplasia categories: Riddell classification and histologic criteria

Category Histologic criteria Sources
Negative for dysplasia Normal mucosa, quiescent colitis, chronic active colitis and resolving colitis, with no atypia beyond reactive change Riddell et al. 1983; DeRoche et al. 2014
Indefinite for dysplasia Changes that exceed ordinary regeneration but are insufficient for an unequivocal diagnosis: atypia in florid inflammation or ulceration, atypia at crypt bases when the surface cannot be assessed, or processing artifacts; optional subcategories probably negative, unknown and probably positive Riddell et al. 1983; DeRoche et al. 2014
Low-grade dysplasia Enlarged, crowded, hyperchromatic, elongated nuclei confined to the basal half of the cells, with preserved polarity, involving crypts and surface without surface maturation; goblet cells reduced but easily identified DeRoche et al. 2014; Choi 2021
High-grade dysplasia Enlarged, rounder, pleomorphic nuclei with loss of polarity and stratification reaching the apical cytoplasm, and/or architectural complexity (crowded, back-to-back or cribriform glands, villiform surface); mitoses sometimes atypical DeRoche et al. 2014; Choi 2021; Villanacci et al. 2021
  • Origin of the classification. The 1983 classification reserved "dysplasia" for unequivocally neoplastic epithelium that can give rise directly to invasive carcinoma and grouped specimens as negative, indefinite or positive (low-grade or high-grade). It recommended early repeat biopsy for indefinite results, confirmation and either early repeat biopsy or colectomy, depending on other findings, for low-grade dysplasia, and strong consideration of colectomy after confirmed high-grade dysplasia (Riddell et al. 1983).
  • Surface involvement. High-grade dysplasia does not require surface involvement, but atypia limited to crypt bases without surface involvement is usually reported as indefinite for dysplasia or reactive atypia, on the assumption that dysplastic cells do not mature toward the surface (Choi 2021).
  • Abrupt transition. An abrupt transition to a distinct area of glands that lack surface maturation, with mucin depletion and nuclear enlargement, is a key feature of low-grade dysplasia (Villanacci et al. 2021).

Regenerative atypia compared with dysplasia

  • Active colitis. Regenerating epithelium in active colitis loses mucin, but the presence of active inflammation and epithelial damage, with no significant nuclear enlargement, hyperchromasia or pleomorphism, supports a negative interpretation (DeRoche et al. 2014).
  • Resolving colitis. In the resolving phase, crypts can show nuclear enlargement, hyperchromasia, stratification and brisk mitoses without neutrophilic injury. At least partial surface maturation and increased lamina propria inflammatory cells indicate regeneration, and a recent flare is a helpful clinical clue (DeRoche et al. 2014).
  • Maturation. Maturation of nuclei toward the luminal surface is the hallmark of regeneration, whereas dysplasia extends uniformly along the crypt axis and the surface epithelium (Villanacci et al. 2021).
  • Reproducibility. Indefinite for dysplasia has the lowest interobserver agreement, followed by low-grade dysplasia. Agreement is best for negative results and for high-grade dysplasia, which still shows only moderate agreement among gastrointestinal and general pathologists (DeRoche et al. 2014). Among four gastrointestinal pathologists grading 38 ulcerative colitis cases, agreement was fair on digitized images (κ 0.40) and on glass slides (κ 0.43), poorest for indefinite and low-grade dysplasia. Glass-slide review changed the image-based diagnosis in 38% of slides, mostly to a higher grade (Odze et al. 2002).
  • AMACR immunohistochemistry. In 74 IBD specimens, α-methylacyl-CoA racemase (AMACR) was expressed in no focus negative for dysplasia and in 96% of low-grade dysplasia, 80% of high-grade dysplasia and 71% of adenocarcinoma foci. One of 7 indefinite foci was focally positive, and specificity for dysplasia or carcinoma was 100% (Dorer and Odze 2006).
  • Expert review of indefinite for dysplasia. Expert re-review of invisible indefinite for dysplasia lowered the estimated 5-year advanced neoplasia incidence from 21% to 5%. The pooled risk of advanced neoplasia after indefinite for dysplasia (2.4 per 100 person-years) was comparable to that after low-grade dysplasia (2.1 per 100 person-years) (East et al. 2025).

Conventional dysplasia: colitis-associated dysplasia compared with sporadic adenoma

  • Definition. Conventional (intestinal-type) dysplasia has histologic features fundamentally identical to those of sporadic adenomas (Choi 2021).
  • Features favoring colitis-associated origin. A lesion within a segment of colon that is or has been affected by IBD favors colitis-associated dysplasia. Colitis-associated dysplasia can be less well defined than a sporadic adenoma, can contain a mixture of dysplastic and non-dysplastic crypts, and can be accompanied by dysplasia in biopsies of the surrounding mucosa (East et al. 2025).
  • Lesions outside the colitis segment. An adenoma or serrated lesion outside a colitis-affected segment is managed according to sporadic post-polypectomy guidelines. In a St Mark's cohort, the 5-year and 10-year cumulative incidences of carcinoma were 3.2% and 6.5% after a sporadic adenoma and 21.2% and 32.8% after colitis-associated low-grade dysplasia (East et al. 2025). Sporadic adenomas are covered in Colorectal Adenomas, Serrated Polyps and Other Colorectal Polyps.
  • p53 in this distinction. An abnormal p53 pattern may favor IBD-associated low-grade dysplasia over sporadic low-grade dysplasia (East et al. 2025).
  • Historical terms. "Dysplasia-associated lesion or mass" (DALM) was considered an indication for colectomy and was later divided into sporadic adenoma, adenoma-like polypoid dysplasia within colitis and non-adenoma-like dysplasia (DeRoche et al. 2014). The SCENIC consensus of 2015 recommended abandoning the terms "DALM", "adenoma-like" and "non-adenoma-like" (Laine et al. 2015, as summarized by Li and Wang 2022). After SCENIC, polypoid dysplastic lesions in one institution were reported simply as adenoma in 97.1% of cases, compared with 65.0% before (Li and Wang 2022).
  • Polypectomy for adenoma-like lesions. Of 24 patients with ulcerative colitis whose adenoma-like dysplastic lesion was removed by polypectomy, 14 (58%) developed further adenoma-like lesions, 1 (4%) developed an isolated focus of low-grade dysplasia and none developed adenocarcinoma during a mean follow-up of 42.4 months, regardless of location inside or outside the colitis (Engelsgjerd et al. 1999).

Non-conventional dysplasia: classification

Category (Harpaz classification as reproduced in BSG 2025, box 2) Subtypes
Intestinal dysplasia Tubular or villous adenoma-like (conventional) dysplasia; goblet cell-deficient; crypt cell; sessile serrated lesion-like; traditional serrated adenoma-like; serrated not otherwise specified
Gastric dysplasia Tubular or villous adenoma-like; serrated
Mixed dysplasia Mixed intestinal-gastric
Non-dysplastic lesions Sessile serrated lesion without dysplasia; hyperplastic polyp; serrated epithelial change

Source: East et al. 2025.

  • Reporting under BSG 2025. BSG 2025 recommends that pathologists recognize conventional, non-conventional and mixed dysplasia. The report comments on whether the dysplasia is conventional (adenomatous-like) or shows non-conventional features. The Harpaz classification may be referenced, but its use is not mandatory (East et al. 2025).
  • WHO classification. The 5th edition briefly listed seven subtypes of IBD-associated dysplasia: conventional adenoma-like, hypermucinous, sessile serrated lesion-like, traditional serrated adenoma-like, dysplasia with terminal epithelial differentiation, goblet cell-deficient and serrated not otherwise specified (Villanacci et al. 2021). The open summary of the 6th edition does not describe changes to IBD dysplasia subtypes (Arends et al. 2026).
  • Risk as a group. Non-conventional dysplasia appears to carry a similar or higher risk of later advanced colorectal neoplasia than conventional dysplasia (East et al. 2025). At least seven non-conventional subtypes are described; they often present as invisible or flat dysplasia and are more often associated with advanced neoplasia on follow-up (Choi et al. 2022; Choi 2023).
  • Group data. Non-conventional dysplasia was present in 45% of 58 patients with IBD-associated carcinoma and was the only dysplasia in up to 21%. It was associated with advanced neoplasia more often than conventional dysplasia (38% compared with 19%), was more often invisible or flat (41% compared with 18%), and its low-grade forms were aneuploid more often (46%) than low-grade conventional dysplasia (8%) or sporadic adenomas (9%) (Choi 2021).

Non-conventional dysplasia subtypes: morphology and reported risk

Subtype Share of IBD dysplasia and clinical setting Histologic criteria Reported risk and molecular findings Sources
Hypermucinous About 2%; ulcerative colitis 86%; PSC 29%; mean IBD duration 23 years; mostly polypoid, mean 2.1 cm; left colon 57% Tubulovillous or villous architecture lined by tall mucinous cells forming more than 50% of the lesion; atypia decreases toward the surface; high-grade nuclear features in 29% Advanced neoplasia in 57%; KRAS mutation in 61% (low-grade conventional dysplasia 4%); aneuploidy in 80% of low-grade lesions Choi 2021
Crypt cell About 4%; PSC 43%; mean IBD duration 15 years; left colon 79%; exclusively invisible or flat Mildly enlarged, round to oval, crowded, hyperchromatic nuclei limited to the crypt base without surface involvement or significant architectural atypia; increased basal mitoses; no significant neutrophilic inflammation or ulceration High-grade dysplasia or carcinoma in 6 of 7 patients within a mean of 27 months; aneuploidy in all 14 biopsies; strong diffuse p53 in up to 63%; TP53 mutation 43%, KRAS 14% Choi 2021
Dysplasia with increased Paneth cell differentiation 13% of all IBD dysplasia; PSC 9%; polypoid in 70%, mean 1 cm; right colon 45%; male 82% Paneth cell differentiation in at least two contiguous dysplastic crypts in two foci, beyond that of the background mucosa; tubular architecture; goblet cells reduced but present Advanced neoplasia in 15% (conventional 19%); aneuploidy 12%; probably a lower-risk lesion Choi 2021
Goblet cell-deficient About 3%; PSC 14%; invisible or flat in 40%; visible lesions large, mean 1.9 cm; right and left colon equally Complete or near-complete absence of goblet cells with intensely eosinophilic cytoplasm; tubular architecture; eosinophilic luminal secretions; high-grade dysplasia at diagnosis in up to 40% Advanced neoplasia in 40%; aneuploidy 25% of low-grade lesions; TP53 44%, KRAS 22%, PIK3CA 56% Choi 2021
Sessile serrated lesion-like Usually polypoid (serrated dysplasia as a group: mean 1.2 cm); more common in the right colon Distorted serrated crypts with basal dilatation (L-shaped or inverted T-shaped crypts) at the muscularis mucosae Usually lacks aneuploidy Choi 2021
Traditional serrated adenoma-like Usually polypoid; left colon Tubulovillous or villous architecture lined by tall columnar cells with intensely eosinophilic cytoplasm and ectopic crypts Low-grade serrated dysplasia: KRAS mutation in 45% Choi 2021
Serrated not otherwise specified Usually polypoid Serrated architecture forming more than 50% of the lesion without features of the other serrated subtypes Not separately reported Choi 2021
  • Serrated dysplasia as a group. Low-grade serrated dysplasia (often TSA-like) had a 10-year advanced neoplasia rate of 17%, similar to low-grade conventional dysplasia (23%), and prevalent neoplasia in 76% (Choi 2021).
  • Crypt cell atypia. Interobserver agreement for crypt cell dysplasia is poor: pathologists recognized atypia in 83% of readings but classified it as indefinite for dysplasia in 50%, low-grade dysplasia in 13% and high-grade dysplasia in 19%. "Crypt cell atypia" with repeat colonoscopy within 3–6 months has been proposed for uncertain cases (Choi 2021).
  • Mixed lesions. A lesion is classified as a specific hypermucinous or serrated subtype when that component forms more than 50% of it (Choi 2021).
  • PSC-IBD. Dysplasia in PSC-IBD is often invisible and non-conventional, including crypt cell, hypermucinous and goblet cell-deficient types (Andrews and Putra 2025). In 173 patients with PSC-IBD, 31% developed dysplasia, which was often non-conventional (61%), invisible (66%) and right-sided (59%), compared with 25%, 21% and 47% in non-PSC IBD with neoplasia. Crypt cell dysplasia was the commonest non-conventional subtype (30% of lesions), and advanced neoplasia followed in 37% compared with 22% (Zhang et al. 2022).

Serrated epithelial change and serrated lesions in IBD

  • Serrated epithelial change (SEC). SEC is architectural serration without the nuclear changes of dysplasia. It can be difficult to separate from serrated forms of non-conventional dysplasia, and it is unclear whether it is a consequence of longstanding inflammation or a separate risk factor (East et al. 2025).
  • BSG 2025 position. SEC on biopsy without a corresponding mucosal lesion and without dysplasia does not, by itself, lead to more intensive surveillance. SEC with dysplasia, or with hypermucinous or pronounced villiform change, leads to multidisciplinary team (MDT) review and repeat colonoscopy by an expert endoscopist (East et al. 2025).
  • Sessile serrated lesions. Sessile serrated lesions without dysplasia, inside or outside the colitis segment, are managed as sporadic serrated lesions, and uncertainty about dysplasia leads to an expert second opinion. In 6602 patients with IBD and 78 serrated lesions, no patient with a non-dysplastic serrated lesion developed advanced neoplasia in 10 years, and in 198 Dutch patients, sessile serrated lesions without dysplasia did not affect later advanced neoplasia risk (hazard ratio 0.87) (East et al. 2025).
  • DNA content of serrated epithelial change. By DNA flow cytometry, 1 of 10 non-targeted SEC biopsies was aneuploid, and that patient developed high-grade dysplasia within 4 months. The other 9 had normal DNA content without later dysplasia or carcinoma, and all sessile serrated lesions, with or without dysplasia, and all hyperplastic polyps had normal DNA content (Choi et al. 2018).
  • Frequency. The prevalence, distribution and rate of dysplasia of sessile serrated lesions and traditional serrated adenomas in IBD are similar to those of the general population (Villanacci et al. 2021). Low-grade serrated dysplasia had higher rates of advanced (17% within 10 years) and prevalent (76%) neoplasia than serrated lesions without dysplasia (0% and 11%) (Choi 2021).

Visible and invisible dysplasia in IBD: lesion description and colectomy indications

  • Invisible dysplasia. Invisible dysplasia is dysplasia diagnosed in a random biopsy from a site with no corresponding visible lesion at colonoscopy (East et al. 2025). Invisible ("flat") dysplasia detected in random biopsies was historically associated with synchronous adenocarcinoma in 42%–67% of cases (Villanacci et al. 2021), and 50%–67% of colectomies after invisible high-grade dysplasia contained carcinoma (Choi 2021). In a modern cohort, 88% of invisible low-grade dysplasia was detected before 2010 and 12% after the introduction of chromoendoscopy and high-definition imaging (East et al. 2025).
  • Chromoendoscopy yield. In a meta-analysis of 6 studies (1277 patients), chromoendoscopy detected dysplasia in 7% more patients than white-light endoscopy (number needed to treat 14.3), and the proportion of lesions detected by targeted biopsy was 44% higher and the proportion of flat lesions 27% higher with chromoendoscopy (Subramanian et al. 2011).
  • Previous rule, SCENIC 2015. SCENIC divided visible dysplasia into polypoid lesions (2.5 mm or more above the mucosa, pedunculated or sessile) and non-polypoid lesions (superficially elevated less than 2.5 mm, flat or depressed) (Laine et al. 2015, as summarized by Li and Wang 2022). For endoscopically visible and resectable lesions, polypoid or non-polypoid, SCENIC regarded complete endoscopic resection followed by continued surveillance as sufficient treatment (Laine et al. 2015, as summarized by Li and Wang 2022). Invisible dysplasia, particularly high-grade, often led to colectomy, and colectomy was usually recommended for multifocal invisible low-grade dysplasia (Laine et al. 2015, as summarized by Choi 2021).
  • Current rule, BSG 2025: lesion report. A visible dysplastic lesion is reported with its site, morphology by the modified Paris classification of the SCENIC statement, diameter, whether it is clearly delineated, any ulcer, features of submucosal fibrosis or invasion (irregular surface, depression, tethering) and surrounding inflammatory activity (East et al. 2025).
  • Current rule, BSG 2025: resection. Clearly delineated visible lesions without signs of invasion are considered for endoscopic resection; biopsies of the surrounding mucosa are not required unless resection may be incomplete (East et al. 2025).
  • Risk factors for progression. Lesion size above 1 cm, non-polypoid morphology and R1 margins predicted advanced neoplasia or recurrence (East et al. 2025).
  • Indications to discuss colectomy (BSG 2025). Visible dysplasia that cannot be managed endoscopically; invisible dysplasia with high future risk; multifocal dysplasia with high future risk; ineffective or impossible surveillance, such as very severe pseudopolyposis or strictures; and coexisting risk factors such as PSC or uncontrolled inflammation. Confirmed invisible high-grade dysplasia or multifocal invisible low-grade dysplasia makes colectomy the preferred option (East et al. 2025).
  • Synchronous carcinoma at colectomy. Incidental synchronous carcinoma was found in 14% of colectomies for visible high-grade dysplasia, 11% for invisible high-grade dysplasia, 2.7% for visible low-grade dysplasia and 2.4% for invisible low-grade dysplasia in a meta-analysis. A Cleveland Clinic cohort found synchronous carcinoma in 22.2% of colectomies after invisible high-grade dysplasia (East et al. 2025).

Surveillance risk categories and biopsy sampling in IBD: BSG 2025 with the BSG 2010 rule

Pathology reports supply the histologic activity grade, dysplasia status and extent that assign a patient to a BSG 2025 surveillance category.

Category Findings after optimized medical therapy Action
Large calculated 5-year risk (BSG 2025) Severe active inflammation (endoscopic or histologic) Colectomy considered
Moderate 5-year risk (BSG 2025) Moderate active inflammation, dysplasia, PSC or a colonic stricture Annual surveillance
Small 5-year risk (BSG 2025) Mild active inflammation; extensive disease (ulcerative colitis proximal to the splenic flexure, or Crohn colitis involving more than 50% of the colon or three or more segments); post-inflammatory polyps; colorectal carcinoma in a first-degree relative Surveillance every 3 years
Close to population risk (BSG 2025) None of the above risk factors Reassessment every 10 years with population screening
Previous rule, BSG 2010 All patients with disease beyond proctitis were assumed to need indefinite surveillance Lowest-risk group offered colonoscopy every 5 years

Source: East et al. 2025.

  • Start of surveillance. A baseline risk-assessment colonoscopy is offered 8 years after the onset of IBD symptoms. Patients with concurrent PSC, or after liver transplantation for PSC, have annual surveillance from the diagnosis of IBD. Crohn disease not involving the colon proximal to the rectum, isolated small bowel disease and ulcerative colitis endoscopically confirmed as confined to the rectum are not offered surveillance and join population screening. The guideline applies to patients aged 16 years or older (East et al. 2025).
  • PSC surveillance in the AASLD guidance. Colonoscopic surveillance in PSC with IBD begins at age 15 years (Saffioti and Mavroeidis 2024). The liver disease is covered in Cholestatic and Biliary Liver Disease: Primary Biliary Cholangitis, Primary and IgG4-Related Sclerosing Cholangitis, Pediatric Cholestasis, Ductal Plate Malformations and Hepatic Cysts.
  • Rationale for the change. BSG 2025 considers 3 years the appropriate minimum interval for effective surveillance. SCENIC was combined into the 2019 BSG IBD guidance before this update (East et al. 2025).
  • Non-targeted biopsies. Biopsies from each segment and the rectum assess activity and extent. Additional quadrantic mapping biopsies every 10 cm or from each segment are taken in PSC, after dysplasia in the colitis segment within 5 years, before segmental colectomy, in a retained rectum and in the rectal cuff of an ileal pouch (East et al. 2025). The former four-quadrant biopsies every 10 cm were based on an estimate of 33 biopsies for 90% confidence of detecting dysplasia (DeRoche et al. 2014).
  • Site labeling and extent. Quiescent IBD mucosa can look histologically normal, so knowledge of the anatomic site of each biopsy is needed to assess extent (East et al. 2025).
  • Double reporting and MDT. When dysplasia is suspected, a second pathologist, ideally a gastrointestinal specialist, reviews the case. Any dysplasia in the colitis segment, including indefinite for dysplasia, is reviewed at an MDT meeting that includes a pathologist (auditable minimum standard 95%) (East et al. 2025).
  • Follow-up after dysplasia. BSG 2025 assigns short-interval repeat colonoscopy (3–6 months) after high-grade, non-polypoid, multifocal, incompletely resected or invisible dysplasia, and after indefinite for dysplasia confirmed by two gastrointestinal pathologists (East et al. 2025).
  • Progression of low-grade dysplasia. In 668 patients with low-grade dysplasia, progression to high-grade dysplasia was 7.8% at 5 years. PSC, male sex, ulcerative colitis and increasing age were associated with progression (East et al. 2025). An earlier meta-analysis of 20 surveillance studies of flat low-grade dysplasia or dysplasia-associated lesions in ulcerative colitis found a cancer incidence of 14 per 1000 person-years and an advanced-lesion incidence of 30 per 1000 person-years, with a 9-fold risk of cancer (odds ratio 9.0) and a 12-fold risk of any advanced lesion (odds ratio 11.9) (Thomas et al. 2007).

Ancillary tests: p53 immunohistochemistry and DNA content

  • Biology. TP53 mutation is a relatively late event in sporadic colorectal carcinogenesis and an early event in IBD-associated neoplasia, and loss of p53 function and microsatellite instability precede APC loss in colitis-associated carcinoma (East et al. 2025; Villanacci et al. 2021).
  • p53 immunohistochemistry. BSG 2025 states, as expert opinion, that p53 immunohistochemistry may be used as an optional adjunct to separate dysplasia from reactive change. An abnormal pattern, either overexpression or complete absence (null phenotype), supports dysplasia over reactive atypia (East et al. 2025). Dysplastic epithelium stains strongly or not at all ("all or nothing"), although the use of this pattern remains debated (Villanacci et al. 2021). Strong, diffuse p53 staining was reported in up to 63% of crypt cell dysplasia (Choi 2021).
  • Aneuploidy. Chromosomal copy number change is an early feature of IBD carcinogenesis and can be found in non-neoplastic colitic epithelium. Many low-grade dysplastic lesions carry an aneuploidy burden comparable to carcinoma, whereas aneuploidy is a late event in sporadic adenomas. BSG 2025 judges copy number analysis promising for risk stratification but not yet validated for routine practice (East et al. 2025).
  • Exome sequencing of IBD-associated carcinoma. In 31 IBD-associated colorectal carcinomas, TP53 was the most frequently mutated gene (63%), at a rate similar to sporadic carcinoma. APC (13%) and KRAS (20%) mutations were significantly less frequent than in sporadic carcinoma, and SOX9, EP300, NRG1 and IL16 were mutated more often or only in IBD-associated tumors (Robles et al. 2016).
  • Aneuploidy in invisible dysplasia. Aneuploidy was found in 41% of invisible low-grade dysplasia and 93% of invisible high-grade dysplasia, compared with 8% of low-grade conventional dysplasia and 9% of sporadic adenomas. In invisible low-grade dysplasia, aneuploidy was an independent risk factor for later advanced neoplasia (multivariate hazard ratio 4.5) (Choi 2021).

Colitis-associated colorectal carcinoma

  • Risk. The average colorectal carcinoma risk in IBD is about 1.4–1.7 times that of the general population. In ulcerative colitis, risk rises above the population level about 8 years after diagnosis. Ulcerative proctitis (hazard ratio 0.97) and isolated terminal ileal Crohn disease (hazard ratio 1.09) carry no significant excess risk. One PSC cohort estimated a 9% risk of carcinoma or dysplasia in the first 10 years. The cumulative colorectal carcinoma risk in IBD is 0.8% in the first 10 years, 2.2% between 10 and 20 years and 4.5% after 20 years (East et al. 2025).
  • Earlier risk estimates. A 2001 meta-analysis of 116 studies estimated cumulative colorectal carcinoma probabilities in ulcerative colitis of 2% by 10 years, 8% by 20 years and 18% by 30 years of disease (Eaden et al. 2001). In a population-based cohort of 3117 patients, the standardized incidence ratio was 5.7 overall, 1.7 for proctitis, 2.8 for left-sided colitis and 14.8 for pancolitis, and extent and age at diagnosis were independent risk factors (Ekbom et al. 1990).
  • Risk factors. Fixed risk factors are sex, age at IBD diagnosis, family history of colorectal carcinoma, PSC, disease extent and disease duration. The main modifiable risk factor is the severity of inflammation and its complications, including strictures, post-inflammatory polyps and dysplasia (East et al. 2025).
  • Histologic inflammation. In a case-control study of long-standing extensive ulcerative colitis, histologic inflammation (odds ratio 5.1) and colonoscopic inflammation (odds ratio 2.5) scores were associated with colorectal neoplasia on univariate analysis, and only histologic inflammation remained significant on multivariate analysis (odds ratio 4.7) (Rutter et al. 2004).
  • PSC. Ulcerative colitis with PSC carries a higher risk of colorectal neoplasia (odds ratio 4.79) and of carcinoma alone (odds ratio 4.09) than ulcerative colitis without PSC (Soetikno et al. 2002).
  • Backwash ileitis. In 590 proctocolectomies for ulcerative colitis, carcinoma was present in 29.0% of patients with pancolitis and backwash ileitis, 9.0% with pancolitis without backwash ileitis and 1.8% with left-sided colitis (Heuschen et al. 2001).
  • Strictures. The pooled 10-year rate of colonic stricture was 3.2%, and 21.9% of strictures were associated with high-grade dysplasia or carcinoma. A stricture carried an odds ratio of 7.78 for advanced neoplasia in one meta-analysis, but the association was not confirmed in a single-center cohort of 789 patients (East et al. 2025).
  • Gross and microscopic features. Carcinoma in ulcerative colitis is poorly delimited and can resemble an inflammatory stricture, fistula, ulcer or inflammatory polyp. Multifocal carcinoma is present in up to 23%. Mucinous differentiation (53%), tumor heterogeneity (48%) and signet ring features (20%) are more frequent than in sporadic carcinoma, and about 34% are well differentiated (DeRoche et al. 2014). IBD-associated carcinoma arises on average 20 years earlier than sporadic carcinoma, and carcinomas complicating Crohn disease are often found in bypassed or excluded segments (Villanacci et al. 2021).
  • Low-grade tubuloglandular adenocarcinoma. In the WHO 6th edition (2026), the distinctive colorectal low-grade tubuloglandular adenocarcinoma, typically seen in IBD, is included as a new morphological subtype. It is a rare subtype, which may arise from low-grade conventional dysplasia or from non-conventional colitis-associated dysplasia in IBD. Arends et al. list it among the entities newly introduced in the 6th edition (Arends et al. 2026). Its morphology is described in Colorectal Adenocarcinoma: Histologic Subtypes, Grade, Tumor Budding and the Malignant Polyp.
  • Clinical profile. Compared with sporadic carcinoma, IBD-associated carcinoma occurs in younger patients, is more often right-sided and has poorer survival (East et al. 2025).

Dysplasia in the ileal pouch, anal transition zone and retained rectum

  • Pouch neoplasia. Neoplasia after ileal pouch-anal anastomosis includes low-grade dysplasia, high-grade dysplasia, adenocarcinoma and, very rarely, squamous cell carcinoma and lymphoma. The pooled prevalence of dysplasia in the pouch, anal transition zone or rectal cuff was 1.13% in 2040 patients with ulcerative colitis, and the pooled prevalence of pouch adenocarcinoma was 0.5% in 8403 patients (East et al. 2025).
  • Pouch risk factors. Prior colorectal neoplasia is the strongest risk factor (hazard ratio 3.7 after preoperative dysplasia and 24.6 after preoperative carcinoma), and 28 of 49 patients with pouch carcinoma (57.1%) had prior colorectal neoplasia. Less established risk factors are PSC, chronic pouchitis, chronic cuffitis, Crohn disease of the pouch, ulcerative colitis lasting 8 years or more and a first-degree relative with colorectal carcinoma (East et al. 2025).
  • Pouch biopsies. Surveillance pouchoscopy samples the pre-pouch ileum, the body of the pouch and the anal transition zone (rectal cuff), together with any visible lesion (East et al. 2025).
  • Retained rectum. Rectal carcinoma after colectomy occurred in 1.3% overall, more after ileorectal anastomosis (3.2%) than in a defunctionalized rectal stump (0.7%). BSG 2025 suggests annual surveillance of the pouch or retained rectum after surgery for colitis-associated dysplasia or carcinoma (East et al. 2025).

Microscopic, Ischemic, Drug-Induced, Radiation and GVHD Colitis, GI Vasculitis and Neutropenic Enterocolitis

Definition. Microscopic colitis is chronic watery diarrhea with a normal or nearly normal colonoscopy and a defining histologic lesion (Miehlke et al. 2021). Ischemic colitis, radiation injury, drug-induced colitis, colonic graft-versus-host disease (GVHD), vasculitis and phlebitis, and neutropenic enterocolitis are defined by a pattern of mucosal injury together with its clinical setting (Misiakos et al. 2017; Xia and Zhang 2019).

Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (mycophenolate, PD-1 inhibitor and colchicine injury; Kayexalate, sevelamer and cholestyramine crystal morphology; GVHD with Lerner grading; CMV and adenovirus in biopsies) Related page: Esophagitis and Non-Neoplastic Diseases of the Esophagus (CMV and HSV inclusion morphology; pill injury) Related page: Gastritis, Gastropathies and Non-Neoplastic Gastric Polyps (lymphocytic and collagenous gastritis) Related page: ANCA, Anti-GBM and Organ-Specific Autoantibodies: Kidney, Liver, Thyroid, Pancreas and Nervous System (ANCA and other vasculitis serology) Related page: Gram-Positive Bacteria and Anaerobes: Staphylococci, Streptococci, Enterococci, Gram-Positive Rods and Clostridioides difficile (Clostridioides difficile testing) Related page: Gram-Negative Bacteria: Enterobacterales, Nonfermenters, Neisseria, Haemophilus and Fastidious Gram-Negative Rods (Shiga toxin-producing Escherichia coli detection) Related page: Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides (Shiga toxin-producing E. coli colitis morphology; C. difficile pseudomembranous colitis) Related page: Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD (ulcerative colitis, Crohn disease and other IBD mimics) Related page: DIC, Thrombotic Microangiopathy and Viscoelastic Testing (STEC-associated hemolytic uremic syndrome)

Microscopic colitis: UEG/EMCG 2021 histologic criteria

The 2021 United European Gastroenterology and European Microscopic Colitis Group (UEG/EMCG) guideline defines three histologic subtypes: collagenous colitis, lymphocytic colitis and incomplete microscopic colitis. The criteria apply to hematoxylin and eosin (H&E)-stained sections (Miehlke et al. 2021).

Subtype Subepithelial collagen band Surface intraepithelial lymphocytes (IELs) Lamina propria Source
Collagenous colitis Thickened, ≥10 µm Increased Increased inflammatory infiltrate Miehlke et al. 2021, statement 4.2
Lymphocytic colitis Not significantly thickened (<10 µm) ≥20 per 100 surface epithelial cells Increased inflammatory infiltrate Miehlke et al. 2021, statement 4.3
Incomplete collagenous colitis >5 µm and <10 µm Not defining Mild inflammatory infiltrate Miehlke et al. 2021, statement 4.4
Incomplete lymphocytic colitis Normal >10 and <20 per 100 Mild inflammatory infiltrate Miehlke et al. 2021, statement 4.4
  • Collagenous colitis morphology. The band often has an irregular deep edge and may contain entrapped capillaries, red blood cells and inflammatory cells. Focal surface damage includes detachment from the basement membrane, flattening and mucin depletion. The lamina propria infiltrate is mild to moderate and composed mainly of plasma cells and lymphocytes, with eosinophils, mast cells and, less often, neutrophils. Paneth cell metaplasia and occasional cryptitis occur (Miehlke et al. 2021).
  • Lymphocytic colitis morphology. IELs are counted in the surface epithelium, away from lymphoid aggregates. Surface damage (flattening, mucin depletion, vacuolization) is milder than in collagenous colitis. Occasional cryptitis and Paneth cell metaplasia occur (Miehlke et al. 2021).
  • Orientation and stains. Tangential sectioning can simulate a thickened band, so biopsies are oriented vertically. Van Gieson, Masson trichrome or Sirius red stains highlight the band. CD3 immunostaining facilitates IEL counting in borderline cases but may lead to overdiagnosis, and higher cutoffs have been suggested for CD3-stained slides (Miehlke et al. 2021).
  • Incomplete forms. Earlier terms for incomplete microscopic colitis include microscopic colitis not otherwise specified, microscopic colitis type undesignated, borderline lymphocytic colitis and paucicellular lymphocytic colitis (Miehlke et al. 2021).
  • Biopsy sampling. UEG/EMCG recommends ileocolonoscopy with biopsies from at least the right and left colon. Characteristic changes were present on both sides in 95%–98% of patients in series with paired biopsies, and rectal biopsies alone are insufficient. Endoscopic abnormalities, such as linear ulcerations, mucosal lacerations, erythema, edema and abnormal vascular pattern, were reported in 38.8% of patients but are nonspecific (Miehlke et al. 2021, statement 4.1). Separate containers for right and left colon are favored by the guideline pathologists because normal right colon mucosa is more cellular (Miehlke et al. 2021).
  • Course on rebiopsy. In 283 patients, histologic features persisted for up to 1 year in 77% with collagenous colitis, 64% with lymphocytic colitis and 45% with incomplete microscopic colitis, and 6%, 9% and 18% converted to another subtype (Miehlke et al. 2021).
  • Comparative histology. In a blinded comparison of lymphocytic colitis, collagenous colitis, idiopathic IBD, acute colitis and normal colon, increased surface intraepithelial lymphocytes were the most distinctive feature of lymphocytic colitis, with surface epithelial damage, increased lamina propria chronic inflammation and minimal crypt distortion or active cryptitis. Lymphocytic and collagenous colitis were closely similar, and subepithelial collagen thickening was seen only in collagenous colitis. Idiopathic IBD showed prominent crypt distortion, greater active inflammation and few intraepithelial lymphocytes (Lazenby et al. 1989).
  • Microscopic colitis with giant cells. Subepithelial CD68-positive multinucleated giant cells, probably formed by fusion of subepithelial macrophages, accompanied collagenous colitis in 3 patients and lymphocytic colitis in 1, and diarrhea resolved with budesonide (Libbrecht et al. 2002).

Microscopic colitis: drug, celiac and demographic associations

Feature Data Source
Age Median age at diagnosis over 60 years (collagenous 64.9; lymphocytic 62.2) Miehlke et al. 2021
Sex Female sex: pooled OR 2.52 Miehlke et al. 2021, statement 1.5
Smoking Former and especially current smoking increase risk Miehlke et al. 2021, statement 1.4
Proton pump inhibitors OR 2.95 Miehlke et al. 2021, statement 1.7
NSAIDs OR 2.40 Miehlke et al. 2021, statement 1.7
SSRIs OR 2.98 Miehlke et al. 2021, statement 1.7
Celiac disease 3.3% of patients with microscopic colitis versus 0.4% of controls in one prospective study; screening recommended Miehlke et al. 2021, recommendation 4.8
Colorectal neoplasia No increase in the risk of colorectal cancer or adenoma Miehlke et al. 2021, statement 1.9

The drug associations are statistical and do not establish causation (Miehlke et al. 2021, statement 1.7).

Differential diagnosis of microscopic colitis: normal colon, quiescent IBD and checkpoint inhibitor colitis

Finding Normal colon Microscopic colitis Quiescent inflammatory bowel disease (IBD) Immune checkpoint inhibitor colitis
Crypt architecture Straight, parallel, regularly distributed crypts that reach the muscularis mucosae Criteria are defined by the collagen band and surface IELs (criteria table above); Paneth cell metaplasia may occur Crypt atrophy, irregularity and shortening; thickened muscularis mucosae; Paneth cell metaplasia in the left colon or pyloric metaplasia Crypt distortion in some anti-PD-1 or anti-PD-L1 cases
Lamina propria Mononuclear cells that do not noticeably expand it; more cellular, with more eosinophils, in the right colon Increased plasma cells and lymphocytes No active inflammation Dense lymphoplasmacytic expansion
Surface epithelium and collagen band Normal Band ≥10 µm (collagenous) or ≥20 IELs per 100 surface epithelial cells (lymphocytic) Normal band Thickened band in a minority; increased IELs in some
Neutrophils and crypt injury Absent Occasional cryptitis Absent by definition Crypt apoptosis, cryptitis and crypt abscesses
Sources DeRoche et al. 2014; Miehlke et al. 2021; Villanacci et al. 2021b Miehlke et al. 2021 DeRoche et al. 2014 Nishida et al. 2019; Bani et al. 2025

Ischemic colitis: distribution, clinical patterns and causes

  • Mechanism. Most ischemic colitis is nonocclusive and follows a sudden fall in flow through small colonic arterioles in a low-volume state (Misiakos et al. 2017).
  • Watershed areas. The splenic flexure (Griffith point), where the marginal artery of Drummond is tenuous and absent in almost 5% of patients, and the rectosigmoid junction (Sudeck point), distal to the last sigmoid collateral, are the two vulnerable areas. The right colon has less developed vasa recta and is also prone to low-flow ischemia (Misiakos et al. 2017).
  • Anatomic patterns. In 313 biopsy-proven or biopsy-compatible cases with the whole colon visualized, the left colon was involved most often, followed by the right and distal colon. Ischemic colitis was typically segmental, with normal colon on either side (Brandt et al. 2010).
  • Isolated right colon ischemia. Isolated right colon ischemia was associated with coronary artery disease and dialysis-dependent end-stage kidney disease (Brandt et al. 2010).
  • Clinical patterns. The nongangrenous form accounts for 80%–85% of cases, gangrene for about 15% and fulminant pancolitis for about 1% (Misiakos et al. 2017).
  • Depth and outcome. Ischemia limited to the mucosa may resolve completely. Involvement of the muscularis propria may heal with scarring and stricture, and full-thickness ischemia leads to gangrene and perforation (Misiakos et al. 2017).
  • Causes and risk factors. Atherosclerosis, aortic surgery, transient hypotension, hemodialysis, constipation and constipation-inducing drugs, cocaine and methamphetamine, vasculitis, oral contraceptives and estrogens, calcium channel blockers, diuretics, NSAIDs, sickle cell crisis and systemic lupus erythematosus are reported associations (Misiakos et al. 2017). In older patients, ischemic colitis is more often due to vascular disease. In young patients, it is more often associated with cocaine or systemic autoimmune vascular disease, including Behçet disease and systemic lupus erythematosus (Villanacci et al. 2021b).

Ischemic colitis: biopsy and resection morphology

Phase Findings Sources
Acute Lamina propria hemorrhage, erosion, atrophic "micro-crypts" (withered crypts) lined by small cells with eosinophilic cytoplasm and dark nuclei, hyalinization of the lamina propria, full-thickness mucosal necrosis, pseudomembranes; coagulative necrosis and capillary microthrombi in the early stage Dignan and Greenson 1997; Misiakos et al. 2017; Villanacci et al. 2021b
Advanced Loss of surface epithelium, submucosal congestion and inflammation; transmural necrosis in gangrene Misiakos et al. 2017
Healing and chronic Granulation tissue, hemosiderin-laden macrophages in the submucosa, scarring and stricture Misiakos et al. 2017
  • Ischemic versus C. difficile pseudomembranous colitis. In 49 biopsies with pseudomembranes, lamina propria hyalinization was present in 19 of 24 ischemic cases and in no C. difficile case. Atrophic micro-crypts were seen in 18 ischemic and 6 C. difficile cases. Lamina propria hemorrhage, full-thickness mucosal necrosis and diffuse pseudomembranes on every biopsy fragment also favored ischemia. Endoscopically diffuse pseudomembranes favored C. difficile, and an endoscopic mass or polyp occurred only with ischemia (Dignan and Greenson 1997).
  • Chronic ischemia as an IBD mimic. Chronic or recurrent ischemia can produce crypt distortion, Paneth cell metaplasia and chronic active inflammation. Atrophic and regenerative epithelium, hyalinized lamina propria and microthrombi in adjacent mucosa favor ischemia, and the inflammation is mild relative to the epithelial injury (DeRoche et al. 2014).

Ischemic-type injury: vascular causes

Cause Distinguishing findings Sources
Nonocclusive ischemic colitis Watershed or right colon segment; hyalinized lamina propria, atrophic micro-crypts, hemorrhage Brandt et al. 2010; Dignan and Greenson 1997
Polyarteritis nodosa Necrotizing segmental arteritis of medium-sized arteries; transmural ischemia and perforation Ebert et al. 2008
Enterocolic lymphocytic phlebitis Phlebitis of bowel wall and mesenteric veins with sparing of arteries; venous thrombi Ngo and Chang 2007

Shiga toxin-producing E. coli colitis also produces an ischemic-type pattern; its morphology is in Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides.

Radiation colitis and proctitis: acute and chronic injury

Phase Timing Findings Sources
Acute radiation proctitis During pelvic radiotherapy; histologic changes greater at 2 weeks than at 6 weeks Surface epithelial atrophy, acute cryptitis, crypt abscesses, crypt distortion and atrophy, stromal inflammation Hovdenak et al. 2000
Chronic radiation injury Delayed Mucosal and submucosal fibrosis, atypical stromal fibroblasts, foam cells in the lamina propria, dilated capillaries with atypical endothelial cells, atrophic glands with goblet cell depletion, ulcers, thrombosis Sohn et al. 2004; Wang et al. 2025
  • Chronic injury subtypes. In 111 resections for chronic radiation-induced intestinal injury, four histologic clusters were identified: mixed (48.7%), ulcer (18.0%), fibrosis (17.1%) and telangiectasia (16.2%). The ulcer subtype showed deep serosal ulcers with thrombosis (15 of 20) and was associated with recto-intestinal fistula. The telangiectasia subtype showed marked vascular dilatation (13 of 18) and was associated with anemia. The fibrosis subtype showed severe fibrosis and sclerotic collagen and was associated with obstruction (Wang et al. 2025).
  • Early histology and late proctitis. In 70 men treated for prostate cancer, substantial gland (crypt) loss in early biopsies of the anterior rectal wall predicted late clinical proctitis (Campostrini et al. 2020).

GI vasculitis and enterocolic lymphocytic phlebitis

Disorder Vessels Gastrointestinal findings Sources
IgA vasculitis (Henoch-Schönlein purpura) Small capillaries of the lamina propria Lamina propria hemorrhage in all cases, with fibrin deposition, red cell sludging and nuclear debris in 7; acute duodenitis in 12 of 16 duodenal biopsies (3 severe and erosive); acute colitis or proctitis in 9 of 12 colorectal biopsies; leukocytoclastic vasculitis in only 4 biopsies, all in lamina propria capillaries; intussusception in 1 patient Louie et al. 2018
Polyarteritis nodosa Medium-sized arteries; necrotizing, focal and segmental Gastrointestinal involvement in 14%–65%; transmural necrosis with perforation Ebert et al. 2008
Enterocolic lymphocytic phlebitis (mesenteric inflammatory veno-occlusive disease) Veins of bowel wall and mesentery; arteries spared; no systemic vasculitis Lymphocytic, necrotizing or granulomatous phlebitis, myointimal hyperplasia, venous thrombi, acute ischemic changes; usually an acute abdomen; resection usually curative. In 3 patients with ischemic necrosis, lymphocytic phlebitis with thrombi of different ages was composed of mixed T and B lymphocytes. In 7 patients with mesenteric inflammatory veno-occlusive disease, phlebitis was lymphocytic in 4, necrotizing in 2 and lymphocytic and granulomatous in 1, with myointimal hyperplasia in 3; 6 recovered after resection Ngo and Chang 2007; Saraga and Costa 1989; Flaherty et al. 1994
Intestinal Behçet disease Systemic inflammatory disease with oral and genital aphthous ulcers, uveitis and skin lesions Gastrointestinal involvement in 10%–15% of patients with Behçet disease, with localized lesions in the ileocecal region; clinical overlap with Crohn disease, and diagnosis rests on clinical findings without a pathognomonic laboratory test Grigg et al. 2012; Valenti et al. 2017
Lupus enteritis (systemic lupus erythematosus) Gastrointestinal vasculitis diagnosed clinically and by computed tomography The most common cause of acute abdominal pain in hospitalized patients with lupus (17 of 38); jejunum and ileum most often affected and rectum rarely; all patients responded to corticosteroids Lee et al. 2002
Systemic necrotizing vasculitides with gastrointestinal involvement (polyarteritis nodosa, eosinophilic granulomatosis with polyangiitis, granulomatosis with polyangiitis, microscopic polyangiitis) Small and medium-sized vessels In 62 patients, colorectal ulcers were found in 6, but histologic vasculitis in only 3 colon biopsies; 34% had a surgical abdomen and 15% bowel perforation; peritonitis, bowel perforation, ischemia or infarction, and intestinal occlusion were associated with increased mortality Pagnoux et al. 2005
  • IgA vasculitis biopsy findings. Leukocytoclastic vasculitis is uncommon in gastrointestinal biopsies of IgA vasculitis, and the duodenum is the most commonly affected site. The findings can mimic early inflammatory bowel disease; predominant small bowel involvement, especially erosive duodenitis, suggests IgA vasculitis (Louie et al. 2018).
  • Polyarteritis nodosa sampling. Involvement is segmental, so a negative biopsy does not exclude polyarteritis nodosa (Ebert et al. 2008).

Neutropenic enterocolitis (typhlitis)

  • Setting. Neutropenic enterocolitis occurs mainly after chemotherapy for hematologic malignancies and in other neutropenic or immunosuppressed states. It affects an estimated 5% of patients hospitalized for leukemia, lymphoma, aplastic anemia or chemotherapy-treated solid tumors, and symptoms begin 10–14 days after chemotherapy starts (Xia and Zhang 2019).
  • Distribution. The cecum and right colon are involved in nearly all cases. The terminal ileum, transverse and left colon are variably involved, and lesions have not been reported in the appendix or rectum (Xia and Zhang 2019).
  • Histology. Hemorrhagic necrosis, ulceration, marked submucosal and lamina propria edema, congestion and deep mural or transmural necrosis are present. Inflammatory infiltrate is sparse because of neutropenia, even when bacteria or fungal hyphae invade the wall. Apoptotic bodies are not prominent, which separates neutropenic enterocolitis from GVHD, mycophenolate injury and checkpoint inhibitor colitis (Xia and Zhang 2019).

Drug-induced colitis: colon-specific patterns

Agent Colonic pattern Distinguishing data Sources
NSAIDs (colopathy and diaphragm disease) Inflammation, ulceration and short strictures (diaphragms); an ascending colon diaphragm with crypt dropout and focal chronic active colitis in the reported case Diaphragms show submucosal fibrosis with disorganized smooth muscle, vessels, nerves and ganglion cells; a rim ulcer may be present at the edge. In 7 small bowel resections from NSAID users, the spectrum ranged from multiple pathognomonic ileal mucosal diaphragms to broad strictures Jaber et al. 2025; Lang et al. 1988
NSAIDs (IBD mimic) Five reported colitis types: pseudomembranous, eosinophilic, collagenous, de novo colitis and reactivation of ulcerative colitis A medication history related to onset, and response to withdrawal, establish the cause DeRoche et al. 2014
Idelalisib (PI3Kδ inhibitor) Intraepithelial lymphocytosis, crypt apoptosis and neutrophilic cryptitis Colitis in 12 of 14 biopsied patients; diarrhea in 46% of 50 treated patients; resolves after withdrawal; second series in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies Weidner et al. 2015
Anti-CTLA-4 antibodies Dense lymphoplasmacytic lamina propria expansion, increased IELs, crypt apoptosis, cryptitis and crypt abscesses, occasional eosinophilia Basal plasmacytosis, crypt distortion and granulomas absent Nishida et al. 2019
Anti-PD-1 or anti-PD-L1 antibodies Lymphoplasmacytic expansion with active colitis; crypt distortion, apoptosis, ischemic features or collagenous colitis in some Collagenous colitis was 5.2% of checkpoint inhibitor colitis in one center, with cryptitis in 13 of 14 and surface injury in 10 of 14 Nishida et al. 2019; Bani et al. 2025
Mycophenolate mofetil GVHD-like apoptosis (morphology in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies); pancolitis with IBD-like architectural abnormalities in about 40%; abundant crypt apoptotic bodies and prominent lamina propria eosinophils Versus ulcerative colitis: crypt apoptosis and more prominent right colon involvement favor mycophenolate, and rare cases evolve into IBD. Versus GVHD: lamina propria eosinophils >15 per 10 high-power fields (HPF), absent endocrine cell aggregates and absent apoptotic microabscesses favor mycophenolate (sensitivity 76%, specificity 93%) DeRoche et al. 2014; Star et al. 2013
Sodium polystyrene sulfonate (Kayexalate) in sorbitol Necrosis with crystals in uremic patients Colorectal necrosis in 9 of 12 patients (75%) with colorectal specimens Rashid and Hamilton 1997
Alosetron (5-HT3 antagonist for diarrhea-predominant irritable bowel syndrome) Ischemic colitis Ischemic colitis in 0.15% of treated patients compared with 0% with placebo in pooled trials; all 19 trial cases were reversible; post-marketing rate 1.1 per 1000 patient-years Chang et al. 2006
Glutaraldehyde (endoscope disinfectant) Acute proctocolitis within hours of endoscopy Severe proctocolitis less than 6 hours after a normal sigmoidoscopy in 3 patients; biopsies resemble ischemic colitis and cannot establish the cause alone; acute colitis within 24 hours of a normal colonoscopy should be considered iatrogenic West et al. 1995
Sevelamer Chronic mucosal damage, acute inflammation, ulceration, inflammatory polyp, ischemia or necrosis with crystals Crystals in the colon in 11 of 15 cases; background mucosa normal in only 1; crystal colors and shapes in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies Swanson et al. 2013
  • Checkpoint inhibitor colitis biopsy standards. A RAND/UCLA expert panel judged it appropriate to place biopsies directly in 10% formalin, to orient them along the long axis of the crypts, to assess activity on H&E, and to use CMV immunohistochemistry when infection is suspected on H&E. It judged at least three biopsies per segment from at least five segments, including endoscopically normal and inflamed mucosa, appropriate. The panel voted it appropriate to score apoptosis as the number of apoptotic bodies in 10 consecutive crypts, to score withered crypts with apoptosis or necrotic debris, and to grade surface IELs as increased when >20 per 100 colonocytes. Defining apoptosis as more than 3 apoptotic bodies in 10 crypts was rated uncertain (Ma et al. 2022).
  • Checkpoint inhibitor colitis frequency. Checkpoint inhibitor colitis affects about 15% of patients treated with these agents (Ma et al. 2022).
  • Checkpoint inhibitor colitis versus mimics. Increased apoptosis and crypt atrophy or dropout are not typical of infectious colitis. Chronicity features of inflammatory bowel disease are absent. Lymphoplasmacytic expansion of the lamina propria helps separate checkpoint inhibitor colitis from GVHD (Nishida et al. 2019).

Eosinophilic colitis: primary and secondary causes

  • Normal distribution. The normal segmental distribution of lamina propria eosinophils is tabulated in Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides.
  • Primary eosinophilic colitis. The diagnosis is made after exclusion of secondary causes and with the biopsy site taken into account. Peripheral blood eosinophilia is absent by definition; when present, the diagnosis is intestinal involvement by hypereosinophilic syndrome (Villanacci et al. 2021b).
  • Secondary causes. Most adult eosinophilic colitis is drug related, mainly to NSAIDs. Other causes are infections, parasites, IBD, vasculitis, connective tissue disorders, fungal infection, neoplasia, systemic eosinophil and mast cell disorders, and radiation (Villanacci et al. 2021b).
  • Histologic criteria. No widely accepted count threshold exists. Sheets or aggregates of eosinophils in the lamina propria and muscularis mucosae, and eosinophils within crypt epithelium, are highly suggestive. Severe disease can show transmural eosinophilic infiltration with serosal involvement and ascites (Villanacci et al. 2021b).

Colonic graft-versus-host disease: apoptosis thresholds and grading

Farooq component Score 0 Score 1 Score 2
Crypt damage No crypt dropout or ulceration Crypt dropout without ulceration Ulceration
Crypt apoptotic count No apoptosis 1–6 apoptotic bodies per 10 contiguous crypts >6 apoptotic bodies per 10 contiguous crypts

Source: Farooq et al. 2022. The two scores are added for an overall grade of 0–4.

  • Performance. In the development cohort (n = 191), the Farooq grade and the Lerner grade gave similar prognostic stratification for GVHD-related death within 6 months (AUC 0.705 and 0.707). In the external validation cohort (n = 97), only the Lerner grade was associated with GVHD-related death, and the authors did not recommend widespread adoption because of limited reproducibility (Farooq et al. 2022).
  • Pediatric validation. In 101 children, 67% of Lerner grade 1 cases were indeterminate for GVHD by the Farooq grade, agreement between systems was moderate (κ = 0.47), and neither system was associated with GVHD-related death (Alkashash et al. 2025).
  • Apoptosis cutoffs. Published cutoffs include ≥7 crypt apoptotic bodies per 10 contiguous crypts for diagnosis, with ≤6 per 10 crypts classified as indeterminate for GVHD. Any crypt apoptotic bodies were reported in only 20%–25% of normal colon specimens, and fewer than 1 apoptotic body per 10 contiguous crypts was associated with a negative clinical GVHD grade and stage and no steroid treatment in a multicenter round-robin study (Hippe et al. 2023).
  • Mimics. Mycophenolate (Star et al. 2013), idelalisib (Louie et al. 2015) and checkpoint inhibitors (Nishida et al. 2019) produce crypt apoptosis. Lerner grades and upper tract GVHD are covered in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.

Melanosis coli and other colonic pigments

  • Pigment and mechanism. Melanosis (pseudomelanosis) coli is lipofuscin pigment in lamina propria macrophages. Anthraquinone laxatives induce epithelial apoptosis; macrophages carry the apoptotic bodies into the lamina propria, where they become lipofuscin. Human biopsies show increased apoptotic bodies in the surface epithelium and lamina propria (Walker et al. 1988).
  • Laxatives and other causes. In 38 patients with melanosis coli, lipofuscin was present in all and colonic epithelial apoptosis was increased compared with controls. Laxative use was recorded in all 15 patients with constipation but not in most of the remainder, so melanosis coli is a nonspecific marker of increased apoptosis (Byers et al. 1997).
  • Reversibility and distribution. Pseudomelanosis coli is benign and reversible. It was more prevalent in the proximal colon at autopsy (Mohammed et al. 2021).
  • Neoplasms. Carcinomas, adenomas and hyperplastic polyps lack the pigment (Mohammed et al. 2021).
  • Brown bowel syndrome. In gastrointestinal lipofuscinosis (brown bowel syndrome), the pigment accumulates in smooth muscle cells. A mitochondrial origin was proposed, with a central role for vitamin E in maintaining mitochondrial membranes (Foster 1979).
  • Barium granuloma. Barium sulfate forced through a discontinuity in the rectal mucosa during a barium enema forms a granuloma that can produce a mass mistaken for carcinoma (Lewis et al. 1975).
  • Medication crystals. Crystal morphology is tabulated in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.

microscopic colitis classifier (UEG/EMCG 2021)

Diverticular Disease, Mucosal Prolapse and Other Structural Colonic Disorders, Appendicitis, and Non-Neoplastic Anal and Perianal Lesions

Definition. Non-neoplastic structural lesions of the colon, appendix and anorectum are defined by wall structure or mechanical injury. They include colonic diverticula and diverticulitis, the mucosal prolapse spectrum, pneumatosis and pseudolipomatosis, angiodysplasia, acute and granulomatous appendicitis, hemorrhoids, anal fibroepithelial polyps, fistulas, pilonidal disease and retrorectal developmental cysts (Kruis et al. 2022; Abid et al. 2012; Carr 2000).

Related page: Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD (segmental colitis associated with diverticulosis; Crohn disease of the appendix and perianal region) Related page: Colorectal Adenomas, Serrated Polyps and Other Colorectal Polyps (inflammatory, prolapse-type, cap and inflammatory myoglandular polyps; epithelial misplacement in adenomas) Related page: Appendiceal Neoplasms: Mucinous Neoplasms, Pseudomyxoma Peritonei, Goblet Cell Adenocarcinoma and Neuroendocrine Tumors (appendiceal mucinous neoplasms, goblet cell adenocarcinoma, appendiceal neuroendocrine tumors) Related page: Anal Canal Neoplasia, Colorectal Neuroendocrine Tumors and Other Lower GI Tumors (anal canal anatomy for staging, squamous intraepithelial lesions, anal carcinoma including fistula-associated adenocarcinoma) Related page: Cytomorphology of Anal Cytology Samples (anal cytology) Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (Meckel diverticulum and duplication cysts) Related page: Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides (Yersinia and other infections in granulomatous appendicitis) Related page: Von Willebrand Factor Testing and Platelet Function Testing (acquired von Willebrand syndrome in aortic stenosis) Related page: Hirschsprung Disease, Pediatric Dysmotility, Intestinal Atresia and Malrotation, Abdominal Wall Defects, Necrotizing Enterocolitis and Congenital Diarrheal Disorders (pneumatosis in necrotizing enterocolitis)

Colonic diverticular disease and diverticulitis

  • Structure. Colonic diverticula are acquired protrusions of mucosa and submucosa through weak points in the muscular wall (Kruis et al. 2022, statement 2.1). Colonic diverticula are pseudodiverticula (false diverticula) (Kruis et al. 2022).
  • Wall changes. Thickening of the muscularis propria is often present. Altered connective tissue fibers and enteric neuropathy are reported in diverticulosis and diverticular disease (Kruis et al. 2022, statements 2.3–2.5). In 25 sigmoid resections for uncomplicated diverticular disease, the muscle cells showed neither hypertrophy nor hyperplasia by light and electron microscopy. Elastin in the taeniae coli was increased by more than 200%, with distortion of their fascicular pattern, and the circular muscle elastin content was unchanged. Contracture of the taeniae was proposed to cause the concertina-like corrugation of the circular muscle (Whiteway and Morson 1985).
  • Location. Diverticula in Western countries are mostly in the sigmoid colon. In Asian patients they are mostly in the right colon. Right-sided diverticula were traditionally considered congenital true diverticula containing all wall layers, and left-sided diverticula acquired false diverticula; later studies found most or all right-sided diverticula to be false as well. In Western patients with right-sided diverticulitis, misdiagnosis occurred in 38.4% (162 of 422), and 56.8% of misdiagnoses were acute appendicitis (Epifani et al. 2021).
  • Prevalence. Prevalence rises with age, from about 10% before 40 years to more than 70% after 80 years (Piscopo and Ellul 2020).
  • Diverticular bleeding. Diverticulosis is the commonest cause of lower gastrointestinal bleeding in patients older than 60 years (Johnson et al. 2021).
Term Definition Source
Diverticulitis Inflammation beginning in a diverticulum (peridiverticulitis) and spreading to the wall (focal pericolitis) Kruis et al. 2022, statement 2.2
Complicated acute diverticulitis Diverticulitis with perforation, fistula or abscess Kruis et al. 2022
Chronic diverticulitis Recurrent or persistent inflammation with stenosis or fistulas Kruis et al. 2022
Other complications Covert or overt perforation with peritonitis, inflammatory "diverticulitic tumor", hemorrhage Kruis et al. 2022, statement 2.2

Segmental colitis associated with diverticulosis is taught in Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD.

  • Hinchey sequence of perforated diverticulitis. Inflammation around a single diverticulum leads to a pericolic or pelvic abscess. Free perforation of an abscess causes purulent peritonitis, and a free communication between the bowel lumen and the peritoneal cavity causes fecal peritonitis, which carries an extremely high mortality (Hinchey et al. 1978).
  • Polypoid prolapsing mucosal folds. In 8 sigmoid resections for diverticular disease, swollen mucosal folds showed vascular congestion, scanty thrombi, edema, hemorrhage and hemosiderin, and larger leaflike polyps showed crypt elongation, muscle upgrowth from the muscularis mucosae and the changes of mucosal prolapse. Two cases showed diffuse mucosal inflammation resembling IBD near the polyps (Kelly 1991).
  • Carcinoma after diverticulitis. Colorectal cancer was found at colonoscopy in 7.9% of patients after complicated diverticulitis and 1.3% after uncomplicated diverticulitis (Kruis et al. 2022).

Mucosal prolapse, solitary rectal ulcer syndrome and colitis cystica profunda

  • Mucosal prolapse spectrum. Solitary rectal ulcer syndrome (SRUS), colitis cystica profunda and the prolapse-type polyps belong to the mucosal prolapse spectrum (Abid et al. 2012). Polyp forms are taught in Colorectal Adenomas, Serrated Polyps and Other Colorectal Polyps.
  • Histologic criteria. SRUS is defined by fibromuscular obliteration of the lamina propria from splaying of smooth muscle cells and fibrosis, with surface ulceration and crypt distortion and hyperplasia that may produce a polypoid lesion. The muscularis mucosae is thickened and splayed (Abid et al. 2012).
  • Frequency of findings. In 116 patients, fibromuscular obliteration was present in all, surface ulceration in 59%, crypt distortion in 17% and chronic inflammation in 33% (Abid et al. 2012).
  • Endoscopy. Lesions were solitary in 68% and multiple in 28%, ulcerative in 78% and polypoid or nodular in 25% (Abid et al. 2012). Ulcers measure 0.5–4 cm, and most are on the anterior rectal wall within 10 cm of the anal verge (Sadeghi et al. 2019).
  • Mechanism. The most accepted mechanism is chronic ischemic injury from mucosal hypoperfusion. It is associated with paradoxical contraction of the pelvic floor, which leads to mucosal prolapse and pressure necrosis (Abid et al. 2012). The original description proposed prolapse, trauma and ischemia from excessive straining at stool as likely factors, with failure of normal puborectalis behavior possibly involved in some cases (Rutter and Riddell 1975).
  • Colitis cystica profunda. Entrapment of glands in the submucosa beneath SRUS is termed colitis cystica profunda (Sadeghi et al. 2019). Endoscopic ultrasound and cross-sectional imaging show submucosal cystic lesions with an intact muscularis propria (Stirrat et al. 2026).
  • Colitis cystica profunda versus carcinoma. In a systematic review of 92 patients, colitis cystica profunda mimicked colorectal cancer, superficial biopsies reached the submucosa in only 32%, dysplasia was reported in 10% and coexisting invasive adenocarcinoma in 4% (Stirrat et al. 2026). Coexisting adenocarcinoma was also diagnosed on repeat biopsy of an upper rectal mass first biopsied as SRUS (Abid et al. 2012).

Pneumatosis intestinalis and pseudolipomatosis

Feature Pneumatosis intestinalis Mucosal pseudolipomatosis
Location of spaces Submucosa or subserosa of small and large bowel; small bowel commonest (36.4%), then colon and rectum (29.7%) Lamina propria, extending to the muscularis mucosae
Histology Gas cysts lined by histiocytes and multinucleated giant cells; subserosal cysts surrounded by neutrophils, lymphocytes and giant cells in a resected case Optically empty unilocular vacuoles of 10–50 µm, sometimes confluent, with mononuclear cells; crypt contours compressed in one series, although glandular structures are usually preserved
Endoscopy Polypoid cysts that deflate with biopsy Flat or slightly raised whitish-yellow plaques, sometimes confluent and pseudomembrane-like
Cause Primary (15%) or secondary (85%); more than 60 associated conditions Mechanical or chemical injury, including endoscope disinfectants
Sources Perrone et al. 2024; Medgyesy et al. 2020; Bolanaki et al. 2025 Baccouche et al. 2024
  • Pseudolipomatosis versus fat and lymphatics. Mature adipocytes have a peripheral nucleus and defined cell outlines, and lymphatic vessels have an endothelial lining. Both respect crypt architecture, whereas pseudolipomatosis vacuoles compressed and distorted crypts in one series (Baccouche et al. 2024).
  • Pseudolipomatosis cluster. Eight cases in 3 months were traced to an endoscope disinfectant containing hydrogen peroxide and acetic acid (Baccouche et al. 2024).

Angiodysplasia

  • Histology. Angiodysplasia (angioectasia) consists of abnormal, dilated small blood vessels in the mucosa and submucosa (Johnson et al. 2021).
  • Definition and site. Angiodysplasia is a vascular malformation of the gastrointestinal tract, mostly in patients aged 60 years or older. Lesions are usually smaller than 10 mm and are proximal to the hepatic flexure in 80% (Johnson et al. 2021).
  • Pathogenesis. Intermittent obstruction of submucosal venous outflow where vessels pierce the muscularis propria dilates submucosal veins, venules and arterioles, then capillary rings. Loss of precapillary sphincter competence creates small arteriovenous communications, which explain early venous filling at angiography (Johnson et al. 2021). In injected and cleared colons, dilated tortuous submucosal veins were the more prominent change and were often present without a mucosal ectasia. Among 15 right colons resected for carcinoma without bleeding, mucosal ectasias were found in 4 and submucosal ectasias in 8, which supports a degenerative lesion of aging (Boley et al. 1977).
  • Clinical features. In patients older than 60 years, angiodysplasia is the second commonest cause of lower gastrointestinal bleeding, after diverticulosis. Endoscopically, the lesions are flat, cherry-red and 5–10 mm, with ectatic vessels radiating from a central vessel (Johnson et al. 2021).
  • Heyde syndrome. Heyde syndrome is gastrointestinal bleeding from angiodysplasia with aortic stenosis (Johnson et al. 2021). The acquired von Willebrand mechanism and laboratory evaluation are taught in Von Willebrand Factor Testing and Platelet Function Testing.

Acute appendicitis: histologic categories and complications

  • Epidemiology. In United States hospital discharge data, appendicitis incidence peaked at 10–19 years of age (23.3 per 10,000 per year), males were affected 1.4 times as often as females, and the estimated lifetime risk was 8.6% for males and 6.7% for females (Addiss et al. 1990).
  • Defining lesion. Acute appendicitis is a neutrophil-rich inflammation that begins in the mucosa and spreads through the wall to the serosa. Periappendiceal (serosal) inflammation is described in more than half of pediatric acute appendicitis, mostly with moderate to severe inflammation (Fabi et al. 2022).
  • Carr classification. Carr proposed six histologic categories for appendices removed for suspected appendicitis: intraluminal inflammation, acute mucosal inflammation, acute mucosal and submucosal inflammation, suppurative (phlegmonous) appendicitis, gangrenous appendicitis and periappendicitis (Carr 2000).
  • Periappendicitis. Serosal inflammation with absent or mild mucosal inflammation can reflect an extra-appendiceal or systemic process. In three children with multisystem inflammatory syndrome in children (MIS-C) who had appendectomy for suspected appendicitis, inflammation involved the walls of periappendiceal arteries and veins, with none-to-mild mucosal inflammation (Fabi et al. 2022).
  • Pathogenesis. Obstruction is unlikely to be the primary cause in most cases (Carr 2000). Some inflamed appendices lack luminal obstruction by a fecalith (Butler 1981).
  • Perforation. Perforation follows transmural necrosis and relates more to the duration of symptoms before surgery than to a fecalith. In 217 emergency appendectomies, acute appendicitis was present in 160 (74%), and 54 of these were perforated (Butler 1981).
  • Interval appendectomy. All 149 children who had interval appendectomy after nonoperative management of complicated appendicitis had persistent inflammation, 17% had an appendicolith and none had a neoplasm (Fouad et al. 2020).

Granulomatous and infectious appendicitis, Crohn disease, Enterobius, appendiceal diverticula and neurogenic appendicopathy

  • Granulomatous appendicitis in children. Granulomatous appendicitis was found in 0.4% of pediatric appendectomies, and 51% followed perforated appendicitis managed medically before interval appendectomy. Granulomas in interval specimens were mainly serosal, and noninterval specimens more often had mucosal-only granulomas. Special stains for organisms had low yield (Wu et al. 2020). Yersinia in granulomatous appendicitis is taught in Colon Biopsy Evaluation, GI Specimen Handling and Stains, and Acute and Infectious Colitides.
  • Xanthogranulomatous appendicitis. Xanthogranulomatous inflammation is a collection of lipid-laden macrophages admixed with lymphocytes, plasma cells, neutrophils and often multinucleated giant cells, with or without cholesterol clefts. Of 38 reported patients with xanthogranulomatous appendicitis, 16 had interval appendectomy and 13 had surgery for a tumoral lesion of the ileocecal region (Akbulut et al. 2021).
  • Crohn disease and the appendix. In 100 ileocolic resections for stricturing and fistulizing Crohn disease, the appendix was normal in 26% and showed fibrous obliteration in 50%. Only 4 contained epithelioid granulomas. None of 27 patients with granulomatous appendicitis in appendectomy specimens had or developed Crohn disease (Mostyka et al. 2021). Granulomatous appendicitis was seen in 6% of pediatric bowel resections for Crohn disease (Wu et al. 2020).
  • Enterobius vermicularis. Pinworms were found in 20 of 7628 appendectomies (0.26%), 70% in patients younger than 20 years. Histology showed lymphoid follicular hyperplasia in 11, acute appendicitis in 6, gangrene in 1 and a normal appendix in 2. Sections show worms with triangular lateral alae and eggs in the uterus of females (Mohtasebi et al. 2023).
  • Infections of the appendix. Infections of the appendix include adenovirus, cytomegalovirus, Yersinia, Actinomyces, Mycobacterium and Histoplasma species, Enterobius vermicularis, schistosomiasis and Strongyloides stercoralis. Some produce specific histologic findings, and others nonspecific findings that need further evaluation (Lamps 2010).
  • Schistosomiasis. Schistosomal appendicitis was found in 35 of 843 appendectomies (4.2%) in a Nigerian series; 23 had acute appendicitis and 12 had schistosomiasis without active inflammation. Oviposition in the wall was associated with submucosal fibrosis and luminal narrowing, and 6 cases showed active granulomas with tissue eosinophilia (Badmos et al. 2006).
  • Endometriosis. Appendiceal endometriosis was found in 4.1% of women with biopsy-proven endometriosis in one series. Reported series give 2.8% in women with endometriosis and 0.4% in all patients (Gustofson et al. 2006).
  • Appendiceal diverticular disease compared with low-grade appendiceal mucinous neoplasm. In consultation material, 71% of complicated appendiceal diverticula had been diagnosed as low-grade appendiceal mucinous neoplasm (LAMN) by referring pathologists. Diverticular disease retains the lamina propria and regular crypt architecture, with epithelial hyperplasia and no nuclear abnormality along the crypts, and mucosal neuromas were significantly associated with it. Loss of lamina propria, a filiform architecture and hypermucinosis were significantly associated with LAMN, which carries a risk of transcoelomic spread (Lowes et al. 2019).
  • Unusual findings in adults. Unusual findings were present in 3.88% of 1466 adult appendectomies: mucinous neoplasms reported as mucinous cystadenoma or mucocele (1.09%), Enterobius (1.02%), neuroendocrine tumors (0.47%), mucinous adenocarcinoma (0.4%), amebiasis (0.27%), and single cases of lymphoma, endometriosis, actinomycosis and foreign-body granuloma (Yabanoglu et al. 2014). Appendiceal neoplasms are taught in Appendiceal Neoplasms: Mucinous Neoplasms, Pseudomyxoma Peritonei, Goblet Cell Adenocarcinoma and Neuroendocrine Tumors.
  • Neurogenic appendicopathy. Neurogenic appendicopathy is defined by a clinical presentation of acute appendicitis, absence of acute inflammation and S100-positive spindle cells or Schwann cell proliferation. It accounted for 10.4% of appendectomies for suspected appendicitis (range 1.8%–32%) and causes recurrent, longer-lasting pain (Peisl et al. 2021).

Anal canal epithelium: immunophenotype by zone

The anal canal zones (colorectal, transitional and squamous), canal boundaries, anal glands and nodal drainage are taught in Anal Canal Neoplasia, Colorectal Neuroendocrine Tumors and Other Lower GI Tumors.

Zone Immunophenotype Sources
Colorectal zone (proximal anal canal) MUC2-positive and CDX2-positive colorectal cells Muranaka et al. 2018
Anal transitional zone and anal glands SOX2-positive and p63-positive; MUC5AC predominates over MUC5B; the MUC5AC-positive, SOX2-positive, MUC2-negative, CDX2-negative profile, the reverse of colorectal mucosa, helps identify adenocarcinoma arising there Muranaka et al. 2018
Perianal skin SOX2-negative; the anal squamous zone is SOX2-positive Muranaka et al. 2018

Hemorrhoids and hemorrhoidectomy specimens

  • Anal cushions. The anal canal is lined by specialized cushions of submucosal tissue, and hemorrhoids (piles) result from their displacement (Thomson 1975).
  • Anatomy. Internal hemorrhoids arise from the internal hemorrhoidal plexus above the dentate line, and external hemorrhoids from the external plexus below it. The internal plexus is located in the submucosa between the dentate line and the anorectal ring and is covered by transitional columnar epithelium (Margetis 2019).
  • Histology of the anal cushion. The vascular part consists of arteriolar-venular anastomoses, most of which lack a muscular wall (sinusoids). The nonvascular part consists of epithelium, elastic and collagenous connective tissue and the Treitz muscle, whose deterioration is a main factor in cushion prolapse (Margetis 2019).
  • Thrombosis. Sinusoidal congestion, strangulation and inflammation cause stasis, local hypercoagulability and thrombosis. Thrombosis is a rare complication of internal hemorrhoids (Margetis 2019).
  • Incidental findings. Clinically significant incidental findings were present in 72 of 1612 hemorrhoidectomies (4.5%): 7 malignancies, 54 anal intraepithelial neoplasias (high-grade squamous intraepithelial lesion [HSIL] 2.6%, low-grade squamous intraepithelial lesion [LSIL] alone 0.7%) and 11 benign lesions. The finding was a first diagnosis in 72.2% (Navale et al. 2021). A meta-analysis of 48,365 specimens found anal cancer in 0.13% and cancer or anal intraepithelial neoplasia in 1.16% (Men et al. 2024).

Anal fibroepithelial polyps

  • Histology. Anal fibroepithelial polyps consist of myxoid or collagenous stroma covered by squamous epithelium. In 40 polyps, stromal cells with two or more nuclei were present in 80%, and atypical nuclei in 12%, all in large polyps. Mast cells were frequent (Groisman and Polak-Charcon 1998).
  • Immunophenotype. Stromal cells were vimentin-positive and actin-negative, with desmin in 30%. Ultrastructure showed fibroblastic and myofibroblastic differentiation (Groisman and Polak-Charcon 1998).
  • Pathogenesis. Normal anal subepithelial connective tissue contains similar bizarre multinucleated cells and mast cells, which supports a reactive hyperplasia of this layer (Groisman and Polak-Charcon 1998).
  • Pseudoinvasion. Benign squamous epithelium displaced into vessels has been reported in a traumatized anal fibroepithelial polyp (Fellegara and Di Mari 2020).

Anal fistula, abscess and pilonidal disease

  • Cryptoglandular fistula. Cryptoglandular perianal fistulas are the chronic stage of perianal abscesses and typically originate in the anal glands and crypts at the dentate line (Włodarczyk et al. 2024). Parks derived a classification from 400 cases, based on the pathogenesis of the disease and the muscular anatomy of the pelvic floor, with four main types and numerous variations (Parks et al. 1976). The four types, defined by their relation to the sphincters, are intersphincteric, trans-sphincteric, suprasphincteric and extrasphincteric (Teymouri et al. 2025). Carcinoma arising in chronic anorectal fistulas, including in Crohn disease, is taught in Anal Canal Neoplasia, Colorectal Neuroendocrine Tumors and Other Lower GI Tumors.
  • Pilonidal disease. Pilonidal disease is an acquired condition of the gluteal cleft and sacrococcygeal region, with sinus and abscess formation around midline pits that trap hair and debris. Its pathophysiology is an inflammatory foreign-body response to entrapped hair, and granulomas with recurrent drainage formed when hair was retained in the sinus (Nepomuceno et al. 2024).
  • Malignancy in pilonidal disease. Malignant change is rare (estimated incidence 0.1%, fewer than 100 reported cases), occurs mostly in long-standing neglected disease, and is squamous cell carcinoma in 88% (Parpoudi et al. 2015).
  • Differential diagnosis. Retrorectal developmental cysts are often misdiagnosed as supralevator abscess or complex anal fistula, and 9 of 15 patients in one series had undergone 1–9 earlier operations (Baek et al. 2011). Hidradenitis suppurativa and the follicular occlusion tetrad, which includes pilonidal disease, are taught in Follicular Disorders, Alopecia, Nail Unit Pathology and Panniculitis: Rosacea, Folliculitis, Hidradenitis Suppurativa, Scarring and Non-scarring Alopecia, Hair Shaft and Nail Disorders, Septal and Lobular Panniculitis.

Retrorectal developmental cysts

Lesion Lining and wall Distinguishing features Sources
Tailgut cyst (retrorectal cystic hamartoma) Multilocular; ciliated columnar, mucinous columnar, transitional and squamous epithelium, sometimes in one cyst; scattered disorganized smooth muscle bundles without neural plexus Mainly women (female to male about 3:1); inflammation in 50%; infection is the commonest complication; adenocarcinoma, neuroendocrine tumor and sarcoma can arise Hjermstad and Helwig 1988; Malutan et al. 2025; Baek et al. 2011
Epidermoid cyst Squamous epithelium only Squamous cell carcinoma can arise Baek et al. 2011
Dermoid cyst Squamous epithelium with adnexa (sebaceous and sweat glands, hair follicles) Shares squamous lining with epidermoid cyst Baek et al. 2011; Malutan et al. 2025
Rectal duplication cyst Two organized smooth muscle layers with myenteric plexus Attached to the rectum Malutan et al. 2025; Baek et al. 2011
Teratoma Tissues from all three germ layers Higher malignant risk with age and solid components; malignant in 5%–10% of untreated adult cases Baek et al. 2011
  • Other congenital retrorectal lesions. Chordomas, teratomas and anterior sacral meningoceles are the other notable congenital lesions of the retrorectal space (Malutan et al. 2025).
  • Currarino triad. The triad combines a low anorectal malformation (anorectal stenosis or low imperforate anus), an anterior sacral defect and a presacral mass. In 11 patients, the masses were 7 teratomas, 2 meningoceles, 1 dermoid cyst and 1 enteric cyst with a dermoid cyst, and all had a deformed sacrum (Lee et al. 1997). The homeobox gene HLXB9 (MNX1) is the major locus for dominantly inherited sacral agenesis, which with anterior meningocele, presacral teratoma and anorectal anomalies forms the Currarino triad (Ross et al. 1998).
  • Tailgut cyst origin. Tailgut cysts are thought to arise from remnants of the embryonic tailgut, which normally involutes by about the 56th day of gestation (Malutan et al. 2025).
  • Malignancy. One of 53 tailgut cysts contained poorly differentiated adenocarcinoma, and complete excision prevents recurrent draining sinuses and removes the risk of malignant change (Hjermstad and Helwig 1988). A Mayo Clinic series reported malignancy in 13% (Malutan et al. 2025).

Hirschsprung Disease, Pediatric Dysmotility, Intestinal Atresia and Malrotation, Abdominal Wall Defects, Necrotizing Enterocolitis and Congenital Diarrheal Disorders

Definition. Hirschsprung disease (HSCR) is a congenital malformation of the enteric nervous system with absent ganglion cells in the myenteric and submucosal plexuses of the distal intestine, which causes functional obstruction (Rossi et al. 2026).

Related page: Parathyroid Pathology and Multiple Endocrine Neoplasia Syndromes (RET and multiple endocrine neoplasia type 2) Related page: Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies (Meckel diverticulum, duplication cysts and autoimmune enteropathy) Related page: Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD (very early onset inflammatory bowel disease) Related page: Non-Neoplastic Pancreas: Developmental Anomalies, Acute, Chronic, Hereditary and Autoimmune Pancreatitis, Pseudocysts and Non-Neoplastic Cysts, Allograft and Islet Pathology (cystic fibrosis pancreas) Related page: Newborn Screening and Biochemical Genetics: Amino Acid, Organic Acid, Fatty Acid Oxidation, Urea Cycle, Lysosomal and Peroxisomal Disorders (cystic fibrosis newborn screening and sweat chloride) Related page: Cholestatic and Biliary Liver Disease: Primary Biliary Cholangitis, Primary and IgG4-Related Sclerosing Cholangitis, Pediatric Cholestasis, Ductal Plate Malformations and Hepatic Cysts (biliary atresia) Related page: Neuroendocrine, Mesenchymal and Lymphoid Tumors of the Esophagus, Stomach and Small Intestine (gastrointestinal lymphomas, including Burkitt lymphoma) Related page: Diverticular Disease, Mucosal Prolapse and Other Structural Colonic Disorders, Appendicitis, and Non-Neoplastic Anal and Perianal Lesions (pneumatosis intestinalis in adults)

Hirschsprung disease: epidemiology, extent and genetics

Feature Data Sources
Incidence 1.43 (1.37–1.50) per 10,000 live births in ERNICA 2026; 1 in 5000 in ERNICA 2020 Rossi et al. 2026; Kyrklund et al. 2020
Sex Male to female about 4:1 Rossi et al. 2026
Short-segment disease 80% of cases; aganglionosis does not extend beyond the sigmoid colon Karim et al. 2021
Long-segment disease 20% of cases; extends proximal to the sigmoid colon Karim et al. 2021
Total colonic aganglionosis About 5% of cases; extends to at least the ileocecal valve. Aganglionosis extends through the entire colon or into the small intestine in 5%–10% (ERNICA 2026) Karim et al. 2021; Rossi et al. 2026
Isolated versus syndromic About 70% isolated Karim et al. 2021
Inheritance 80%–90% sporadic, mostly short-segment and multifactorial; 10%–20% familial, more often long-segment or total colonic, with autosomal dominant inheritance Karim et al. 2021
RET Damaging coding variants in about 50% of familial and 15%–20% of sporadic cases; HSCR co-occurs with MEN2. In 27 patients, one frameshift and three missense mutations disrupted or altered the RET tyrosine kinase domain. MEN2A mutations had been found in the extracellular cysteine-rich domain Karim et al. 2021; Romeo et al. 1994
Common RET enhancer variant Intron 1 enhancer variant rs2435357 (RET+3) reduces RET expression and increases risk (odds ratio about 5); risk allele in about 60% of European and 80% of Asian cases Karim et al. 2021
EDNRB pathway Rare damaging variants (EDNRB, EDN3, ECE1) in about 5%; homozygous EDNRB and EDN3 variants are more commonly associated with Shah-Waardenburg syndrome (Waardenburg type 4). In a Mennonite kindred, the dosage-sensitive EDNRB W276C variant (chromosome 13q22) carried a 74% risk of HSCR in homozygotes and 21% in heterozygotes Karim et al. 2021; Puffenberger et al. 1994
Other syndromes SOX10 (Shah-Waardenburg syndrome; rarely isolated HSCR); ZEB2 (Mowat-Wilson syndrome, HSCR in about half; not described in isolated HSCR); PHOX2B (congenital central hypoventilation syndrome, with HSCR in 15%–20%); KIAA1279 (Goldberg-Shprintzen syndrome, HSCR in 64%) Karim et al. 2021
Down syndrome Up to 10% of HSCR cases; 50- to 100-fold increased risk Karim et al. 2021

Rectal suction biopsy for Hirschsprung disease: ERNICA 2026 recommendations

The updated European Reference Network for rare Inherited and Congenital Digestive and Gastrointestinal Anomalies (ERNICA) guideline (Rossi et al. 2026) revised the diagnosis section. The previous rule is the 2020 ERNICA guideline (Kyrklund et al. 2020).

Topic ERNICA 2026 ERNICA 2020 (previous rule)
Basis of diagnosis Representative rectal histology, confirmed before pull-through surgery Unchanged
Biopsy method Rectal suction biopsy and open biopsy equally accurate with enough submucosa; least invasive feasible method Unchanged
Biopsy site Posterior and/or lateral rectal wall at least 2 cm proximal to the dentate line or 3 cm from the anal orifice, with representative submucosa Unchanged
Number of samples At least one representative sample; 2–3 suction biopsies advisable Unchanged
Ganglion cells on H&E Any number of ganglion cells on H&E excludes HSCR Unchanged
No ganglion cells seen Further histologic evaluation is required before HSCR is confirmed Additional histologic evaluation should be considered
Ancillary stain H&E combined with calretinin is recommended, especially in premature infants with small ganglion cells Calretinin and/or peripherin to identify ganglion cells, particularly in premature infants
Findings in HSCR Acetylcholinesterase (AChE) activity increased; calretinin immunohistochemistry negative Unchanged
  • ERNICA 2026: calretinin and AChE patterns. Calretinin offers higher specificity than other stains. In HSCR, AChE marks extrinsic cholinergic nerves, mostly in the mucosa, and calretinin is negative except within 1–2 cm of the transition zone (Rossi et al. 2026).
  • ERNICA 2020: biopsy site and adequacy. Biopsies are taken at least 2 cm above the dentate line to avoid the physiologic aganglionic or hypoganglionic zone of the distal rectum. The International Working Group of 2009 advocated a specimen at least 3 mm in diameter with at least one-third submucosa. AChE false negatives are related to age, and absence of an AChE reaction does not reliably exclude HSCR in very young neonates (Kyrklund et al. 2020).
  • Clinical triad (both editions). The classic triad is delayed passage of meconium (>24 hours in a term infant), abdominal distension and bilious vomiting (Rossi et al. 2026; Kyrklund et al. 2020).

Histologic diagnosis of Hirschsprung disease on rectal biopsies

  • Role of H&E. For an experienced pathologist, H&E sections often suffice to exclude or establish HSCR, and AChE histochemistry and calretinin immunohistochemistry are complementary ancillary tests (Ambartsumyan et al. 2020).
  • Diagnostic H&E features. An aganglionic suction biopsy with hypertrophic, tortuous submucosal nerves ≥40 µm in transverse diameter is diagnostic of HSCR. More than two hypertrophic submucosal nerves increase diagnostic confidence. Normal submucosal nerves in infants and young children measure 10–30 µm. Suction biopsies may lack nerve hypertrophy in total colonic aganglionosis and Down syndrome (Monforte et al. 2025).
  • Sampling. The suction device is placed about 2–3 cm from the dentate line, beyond the normally hypoganglionic zone. Transitional-type mucosa indicates a sample from the normally hypoganglionic zone. Two biopsies from distinct levels reduce inconclusive results. An adequate biopsy has colorectal-type mucosa and submucosa at least as deep as the mucosa is thick, usually 300–500 µm and ideally 1 mm (Monforte et al. 2025).
  • Calretinin pattern. Calretinin highlights lamina propria nerve fibers and most submucosal ganglion cell classes. Absent lamina propria calretinin staining is diagnostically useful when internal controls are positive; mast cells provide a built-in positive control (Monforte et al. 2025).
  • Hirschsprung-associated enterocolitis. Inflammatory changes in a rectal suction biopsy raise Hirschsprung-associated enterocolitis, which is graded and reported promptly to the clinical team (Monforte et al. 2025). Hirschsprung-associated enterocolitis is the leading cause of serious morbidity and death in HSCR, and the American Pediatric Surgical Association guideline grades it from clinical history, physical examination and radiographic findings (Gosain et al. 2017).
  • Ultrashort-segment disease. Ultrashort-segment HSCR describes an aganglionic or hypoganglionic distal 1–2 cm (up to 4 cm in some references), with abnormal calretinin, choline transporter or AChE patterns, in a constipated patient (Monforte et al. 2025).
  • Calretinin pattern in ganglionated and aganglionic biopsies. In ganglionated suction biopsies, small nerves in the lamina propria, muscularis mucosae and superficial submucosa show granular calretinin immunoreactivity, which is completely absent in aganglionic biopsies. Five blinded observers reviewed biopsies from 14 patients with HSCR and 17 controls. Calretinin produced no misdiagnoses or major interobserver discrepancies. AChE produced 2 misdiagnoses and significantly more interobserver disagreement (Kapur et al. 2009).
  • Calretinin versus AChE. Read by pathology residents, calretinin had a sensitivity of 80.0% and specificity of 100% (AUC 0.87), compared with 74.5% and 65.4% (AUC 0.59) for AChE with H&E. Interobserver agreement was substantial with calretinin (κ 0.72) and fair with AChE (κ 0.34) (Beltman et al. 2022).

Intraoperative frozen sections, the transition zone and the pull-through specimen

All four intraoperative recommendations below have the same wording in ERNICA 2026 and ERNICA 2020 (Rossi et al. 2026; Kyrklund et al. 2020).

Topic Recommendation Sources
Frozen sections Fresh frozen sections are valid for confirming normal ganglionated bowel; single samples may miss asymmetric extension of the transition zone Rossi et al. 2026; Kyrklund et al. 2020
Level of transection At least 5–10 cm proximal to the first normal biopsy, to avoid a transition zone pull-through Rossi et al. 2026; Kyrklund et al. 2020
Doughnut A circumferential doughnut biopsy from the transection level allows four-quadrant assessment Rossi et al. 2026; Kyrklund et al. 2020
Specimen The resected specimen is sent in full, marked oral to anal Rossi et al. 2026; Kyrklund et al. 2020
  • Transition zone histology. Common definitions of the transition zone include partial circumferential aganglionosis, myenteric hypoganglionosis and submucosal nerve hypertrophy (Tomuschat et al. 2022). A doughnut margin with aganglionic or hypoganglionic appearance over at least one-eighth (45°) of the circumference meets a formal transition zone threshold (Monforte et al. 2025).
  • Transition zone length. In 50 children with rectosigmoid HSCR, the mean transition zone length was 2.6 cm (range 0–10 cm) and the mean aganglionic length 8.9 cm (range 1–30 cm). Five patients had a transition zone longer than 5 cm (Tomuschat et al. 2022).
  • Frozen section features of the transition zone. Rare ganglion cells (1–2 per ganglion), hypertrophic or tortuous nerves and a myenteric zone with little neuropil indicate suboptimal innervation at a proposed pull-through level (Monforte et al. 2025).
  • Persistent symptoms after pull-through. Review of the proximal margin histology of the original resection and repeat rectal biopsies to confirm normal innervation of the pulled-through bowel are recommended, and redo surgery is considered for a transition zone pull-through (Rossi et al. 2026; Kyrklund et al. 2020).

Pediatric dysmotility: the London classification, intestinal neuronal dysplasia and visceral myopathy

  • London classification. The 2009 International Working Group classification of gastrointestinal neuromuscular pathology (the London classification) is based on defined histologic criteria for suction rectal biopsies and full-thickness tissue (Knowles et al. 2010). Its three main groups are neuropathies, myopathies and abnormalities of interstitial cells of Cajal (enteric mesenchymopathy). The most common neuropathies are absent neurons, decreased or increased neuron numbers and degenerative neuropathy (Popivanov et al. 2026).
  • Weak causal inference. The London classification authors state that morphologic abnormalities provide weak evidence of pathogenesis and may not be causally related to the clinical disorder (Popivanov et al. 2026).
Disorder Histologic definition or finding Comment Sources
Hypoganglionosis Rare ganglion cells (1–2 per ganglion) in the submucosal or myenteric plexus Found in 61% of idiopathic megacolon in an earlier analysis cited by Popivanov et al. 2026 Monforte et al. 2025; Popivanov et al. 2026
Immature ganglion cells Small, immature ganglion cells in neonates and premature infants Difficult to identify on H&E; a reason for calretinin in the ERNICA recommendation Rossi et al. 2026
Intestinal neuronal dysplasia type B 15%–20% giant submucosal ganglia (>8 neurons per ganglion) in 30 sections, in patients older than 1 year Controversial; inconsistent criteria and methods prevent universal acceptance; ganglia with >20 nerve cells indicate ganglioneuromatosis of MEN2B (Parathyroid Pathology and Multiple Endocrine Neoplasia Syndromes) Kapur and Reyes-Mugica 2019; Popivanov et al. 2026
ACTG2 visceral myopathy Nonspecific findings in 13 of 16 patients; hyalinized smooth muscle cytoplasmic inclusions in 3 Normal intestinal histology does not exclude the diagnosis; molecular testing is indicated Kapur et al. 2022
Megacystis-microcolon-intestinal hypoperistalsis syndrome Failure of enteric and bladder smooth muscle Heterozygous ACTG2 missense variants in 15 unrelated subjects, 10 apparently de novo; the same variants segregated with intestinal pseudo-obstruction in families Wangler et al. 2014
  • Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). MNGIE is an autosomal recessive mitochondrial disorder with ophthalmoparesis, peripheral neuropathy, leukoencephalopathy and gastrointestinal dysmotility, with multiple mitochondrial DNA deletions in skeletal muscle in 4 of 8 patients (Hirano et al. 1994). It is caused by loss-of-function mutations in the thymidine phosphorylase gene (TYMP, chromosome 22q13.32-qter), and leukocyte thymidine phosphorylase activity is below 5% of control values (Nishino et al. 1999).
  • Clinical features of MMIHS. Megacystis-microcolon-intestinal hypoperistalsis syndrome presents with prenatal bladder enlargement and neonatal functional intestinal obstruction, with dependence on parenteral nutrition and urinary catheterization (Wangler et al. 2014).

Intestinal atresia and malrotation

  • Duodenal atresia and stenosis. Of 103 infants and children with duodenal atresia (79) or stenosis (24), 31 had Down syndrome, 46 were premature and 33 had maternal hydramnios (Grosfeld and Rescorla 1993).
  • Jejunoileal atresia. Jejunoileal atresia occurs in 1 in 5000 to 1 in 14,000 live births. About 33% of affected infants are premature, and fewer than 10% have extra-abdominal anomalies, which is attributed to late localized intrauterine vascular compromise (Goodluck et al. 2022).
Grosfeld type Morphology Sources
I Intact bowel wall with a transluminal septum; proximal dilatation and collapsed distal bowel Ludwig et al. 2022
II Two blind-ending pouches connected by a fibrous band along the edge of an intact mesentery; the band shows a partially intact muscularis propria with fibrous luminal obliteration, calcification and granulation tissue, suggesting intrauterine ischemia Ludwig et al. 2022
IIIa As type II, with a small mesenteric defect Ludwig et al. 2022
IIIb (apple peel) Proximal jejunal atresia with an extensive mesenteric defect, loss of the superior mesenteric artery distal to the middle colic branch and coiling of the ileum around the ileocolic artery Ludwig et al. 2022
IV Multiple atresias ("string of sausages") Ludwig et al. 2022
  • Cystic fibrosis association. In 50 infants with jejunoileal atresia, cystic fibrosis was confirmed in 8%, although only 36% were tested. Other series report about 10% (Siersma et al. 2012). About 8%–11% of children with ileal atresia have cystic fibrosis (Donos et al. 2024). Newborn screening is taught in Newborn Screening and Biochemical Genetics: Amino Acid, Organic Acid, Fatty Acid Oxidation, Urea Cycle, Lysosomal and Peroxisomal Disorders. Multiple intestinal atresias with combined immunodeficiency (TTC7A) are taught in Ulcerative Colitis, Crohn Disease, IBD-Unclassified and IBD Mimics: Diagnosis, Activity and Pediatric IBD.
  • Normal rotation. During midgut herniation into the umbilical cord, the small intestine rotates 270° counterclockwise around the superior mesenteric artery axis (Martin and Shaw-Smith 2010).
  • Malrotation. The cited incidence of intestinal malrotation is 0.2% (1 in 500). Malrotation occurs with heterozygous FOXF1 variants (with alveolar capillary dysplasia), with chromosomal imbalances and in familial forms with midgut volvulus. Malrotation is a feature of heterotaxy syndromes, and FOXF1-related malrotation shares features with them (Martin and Shaw-Smith 2010).
  • Ladd bands. In malrotation, the duodenojejunal junction is most often in the right upper quadrant and the cecum in the mid or upper abdomen, fixed by adhesive bands (Ladd bands) to the duodenum, gallbladder and right abdominal wall; the narrow mesenteric base predisposes to midgut volvulus (Ludwig et al. 2022).

Omphalocele and gastroschisis

Feature Gastroschisis Omphalocele Sources
Defect Right paraumbilical full-thickness defect about 2–3 cm Midline defect with viscera in a membranous sac Popovski et al. 2026
Covering None; bowel floats in amniotic fluid Membranous sac; liver may herniate Popovski et al. 2026
Bowel pathology Wall thickening, edema and an inflammatory peel from amniotic fluid exposure; complex forms with atresia, necrosis, perforation or volvulus (11%–28%; atresia in 10%–15%) Determined by associated anomalies Popovski et al. 2026
Proposed mechanism Involution or thrombosis of the right umbilical vein; early involution of the right omphalomesenteric artery Disrupted midline fusion of the lateral body folds; failure of physiologic midgut herniation to return to the abdomen Popovski et al. 2026
Associations Usually isolated; chromosomal abnormalities rare; young maternal age (<20 years) Trisomies 13, 18 and 21; Beckwith-Wiedemann spectrum; pentalogy of Cantrell Popovski et al. 2026
Prevalence About 1 in 2000–4000 About 1 in 3000–5000 Popovski et al. 2026
  • Physiologic midgut herniation. Physiologic herniation of the midgut into the umbilical cord is normal in the first trimester (Popovski et al. 2026).
  • Body stalk anomaly. Body stalk anomaly is a large, uniformly lethal thoracoabdominal wall defect with severe spinal deformity and an absent or very short umbilical cord (Popovski et al. 2026).

Necrotizing enterocolitis and focal intestinal perforation

  • Histology. Necrotizing enterocolitis (NEC) shows ischemic (coagulative) necrosis, often full thickness, with inflammation and pneumatosis. Focal (spontaneous) intestinal perforation (FIP) shows less inflammation and necrosis and more hemorrhagic ischemia and submucosal atrophy (Berrington and Embleton 2021).
  • Timing. In 174 episodes of NEC or FIP in preterm infants, 42% occurred before 14 days of age. Before 14 days, 59% of laparotomies were for FIP. On or after 14 days, 91% were for NEC (Berrington and Embleton 2021).
  • Radiology. Unequivocal pneumatosis was more common in NEC presenting after 14 days (Berrington and Embleton 2021). Pneumatosis intestinalis, gas produced by bacteria in the submucosa or subserosa, is seen radiographically in 70%–80% of affected infants (Lee and Polin 2003).
  • Risk factors. Prematurity is the only consistently identified risk factor (Walsh and Kliegman 1986; Lee and Polin 2003). Incidence varies inversely with birthweight and gestational age. Infants under 1000 g and under 28 weeks are most susceptible, and the risk persists until a postconceptional age of at least 36 weeks. More than 95% of affected infants received milk feedings before onset. In term infants, NEC presents at a median of 2 days (Lee and Polin 2003).
  • Dysbiosis. Before NEC onset, the fecal microbiome of preterm infants shows increased relative abundance of Proteobacteria and decreased Firmicutes and Bacteroidetes (Pammi et al. 2017).
  • Outcome. Between 27% and 63% of affected infants need surgery, and strictures, mainly colonic, occur in up to 39% (Lee and Polin 2003).
Modified Bell stage Classification Intestinal signs Radiologic signs
IA Suspected NEC Increased pregavage residuals, mild abdominal distension, emesis, guaiac-positive stool Normal or intestinal dilation, mild ileus
IB Suspected NEC Bright-red blood from the rectum As IA
IIA Proven NEC, mildly ill As above, with absent bowel sounds, with or without abdominal tenderness Intestinal dilation, ileus, pneumatosis intestinalis
IIB Proven NEC, moderately ill (mild metabolic acidosis and mild thrombocytopenia) As IIA, plus definite abdominal tenderness, with or without abdominal cellulitis or right lower quadrant mass As IIA, plus portal vein gas, with or without ascites
IIIA Advanced NEC, severely ill, bowel intact (as IIB, plus hypotension, bradycardia, severe apnea, combined respiratory and metabolic acidosis, DIC, neutropenia) As IIB, plus generalized peritonitis, marked tenderness and distension As IIB, plus definite ascites
IIIB Advanced NEC, severely ill, bowel perforated As IIIA As IIB, plus pneumoperitoneum

Source: Lee and Polin 2003 (modified from Walsh and Kliegman 1986). Stage I systemic signs are temperature instability, apnea, bradycardia and lethargy.

Histologic feature within 72 hours Early NEC (n = 16) Late NEC (n = 24) Early FIP (n = 24)
Pneumatosis 19% 38% 0%
Inflammation 88% 70% 17%
Any necrosis 94% 92% 42%
Full-thickness necrosis 75% 67% 38%
Ischemic (coagulative) necrosis 75% 64% 25%
Hemorrhagic ischemia 25% 33% 67%
Submucosal atrophy 6% 4% 21%

Source: Berrington and Embleton 2021.

Meconium ileus, meconium peritonitis and intussusception

  • Meconium ileus. Meconium ileus is mechanical small bowel obstruction in the perinatal period caused by inspissated meconium in the terminal ileum. It occurs in 12%–20% of neonates with cystic fibrosis and is usually the first manifestation (Donos et al. 2024).
  • Complicated meconium ileus. Complicated meconium ileus includes atresia, prenatal volvulus with gangrene or perforation, meconium cyst and meconium peritonitis. Early prenatal perforation can leave only calcifications after birth. About 40% of meconium ileus was complicated in one cited study (Donos et al. 2024).
  • Distal intestinal obstruction syndrome (DIOS). DIOS is complete or incomplete obstruction of the terminal ileum and proximal colon by viscid fecal material in cystic fibrosis, with 5–12 episodes per 1000 children per year. It occurs mainly with pancreatic insufficiency, a history of meconium ileus or previous DIOS (Colombo et al. 2011).
  • Fibrosing colonopathy. In a case-control study of 29 children with cystic fibrosis and fibrosing colonopathy requiring colectomy and 105 controls, the adjusted relative risk was 10.9 with 24,001–50,000 units of lipase per kilogram per day and 199.5 above 50,000 units, compared with 0–24,000 units (FitzSimmons et al. 1997).
  • Meconium plug syndrome. Meconium plug syndrome is colonic obstruction by thick inspissated meconium, and meconium ileus is the small bowel counterpart. Both raise suspicion of cystic fibrosis or Hirschsprung disease (Rook et al. 2025).
  • Meconium peritonitis. Meconium peritonitis is a sterile chemical peritonitis from intrauterine bowel perforation, with an incidence of about 1 in 30,000. Dense adhesions with scattered calcifications were found at surgery in reported cases (Wang et al. 2018).
  • Primary intussusception. More than 95% of pediatric intussusception is primary, usually between 6 months and 2 years of age, with a male to female ratio of about 2–3:1. Lymphoid hyperplasia of Peyer patches and mesenteric nodes in the ileocecal region, often after adenovirus, rotavirus or norovirus infection, is the main pathologic factor (Gao et al. 2026).
  • Pathologic lead points. In 65 children with intussusception due to a pathologic lead point (mean age 4.9 years), lead points were Meckel diverticulum (32), intestinal duplication (14), benign polyps (5), malignant lymphoma (4), Peutz-Jeghers syndrome (3), mesenteric cyst (3), intramural hematoma in hemophilia (2), IgA vasculitis (1) and hamartoma (1). Fifty-one of the 65 had recurrent intussusception before surgical reduction (Lin et al. 2017). Meckel diverticulum and duplication cysts are taught in Small Intestinal Mucosal Disease: Celiac Disease and Its Mimics, Infections, Drug Injury and Immune Enteropathies.

Congenital diarrheal disorders: microvillus inclusion disease, tufting enteropathy and enteroendocrine dysgenesis

Disorder Genes Light microscopy Special stains and IHC Electron microscopy Sources
Microvillus inclusion disease MYO5B in most; STX3; STXBP2 (with familial hemophagocytic lymphohistiocytosis type 5); UNC45A in a microvillus inclusion disease-like syndrome Severe villous atrophy, mild to moderate crypt hyperplasia, normal IEL count PAS shows absent brush border with apical PAS-positive inclusions; CD10 and villin show irregular apical staining. Villin shows brush border loss and outlines the microvillus inclusions clearly Short or absent microvilli and microvillus inclusions in mature enterocytes Arienzo et al. 2025; Shillingford et al. 2015
Congenital tufting enteropathy EPCAM (more than 70%); SPINT2 in a syndromic form with punctate keratitis and choanal atresia Villous blunting, crypt hyperplasia, increased crypt mitoses, basement membrane irregularity without inflammation; epithelial tufts of crowded cells with apical nuclei Loss of EpCAM (MOC31) staining with EPCAM variants; normal staining with SPINT2 variants Tufts and longer, more numerous desmosomes Arienzo et al. 2025; Martin et al. 2014
Enteroendocrine cell dysgenesis NEUROG3 Variable villous atrophy with minimal inflammation Chromogranin shows absent enteroendocrine cells in small intestine or colon; autoimmune enteropathy can also be chromogranin-negative but shows loss of goblet and Paneth cells Normal brush border; no microvillus inclusions Arienzo et al. 2025; Martin et al. 2014
  • Gene discovery. Mutations in MYO5B, which encodes the myosin Vb motor protein, cause microvillus inclusion disease. Mislocalization of the transferrin receptor suggests defective apical and basolateral protein trafficking (Müller et al. 2008). A splice-site mutation in EPCAM (chromosome 2p21) reduces EpCAM expression in congenital tufting enteropathy (Sivagnanam et al. 2008). In 3 patients with NEUROG3 loss-of-function mutations, chromogranin A-positive enteroendocrine cells were few, and Paneth, goblet and absorptive cells were normal in number (Wang et al. 2006).
  • Trichohepatoenteric syndrome. Syndromic diarrhea (trichohepatoenteric syndrome) combines intractable diarrhea with woolly hair and is caused by mutations in TTC37 or SKIV2L, both cofactors of the RNA exosome Ski complex (Fabre et al. 2012).
  • Clinical onset. Microvillus inclusion disease causes secretory diarrhea from the first days of life or within 2–3 months, and up to one-third of patients develop cholestasis. NEUROG3 deficiency may also cause insulin-dependent diabetes (Arienzo et al. 2025).
  • Immunohistochemical panel. In 26 children with intractable diarrhea, CD10 showed diffuse cytoplasmic inclusions in microvillus inclusion disease, EpCAM was lost in tufting enteropathy, and chromogranin was absent in a patient with a NEUROG3 variant. A panel of CD10, EpCAM and chromogranin was recommended because morphology may be subtle (Martin et al. 2014).
  • Villin. In 6 patients with microvillus inclusion disease confirmed by electron microscopy, villin showed attenuation or loss of the brush border and outlined the inclusions, whereas PAS and CD10 also stained other cytoplasmic structures that obscured them (Shillingford et al. 2015). In a separate series, villin staining was heterogeneous with nonspecific cytoplasmic reactivity (Martin et al. 2014).

References

  1. Abid S, Khawaja A, Bhimani SA, et al. The clinical, endoscopic and histological spectrum of the solitary rectal ulcer syndrome: a single-center experience of 116 cases. BMC Gastroenterol. 2012;12:72. doi:10.1186/1471-230X-12-72. PMID 22697798
  2. Addasi Y, Nguyen AH, Sabri A, et al. Gastrointestinal mucormycosis: a clinical review. Gastroenterology Res. 2023;16(5):249–253. doi:10.14740/gr1662. PMID 37937225
  3. Addiss DG, Shaffer N, Fowler BS, et al. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol. 1990;132(5):910–925. doi:10.1093/oxfordjournals.aje.a115734. PMID 2239906
  4. Akbulut S, Demyati K, Koc C, et al. Xanthogranulomatous appendicitis: a comprehensive literature review. World J Gastrointest Surg. 2021;13(1):76–86. doi:10.4240/wjgs.v13.i1.76. PMID 33552395
  5. Akiyama S, Miyatani Y, Rubin DT. The evolving understanding of histology as an endpoint in ulcerative colitis. Intest Res. 2024;22(4):389–396. doi:10.5217/ir.2023.00120. PMID 38475998
  6. Alkashash A, Bhamidipalli S, Wilkins BJ, et al. Validation of a recently proposed histologic grading system (the Farooq grade) for colonic graft-versus-host disease in the pediatric population. Pediatr Dev Pathol. 2025;28(4):253–263. doi:10.1177/10935266251330159. PMID 40183303
  7. Allison MC, Hamilton-Dutoit SJ, Dhillon AP, Pounder RE. The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med. 1987;65(248):985–995. PMID 3455554
  8. Ambartsumyan L, Smith C, Kapur RP. Diagnosis of Hirschsprung disease. Pediatr Dev Pathol. 2020;23(1):8–22. doi:10.1177/1093526619892351. PMID 31791203
  9. Andrews AR, Putra J. Special considerations in pediatric inflammatory bowel disease pathology. Diagnostics (Basel). 2025;15(7):831. doi:10.3390/diagnostics15070831. PMID 40218181
  10. Arends MJ, Esposito I, Gill AJ, et al. Changes in the 6th edition of the World Health Organization classification of tumours of the digestive system. Histopathology. 2026;88(7):1295–1314. doi:10.1111/his.70116. PMID 41724188
  11. Arienzo F, Giovannoni I, Diamanti A, et al. Paediatric congenital enteropathies: clinical and histological review. Diagnostics (Basel). 2025;15(8):946. doi:10.3390/diagnostics15080946. PMID 40310351
  12. Arnold CA, Limketkai BN, Illei PB, et al. Syphilitic and lymphogranuloma venereum (LGV) proctocolitis: clues to a frequently missed diagnosis. Am J Surg Pathol. 2013;37(1):38–46. doi:10.1097/PAS.0b013e31826a523e. PMID 23095509
  13. Baccouche C, Ayari M, Abdelaali I, et al. Endoscope disinfectant-induced colonic pseudolipomatosis: case series of a rare condition. Future Sci OA. 2024;10(1):FSO985. doi:10.2144/fsoa-2023-0210. PMID 38869427
  14. Badmos KB, Komolafe AO, Rotimi O. Schistosomiasis presenting as acute appendicitis. East Afr Med J. 2006;83(10):528–532. doi:10.4314/eamj.v83i10.9464. PMID 17310677
  15. Baek SW, Kang HJ, Yoon JY, et al. Clinical study and review of articles (Korean) about retrorectal developmental cysts in adults. J Korean Soc Coloproctol. 2011;27(6):303–314. doi:10.3393/jksc.2011.27.6.303. PMID 22259746
  16. Bani MA, Dartigues P, Soufan R, et al. Collagenous colitis in patients treated for cancer: role of immune checkpoint inhibitors. Clinical, histological and immunological features in 15 cases. Histopathology. 2025;87(4):514–525. doi:10.1111/his.15530. PMID 40769948
  17. Beltman L, Windster JD, Roelofs JJTH, et al. Diagnostic accuracy of calretinin and acetylcholinesterase staining of rectal suction biopsies in Hirschsprung disease examined by unexperienced pathologists. Virchows Arch. 2022;481(2):245–252. doi:10.1007/s00428-022-03334-3. PMID 35513609
  18. Berrington JE, Embleton ND. Time of onset of necrotizing enterocolitis and focal perforation in preterm infants: impact on clinical, surgical, and histological features. Front Pediatr. 2021;9:724280. doi:10.3389/fped.2021.724280. PMID 34540772
  19. Bolanaki H, Tzimagiorgis I, Mitsala A, et al. Different aspects of pneumatosis intestinalis. Cureus. 2025;17(11):e97041. doi:10.7759/cureus.97041. PMID 41416340
  20. Boley SJ, Sammartano R, Adams A, et al. On the nature and etiology of vascular ectasias of the colon. Degenerative lesions of aging. Gastroenterology. 1977;72(4 Pt 1):650–660. PMID 300063
  21. Brandt LJ, Feuerstadt P, Blaszka MC. Anatomic patterns, patient characteristics, and clinical outcomes in ischemic colitis: a study of 313 cases supported by histology. Am J Gastroenterol. 2010;105(10):2245–2252. doi:10.1038/ajg.2010.217. PMID 20531399
  22. Butler C. Surgical pathology of acute appendicitis. Hum Pathol. 1981;12(10):870–878. doi:10.1016/s0046-8177(81)80190-6. PMID 7298048
  23. Byers RJ, Marsh P, Parkinson D, Haboubi NY. Melanosis coli is associated with an increase in colonic epithelial apoptosis and not with laxative use. Histopathology. 1997;30(2):160–164. doi:10.1046/j.1365-2559.1997.d01-574.x. PMID 9067741
  24. Campostrini F, Remo A, Astati L, et al. Association between acute histopathological changes of rectal walls and late radiation proctitis following radiotherapy for prostate cancer. Strahlenther Onkol. 2020;196(7):617–627. doi:10.1007/s00066-020-01590-3. PMID 32166451
  25. Carr NJ. The pathology of acute appendicitis. Ann Diagn Pathol. 2000;4(1):46–58. doi:10.1016/s1092-9134(00)90011-x. PMID 10684382
  26. Chang L, Chey WD, Harris L, et al. Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data. Am J Gastroenterol. 2006;101(5):1069–1079. doi:10.1111/j.1572-0241.2006.00459.x. PMID 16606352
  27. Choi WT, Kővári BP, Lauwers GY. The significance of flat/invisible dysplasia and nonconventional dysplastic subtypes in inflammatory bowel disease: a review of their morphologic, clinicopathologic, and molecular characteristics. Adv Anat Pathol. 2022;29(1):15–24. doi:10.1097/PAP.0000000000000316. PMID 34469911
  28. Choi WT, Wen KW, Rabinovitch PS, et al. DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas. Histopathology. 2018;73(3):464–472. doi:10.1111/his.13652. PMID 29772067
  29. Choi WT. Characteristics, reporting, and potential clinical significance of nonconventional dysplasia in inflammatory bowel disease. Surg Pathol Clin. 2023;16(4):687–702. doi:10.1016/j.path.2023.05.006. PMID 37863560
  30. Choi WT. Non-conventional dysplastic subtypes in inflammatory bowel disease: a review of their diagnostic characteristics and potential clinical implications. J Pathol Transl Med. 2021;55(2):83–93. doi:10.4132/jptm.2021.02.17. PMID 33677953
  31. Colombo C, Ellemunter H, Houwen R, et al. Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients. J Cyst Fibros. 2011;10(Suppl 2):S24–S28. doi:10.1016/S1569-1993(11)60005-2. PMID 21658638
  32. de la Monte SM, Hutchins GM. Follicular proctocolitis and neuromatous hyperplasia with lymphogranuloma venereum. Hum Pathol. 1985;16(10):1025–1032. doi:10.1016/s0046-8177(85)80280-x. PMID 4043951
  33. De Matos V, Russo PA, Cohen AB, et al. Frequency and clinical correlations of granulomas in children with Crohn disease. J Pediatr Gastroenterol Nutr. 2008;46(4):392–398. doi:10.1097/MPG.0b013e31812e95e1. PMID 18367950
  34. DeRoche TC, Xiao SY, Liu X. Histological evaluation in ulcerative colitis. Gastroenterol Rep (Oxf). 2014;2(3):178–192. doi:10.1093/gastro/gou031. PMID 24942757
  35. Dignan CR, Greenson JK. Can ischemic colitis be differentiated from C difficile colitis in biopsy specimens? Am J Surg Pathol. 1997;21(6):706–710. doi:10.1097/00000478-199706000-00011. PMID 9199649
  36. Donos MA, Ghiga G, Trandafir LM, et al. Diagnosis and management of simple and complicated meconium ileus in cystic fibrosis, a systematic review. Diagnostics (Basel). 2024;14(11):1179. doi:10.3390/diagnostics14111179. PMID 38893705
  37. Dorer R, Odze RD. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease. Am J Surg Pathol. 2006;30(7):871–877. doi:10.1097/01.pas.0000213268.30468.b4. PMID 16819330
  38. Driman DK, Preiksaitis HG. Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol. 1998;29(9):972–978. doi:10.1016/s0046-8177(98)90203-9. PMID 9744314
  39. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006;314(5804):1461–1463. doi:10.1126/science.1135245. PMID 17068223
  40. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–535. doi:10.1136/gut.48.4.526. PMID 11247898
  41. East JE, Gordon M, Nigam GB, et al. British Society of Gastroenterology guidelines on colorectal surveillance in inflammatory bowel disease. Gut. 2026;75(3):e335023. doi:10.1136/gutjnl-2025-335023. PMID 40306978
  42. Ebert EC, Hagspiel KD, Nagar M, Schlesinger N. Gastrointestinal involvement in polyarteritis nodosa. Clin Gastroenterol Hepatol. 2008;6(9):960–966. doi:10.1016/j.cgh.2008.04.004. PMID 18585977
  43. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med. 1990;323(18):1228–1233. doi:10.1056/NEJM199011013231802. PMID 2215606
  44. Ekeng BE, Itam-Eyo AE, Osaigbovo II, et al. Gastrointestinal histoplasmosis: a descriptive review, 2001–2021. Life (Basel). 2023;13(3):689. doi:10.3390/life13030689. PMID 36983844
  45. Engelsgjerd M, Farraye FA, Odze RD. Polypectomy may be adequate treatment for adenoma-like dysplastic lesions in chronic ulcerative colitis. Gastroenterology. 1999;117(6):1288–1294. doi:10.1016/s0016-5085(99)70278-7. PMID 10579969
  46. Epifani AG, Cassini D, Cirocchi R, et al. Right sided diverticulitis in western countries: a review. World J Gastrointest Surg. 2021;13(12):1721–1735. doi:10.4240/wjgs.v13.i12.1721. PMID 35070076
  47. Fabi M, Vasuri F, Guida F, et al. Case report: histological findings of peri-appendicitis in three children with SARS-CoV-2-related multisystem inflammatory syndrome: a mark for systemic inflammation? Front Pediatr. 2022;10:975940. doi:10.3389/fped.2022.975940. PMID 36467465
  48. Fabre A, Charroux B, Martinez-Vinson C, et al. SKIV2L mutations cause syndromic diarrhea, or trichohepatoenteric syndrome. Am J Hum Genet. 2012;90(4):689–692. doi:10.1016/j.ajhg.2012.02.009. PMID 22444670
  49. Farooq A, González IA, Byrnes K, et al. Multi-institutional development and validation of a novel histologic grading system for colonic graft-versus-host disease. Mod Pathol. 2022;35(9):1254–1261. doi:10.1038/s41379-022-01065-z. PMID 35365769
  50. Fellegara G, Di Mari N. Anal fibroepithelial polyp with epithelial vascular pseudoinvasion. Int J Surg Pathol. 2020;28(7):764–767. doi:10.1177/1066896920925919. PMID 32434434
  51. FitzSimmons SC, Burkhart GA, Borowitz D, et al. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med. 1997;336(18):1283–1289. doi:10.1056/NEJM199705013361803. PMID 9113931
  52. Flaherty MJ, Lie JT, Haggitt RC. Mesenteric inflammatory veno-occlusive disease. A seldom recognized cause of intestinal ischemia. Am J Surg Pathol. 1994;18(8):779–784. doi:10.1097/00000478-199408000-00003. PMID 8037291
  53. Foster CS. The brown bowel syndrome: a possible smooth muscle mitochondrial myopathy? Histopathology. 1979;3(1):1–17. doi:10.1111/j.1365-2559.1979.tb02977.x. PMID 372082
  54. Fouad D, Kauffman JD, Chandler NM. Pathology findings following interval appendectomy: should it stay or go? J Pediatr Surg. 2020;55(4):737–741. doi:10.1016/j.jpedsurg.2019.05.001. PMID 31130351
  55. Fu Y, Liu X, Xu J, et al. A combination of pathological features identifies Crohn's disease in surgical bowel resection specimens. Int J Surg Pathol. 2024;32(4):738–747. doi:10.1177/10668969231195028. PMID 37715659
  56. Gao D, Xu Q, Cong N, et al. Research progress on the association between lymphoid hyperplasia and intussusception in the terminal ileum of children. Front Pediatr. 2026;14:1813286. doi:10.3389/fped.2026.1813286. PMID 42317654
  57. Gao YH, Yu M, Wang LN, et al. A retrospective case series of amebic colitis clinical features at a tertiary hospital in Beijing from 2021 to 2024. BMC Infect Dis. 2025;25(1):1527. doi:10.1186/s12879-025-11920-4. PMID 41204402
  58. Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut. 2000;47(3):404–409. doi:10.1136/gut.47.3.404. PMID 10940279
  59. Glickman JN, Bousvaros A, Farraye FA, et al. Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings. Am J Surg Pathol. 2004;28(2):190–197. doi:10.1097/00000478-200402000-00006. PMID 15043308
  60. Goodluck G, Gnanamuttupulle M, Sadiq A, et al. Jejunoileal atresia in a newborn: our experience from northern Tanzania and literature review. Clin Med Insights Pediatr. 2022;16:11795565221075313. doi:10.1177/11795565221075313. PMID 35221742
  61. Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung-associated enterocolitis. Pediatr Surg Int. 2017;33(5):517–521. doi:10.1007/s00383-017-4065-8. PMID 28154902
  62. Greenson JK, Stern RA, Carpenter SL, Barnett JL. The clinical significance of focal active colitis. Hum Pathol. 1997;28(6):729–733. doi:10.1016/s0046-8177(97)90183-0. PMID 9191008
  63. Grigg EL, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal Behçet disease. Gastroenterol Hepatol (N Y). 2012;8(2):103–112. PMID 22485077
  64. Groisman GM, Polak-Charcon S. Fibroepithelial polyps of the anus: a histologic, immunohistochemical, and ultrastructural study, including comparison with the normal anal subepithelial layer. Am J Surg Pathol. 1998;22(1):70–76. doi:10.1097/00000478-199801000-00009. PMID 9422318
  65. Grosfeld JL, Rescorla FJ. Duodenal atresia and stenosis: reassessment of treatment and outcome based on antenatal diagnosis, pathologic variance, and long-term follow-up. World J Surg. 1993;17(3):301–309. doi:10.1007/BF01658696. PMID 8337875
  66. Gustofson RL, Kim N, Liu S, et al. Endometriosis and the appendix: a case series and comprehensive review of the literature. Fertil Steril. 2006;86(2):298–303. doi:10.1016/j.fertnstert.2005.12.076. PMID 16828481
  67. Hall R, Patel K, Poullis A, et al. Separating infectious proctitis from inflammatory bowel disease: a common clinical conundrum. Microorganisms. 2024;12(12):2395. doi:10.3390/microorganisms12122395. PMID 39770599
  68. Harig JM, Soergel KH, Komorowski RA, et al. Treatment of diversion colitis with short-chain-fatty acid irrigation. N Engl J Med. 1989;320(1):23–28. doi:10.1056/NEJM198901053200105. PMID 2909876
  69. Heuschen UA, Hinz U, Allemeyer EH, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120(4):841–847. doi:10.1053/gast.2001.22434. PMID 11231938
  70. Hinchey EJ, Schaal PG, Richards GK. Treatment of perforated diverticular disease of the colon. Adv Surg. 1978;12:85–109. PMID 735943
  71. Hippe K, Kreft A, Reu-Hofer S, et al. Round-Robin test for the histological diagnosis of acute colonic graft-versus-host disease validating established histological criteria and grading systems. Virchows Arch. 2023;483(1):47–58. doi:10.1007/s00428-023-03544-3. PMID 37165134
  72. Hirano M, Silvestri G, Blake DM, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology. 1994;44(4):721–727. doi:10.1212/wnl.44.4.721. PMID 8164833
  73. Hjermstad BM, Helwig EB. Tailgut cysts: report of 53 cases. Am J Clin Pathol. 1988;89(2):139–147. doi:10.1093/ajcp/89.2.139. PMID 3277378
  74. Högenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355(23):2418–2426. doi:10.1056/NEJMoa054765. PMID 17151365
  75. Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48(4):1111–1117. doi:10.1016/s0360-3016(00)00744-6. PMID 11072170
  76. Jaber H, Elias F, Al Souky N, et al. Colonic diaphragm disease induced by chronic non-steroidal anti-inflammatory drug (NSAID)-use requiring multiple endoscopic interventions: a case report. Cureus. 2025;17(6):e85621. doi:10.7759/cureus.85621. PMID 40636650
  77. Jauregui-Amezaga A, Geerits A, Das Y, et al. A simplified Geboes score for ulcerative colitis. J Crohns Colitis. 2017;11(3):305–313. doi:10.1093/ecco-jcc/jjw154. PMID 27571771
  78. Johnson AM, Chovwen PE, Akpan EJ, et al. Aortic valve stenosis, a precipitating factor of recurrent bleed in colonic angiodysplasia: a literature review. Cureus. 2021;13(6):e15903. doi:10.7759/cureus.15903. PMID 34322347
  79. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012;491(7422):119–124. doi:10.1038/nature11582. PMID 23128233
  80. Jucan AE, Gavrilescu O, Dranga M, et al. Evaluation of disease activity in inflammatory bowel disease: diagnostic tools in the assessment of histological healing. Biomedicines. 2023;11(11):3090. doi:10.3390/biomedicines11113090. PMID 38002090
  81. Kambham N, Vij R, Cartwright CA, et al. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004;28(3):365–373. doi:10.1097/00000478-200403000-00009. PMID 15104299
  82. Kapur RP, Goldstein AM, Loeff DS, et al. Intestinal pathology in patients with pathogenic ACTG2-variant visceral myopathy: 16 patients from 12 families and review of the literature. Pediatr Dev Pathol. 2022;25(6):581–597. doi:10.1177/10935266221107449. PMID 35695198
  83. Kapur RP, Reed RC, Finn LS, et al. Calretinin immunohistochemistry versus acetylcholinesterase histochemistry in the evaluation of suction rectal biopsies for Hirschsprung disease. Pediatr Dev Pathol. 2009;12(1):6–15. doi:10.2350/08-02-0424.1. PMID 18442301
  84. Kapur RP, Reyes-Mugica M. Intestinal neuronal dysplasia type B: an updated review of a problematic diagnosis. Arch Pathol Lab Med. 2019;143(2):235–243. doi:10.5858/arpa.2017-0524-RA. PMID 30088780
  85. Karim A, Tang CS, Tam PK. The emerging genetic landscape of Hirschsprung disease and its potential clinical applications. Front Pediatr. 2021;9:638093. doi:10.3389/fped.2021.638093. PMID 34422713
  86. Kariv R, Plesec TP, Gaffney K, et al. Pyloric gland metaplasia and pouchitis in patients with ileal pouch-anal anastomoses. Aliment Pharmacol Ther. 2010;31(8):862–873. doi:10.1111/j.1365-2036.2010.04249.x. PMID 20121720
  87. Kelly J, Oryshak A, Wenetsek M, et al. The colonic pathology of Escherichia coli O157:H7 infection. Am J Surg Pathol. 1990;14(1):87–92. doi:10.1097/00000478-199001000-00010. PMID 2403759
  88. Kelly JK. Polypoid prolapsing mucosal folds in diverticular disease. Am J Surg Pathol. 1991;15(9):871–878. doi:10.1097/00000478-199109000-00007. PMID 1951844
  89. Knowles CH, De Giorgio R, Kapur RP, et al. The London Classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut. 2010;59(7):882–887. doi:10.1136/gut.2009.200444. PMID 20581236
  90. Kruis W, Germer CT, Böhm S, et al. German guideline diverticular disease/diverticulitis: Part I: Methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and classification. United European Gastroenterol J. 2022;10(9):923–939. doi:10.1002/ueg2.12309. PMID 36411504
  91. Kucharzik T, Taylor S, Allocca M, et al. ECCO-ESGAR-ESP-IBUS guideline on diagnostics and monitoring of patients with inflammatory bowel disease: part 1. J Crohns Colitis. 2025;19(7):jjaf106. doi:10.1093/ecco-jcc/jjaf106. PMID 40741688
  92. Kumar NB, Nostrant TT, Appelman HD. The histopathologic spectrum of acute self-limited colitis (acute infectious-type colitis). Am J Surg Pathol. 1982;6(6):523–529. doi:10.1097/00000478-198209000-00004. PMID 7149092
  93. Kyrklund K, Sloots CEJ, de Blaauw I, et al. ERNICA guidelines for the management of rectosigmoid Hirschsprung's disease. Orphanet J Rare Dis. 2020;15(1):164. doi:10.1186/s13023-020-01362-3. PMID 32586397
  94. Laine L, Kaltenbach T, Barkun A, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology. 2015;148(3):639–651.e28. doi:10.1053/j.gastro.2015.01.031. PMID 25702852
  95. Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut. 2019;68(Suppl 3):s1–s106. doi:10.1136/gutjnl-2019-318484. PMID 31562236
  96. Lamps LW, Madhusudhan KT, Greenson JK, et al. The role of Yersinia enterocolitica and Yersinia pseudotuberculosis in granulomatous appendicitis: a histologic and molecular study. Am J Surg Pathol. 2001;25(4):508–515. doi:10.1097/00000478-200104000-00011. PMID 11257626
  97. Lamps LW. Infectious causes of appendicitis. Infect Dis Clin North Am. 2010;24(4):995–1018. doi:10.1016/j.idc.2010.07.012. PMID 20937462
  98. Lang J, Price AB, Levi AJ, et al. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988;41(5):516–526. doi:10.1136/jcp.41.5.516. PMID 3384981
  99. Lazenby AJ, Yardley JH, Giardiello FM, et al. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol. 1989;20(1):18–28. doi:10.1016/0046-8177(89)90198-6. PMID 2912870
  100. Lee CK, Ahn MS, Lee EY, et al. Acute abdominal pain in systemic lupus erythematosus: focus on lupus enteritis (gastrointestinal vasculitis). Ann Rheum Dis. 2002;61(6):547–550. doi:10.1136/ard.61.6.547. PMID 12006332
  101. Lee JS, Polin RA. Treatment and prevention of necrotizing enterocolitis. Semin Neonatol. 2003;8(6):449–459. doi:10.1016/S1084-2756(03)00123-4. PMID 15001117
  102. Lee SC, Chun YS, Jung SE, et al. Currarino triad: anorectal malformation, sacral bony abnormality, and presacral mass—a review of 11 cases. J Pediatr Surg. 1997;32(1):58–61. doi:10.1016/s0022-3468(97)90094-4. PMID 9021570
  103. Lesage S, Zouali H, Cézard JP, et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002;70(4):845–857. doi:10.1086/339432. PMID 11875755
  104. Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17(6):1314–1321. doi:10.1002/ibd.21493. PMID 21560194
  105. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58(6):795–806. doi:10.1097/MPG.0000000000000239. PMID 24231644
  106. Lewis JW, Kerstein MD, Koss N. Barium granuloma of the rectum: an uncommon complication of barium enema. Ann Surg. 1975;181(4):418–423. doi:10.1097/00000658-197504000-00009. PMID 1130860
  107. Li X, Zhang K, Lu J, et al. Clinical, endoscopic, and histopathological features distinguishing amebic colitis from ulcerative colitis in a male cohort: a single-center retrospective study. Infect Drug Resist. 2026;19:643571. doi:10.2147/IDR.S643571. PMID 42974491
  108. Li Y, Wang HL. Influence of SCENIC recommendations on terminology used for histopathologic diagnosis of inflammatory bowel disease-associated dysplasia. World J Gastrointest Oncol. 2022;14(8):1375–1387. doi:10.4251/wjgo.v14.i8.1375. PMID 36160744
  109. Libbrecht L, Croes R, Ectors N, et al. Microscopic colitis with giant cells. Histopathology. 2002;40(4):335–338. doi:10.1046/j.1365-2559.2002.01348.x. PMID 11943017
  110. Lin XK, Xia QZ, Huang XZ, et al. Clinical characteristics of intussusception secondary to pathologic lead points in children: a single-center experience with 65 cases. Pediatr Surg Int. 2017;33(7):793–797. doi:10.1007/s00383-017-4101-8. PMID 28584905
  111. Louie CY, DiMaio MA, Matsukuma KE, et al. Idelalisib-associated enterocolitis: clinicopathologic features and distinction from other enterocolitides. Am J Surg Pathol. 2015;39(12):1653–1660. doi:10.1097/PAS.0000000000000525. PMID 26426383
  112. Louie CY, Gomez AJ, Sibley RK, et al. Histologic features of gastrointestinal tract biopsies in IgA vasculitis (Henoch-Schönlein purpura). Am J Surg Pathol. 2018;42(4):529–533. doi:10.1097/PAS.0000000000001036. PMID 29438165
  113. Lowes H, Rowaiye B, Carr NJ, et al. Complicated appendiceal diverticulosis versus low-grade appendiceal mucinous neoplasms: a major diagnostic dilemma. Histopathology. 2019;75(4):478–485. doi:10.1111/his.13931. PMID 31166613
  114. Ludwig K, De Bartolo D, Salerno A, et al. Congenital anomalies of the tubular gastrointestinal tract. Pathologica. 2022;114(1):40–54. doi:10.32074/1591-951X-553. PMID 35212315
  115. Ma C, Pai RK, Schaeffer DF, et al. Recommendations for standardizing biopsy acquisition and histological assessment of immune checkpoint inhibitor-associated colitis. J Immunother Cancer. 2022;10(3):e004560. doi:10.1136/jitc-2022-004560. PMID 35296560
  116. Magro F, Doherty G, Peyrin-Biroulet L, et al. ECCO position paper: harmonization of the approach to ulcerative colitis histopathology. J Crohns Colitis. 2020;14(11):1503–1511. doi:10.1093/ecco-jcc/jjaa110. PMID 32504534
  117. Magro F, Langner C, Driessen A, et al. European consensus on the histopathology of inflammatory bowel disease. J Crohns Colitis. 2013;7(10):827–851. doi:10.1016/j.crohns.2013.06.001. PMID 23870728
  118. Mahadeva U, Martin JP, Patel NK, et al. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn's disease from ulcerative colitis. Histopathology. 2002;41(1):50–55. doi:10.1046/j.1365-2559.2002.01416.x. PMID 12121237
  119. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta-analysis. Mayo Clin Proc. 2006;81(11):1462–1471. doi:10.4065/81.11.1462. PMID 17120402
  120. Malutan AM, Suciu VE, Ignat FL, et al. Tailgut cyst: gynecologist's pitfall. Literature review and case report. Diagnostics (Basel). 2025;15(1):108. doi:10.3390/diagnostics15010108. PMID 39795636
  121. Marchal-Bressenot A, Salleron J, Boulagnon-Rombi C, et al. Development and validation of the Nancy histological index for UC. Gut. 2017;66(1):43–49. doi:10.1136/gutjnl-2015-310187. PMID 26464414
  122. Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroenterol. 2019;32(3):264–272. doi:10.20524/aog.2019.0355. PMID 31040623
  123. Martin BA, Kerner JA, Hazard FK, Longacre TA. Evaluation of intestinal biopsies for pediatric enteropathy: a proposed immunohistochemical panel approach. Am J Surg Pathol. 2014;38(10):1387–1395. doi:10.1097/PAS.0000000000000314. PMID 25188866
  124. Martin V, Shaw-Smith C. Review of genetic factors in intestinal malrotation. Pediatr Surg Int. 2010;26(8):769–781. doi:10.1007/s00383-010-2622-5. PMID 20549505
  125. McGovern VJ, Slavutin LJ. Pathology of salmonella colitis. Am J Surg Pathol. 1979;3(6):483–490. doi:10.1097/00000478-197912000-00001. PMID 534385
  126. Medgyesy K, Trifonova R, Bevington T, et al. Pneumatosis intestinalis: to biopsy or not to biopsy? Cureus. 2020;12(12):e12140. doi:10.7759/cureus.12140. PMID 33489552
  127. Men V, Kaur D, Bahl P, et al. Is routine histopathological analysis of hemorrhoidectomy specimens necessary? A systematic review and meta-analysis. World J Surg. 2024;48(8):1981–1989. doi:10.1002/wjs.12235. PMID 38797982
  128. Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021;9(1):13–37. doi:10.1177/2050640620951905. PMID 33619914
  129. Misiakos EP, Tsapralis D, Karatzas T, et al. Advents in the diagnosis and management of ischemic colitis. Front Surg. 2017;4:47. doi:10.3389/fsurg.2017.00047. PMID 28929100
  130. Mohammed A, Paranji N, Singh A, et al. Pseudomelanosis coli, its relation to laxative use and association with colorectal neoplasms: a comprehensive review. JGH Open. 2021;5(6):643–646. doi:10.1002/jgh3.12546. PMID 34124379
  131. Mohtasebi S, Shokripour M, Vahid P, et al. Parasitological and histopathological features of appendectomy specimens in Fars Province, southern Iran: a retrospective study. Ann Med Surg (Lond). 2023;85(5):1601–1606. doi:10.1097/MS9.0000000000000208. PMID 37229051
  132. Monforte HL, Wilsey M, Gonzalez R. Surgical pathology of Hirschsprung disease (HSCR). World J Pediatr Surg. 2025;8(3):e000882. doi:10.1136/wjps-2024-000882. PMID 40756452
  133. Mosli MH, Feagan BG, Zou G, et al. Development and validation of a histological index for UC. Gut. 2017;66(1):50–58. doi:10.1136/gutjnl-2015-310393. PMID 26475633
  134. Mostyka M, Fulmer CG, Hissong EM, Yantiss RK. Crohn disease infrequently affects the appendix and rarely causes granulomatous appendicitis. Am J Surg Pathol. 2021;45(12):1703–1706. doi:10.1097/PAS.0000000000001734. PMID 33999557
  135. Müller T, Hess MW, Schiefermeier N, et al. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet. 2008;40(10):1163–1165. doi:10.1038/ng.225. PMID 18724368
  136. Muranaka F, Nakajima T, Iwaya M, et al. A comparative immunohistochemical study of anal canal epithelium in humans and swine, focusing on the anal transitional zone epithelium and the anal glands. Anat Rec (Hoboken). 2018;301(5):796–805. doi:10.1002/ar.23748. PMID 29232767
  137. Nambu R, Mulder DJ, Nakazawa A, et al. Histopathological features of monogenic inflammatory bowel disease: subanalysis of systematic review. Gastro Hep Adv. 2022;1(5):679–681. doi:10.1016/j.gastha.2022.05.011. PMID 39131844
  138. Navale P, Gonzalez RS, Vyas M. Incidental secondary findings in hemorrhoidectomy specimens: a 16-year experience from a single academic center. Hum Pathol. 2021;109:12–20. doi:10.1016/j.humpath.2020.11.008. PMID 33245989
  139. Nepomuceno H, Abrajano C, Chiu B. Pilonidal granuloma formation after an incision and drainage procedure is associated with retained hair within the sinus: a case series. Int J Surg Case Rep. 2024;125:110500. doi:10.1016/j.ijscr.2024.110500. PMID 39461136
  140. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769–2778. doi:10.1016/S0140-6736(17)32448-0. PMID 29050646
  141. Ngo N, Chang F. Enterocolic lymphocytic phlebitis: clinicopathologic features and review of the literature. Arch Pathol Lab Med. 2007;131(7):1130–1134. doi:10.5858/2007-131-1130-ELPCFA. PMID 17617004
  142. Nishida T, Iijima H, Adachi S. Immune checkpoint inhibitor-induced diarrhea/colitis: endoscopic and pathologic findings. World J Gastrointest Pathophysiol. 2019;10(2):17–28. doi:10.4291/wjgp.v10.i2.17. PMID 31559106
  143. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999;283(5402):689–692. doi:10.1126/science.283.5402.689. PMID 9924029
  144. Oberhuber G, Püspök A, Oesterreicher C, et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn's disease. Gastroenterology. 1997;112(3):698–706. doi:10.1053/gast.1997.v112.pm9041230. PMID 9041230
  145. Odze RD, Goldblum J, Noffsinger A, et al. Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology. Mod Pathol. 2002;15(4):379–386. doi:10.1038/modpathol.3880534. PMID 11950911
  146. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001;411(6837):603–606. doi:10.1038/35079114. PMID 11385577
  147. Osmond A, Ashok D, Francoeur CA, et al. Is focal active colitis of greater clinical significance in pediatric patients? A retrospective review of 68 cases with clinical correlation. Hum Pathol. 2018;74:164–169. doi:10.1016/j.humpath.2018.01.012. PMID 29360496
  148. Pagnoux C, Mahr A, Cohen P, et al. Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore). 2005;84(2):115–128. doi:10.1097/01.md.0000158825.87055.0b. PMID 15758841
  149. Pammi M, Cope J, Tarr PI, et al. Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis. Microbiome. 2017;5(1):31. doi:10.1186/s40168-017-0248-8. PMID 28274256
  150. Parks AG, Gordon PH, Hardcastle JD. A classification of fistula-in-ano. Br J Surg. 1976;63(1):1–12. doi:10.1002/bjs.1800630102. PMID 1267867
  151. Parpoudi SN, Kyziridis DS, Patridas DC, et al. Is histological examination necessary when excising a pilonidal cyst? Am J Case Rep. 2015;16:164–168. doi:10.12659/AJCR.892843. PMID 25794794
  152. Pavel C, Diculescu MM, Stepan AE, et al. Considering histologic remission in ulcerative colitis as a long-term target. J Clin Med. 2024;13(1):289. doi:10.3390/jcm13010289. PMID 38202296
  153. Peisl S, Burckhardt O, Egger B. Neurogenic appendicopathy: an underestimated disease. Systematic review of the literature. Int J Colorectal Dis. 2021;36(9):1995–2005. doi:10.1007/s00384-021-03901-1. PMID 33839889
  154. Perrone G, Giuffrida M, Donato V, et al. The challenge of pneumatosis intestinalis: a contemporary systematic review. J Pers Med. 2024;14(2):167. doi:10.3390/jpm14020167. PMID 38392601
  155. Piscopo N, Ellul P. Diverticular disease: a review on pathophysiology and recent evidence. Ulster Med J. 2020;89(2):83–88. PMID 33093692
  156. Popivanov G, Ilcheva B, Konaktchieva M, et al. Idiopathic segmental megacolon: intestinal neuronal dysplasia type B, Cajal cells abnormality, or still "idiopathic" disease? Case report and literature review. Reports (MDPI). 2026;9(4). doi:10.3390/reports9040339. PMID 42924791
  157. Popovski N, Stoyanova N, Caiulo R. Prenatal diagnosis and perinatal management considerations in congenital abdominal wall defects: a case series and narrative review. J Pers Med. 2026;16(9). doi:10.3390/jpm16090460. PMID 42783491
  158. Price AB, Davies DR. Pseudomembranous colitis. J Clin Pathol. 1977;30(1):1–12. doi:10.1136/jcp.30.1.1. PMID 838865
  159. Price AB. Overlap in the spectrum of non-specific inflammatory bowel disease—"colitis indeterminate". J Clin Pathol. 1978;31(6):567–577. doi:10.1136/jcp.31.6.567. PMID 670413
  160. Puffenberger EG, Hosoda K, Washington SS, et al. A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease. Cell. 1994;79(7):1257–1266. doi:10.1016/0092-8674(94)90016-7. PMID 8001158
  161. Rashid A, Hamilton SR. Necrosis of the gastrointestinal tract in uremic patients as a result of sodium polystyrene sulfonate (Kayexalate) in sorbitol: an underrecognized condition. Am J Surg Pathol. 1997;21(1):60–69. doi:10.1097/00000478-199701000-00007. PMID 8990142
  162. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol. 1983;14(11):931–968. doi:10.1016/s0046-8177(83)80175-0. PMID 6629368
  163. Robles AI, Traverso G, Zhang M, et al. Whole-exome sequencing analyses of inflammatory bowel disease-associated colorectal cancers. Gastroenterology. 2016;150(4):931–943. doi:10.1053/j.gastro.2015.12.036. PMID 26764183
  164. Rogler G, Singh A, Kavanaugh A, et al. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161(4):1118–1132. doi:10.1053/j.gastro.2021.07.042. PMID 34358489
  165. Romeo G, Ronchetto P, Luo Y, et al. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367(6461):377–378. doi:10.1038/367377a0. PMID 8114938
  166. Rook JM, Chervu N, Calkins KL, et al. Meconium-related obstruction and clinical outcomes in term and preterm infants. JAMA Netw Open. 2025;8(2):e2459557. doi:10.1001/jamanetworkopen.2024.59557. PMID 39951267
  167. Ross AJ, Ruiz-Perez V, Wang Y, et al. A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet. 1998;20(4):358–361. doi:10.1038/3828. PMID 9843207
  168. Rossi D, Irvine W, Granström AL, et al. Updated European Reference Network for rare Inherited and Congenital Digestive and Gastrointestinal Anomalies guidelines for the management of rectosigmoid Hirschsprung's disease 2025. J Pediatr Gastroenterol Nutr. 2026;83(1):185–207. doi:10.1002/jpn3.70442. PMID 42057764
  169. Rutter KR, Riddell RH. The solitary ulcer syndrome of the rectum. Clin Gastroenterol. 1975;4(3):505–530. doi:10.1016/S0300-5089(21)00249-2. PMID 1183059
  170. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126(2):451–459. doi:10.1053/j.gastro.2003.11.010. PMID 14762782
  171. Sadeghi A, Biglari M, Forootan M, et al. Solitary rectal ulcer syndrome: a narrative review. Middle East J Dig Dis. 2019;11(3):129–134. doi:10.15171/mejdd.2019.138. PMID 31687110
  172. Saffioti F, Mavroeidis VK. Primary sclerosing cholangitis and cholangiocarcinoma: the 2023 practice guidance and future perspectives. Hepatobiliary Surg Nutr. 2024;13(1):172–175. doi:10.21037/hbsn-23-621. PMID 38322224
  173. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity Index. Mayo Clin Proc. 1994;69(5):409–415. doi:10.1016/s0025-6196(12)61634-6. PMID 8170189
  174. Saraga EP, Costa J. Idiopathic entero-colic lymphocytic phlebitis. A cause of ischemic intestinal necrosis. Am J Surg Pathol. 1989;13(4):303–308. doi:10.1097/00000478-198904000-00005. PMID 2929846
  175. Schneider EN, Havens JM, Scott MA, et al. Molecular diagnosis of Campylobacter jejuni infection in cases of focal active colitis. Am J Surg Pathol. 2006;30(6):782–785. doi:10.1097/00000478-200606000-00017. PMID 16723859
  176. Shetty S, Anjarwalla SM, Gupta J, et al. Focal active colitis: a prospective study of clinicopathological correlations in 90 patients. Histopathology. 2011;59(5):850–856. doi:10.1111/j.1365-2559.2011.04019.x. PMID 22092396
  177. Shillingford NM, Calicchio ML, Teot LA, et al. Villin immunohistochemistry is a reliable method for diagnosing microvillus inclusion disease. Am J Surg Pathol. 2015;39(2):245–250. doi:10.1097/PAS.0000000000000355. PMID 25517957
  178. Siersma CL, Rottier BL, Hulscher JB, et al. Jejunoileal atresia and cystic fibrosis: don't miss it. BMC Res Notes. 2012;5:677. doi:10.1186/1756-0500-5-677. PMID 23217263
  179. Sivagnanam M, Mueller JL, Lee H, et al. Identification of EpCAM as the gene for congenital tufting enteropathy. Gastroenterology. 2008;135(2):429–437. doi:10.1053/j.gastro.2008.05.036. PMID 18572020
  180. Soetikno RM, Lin OS, Heidenreich PA, et al. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56(1):48–54. doi:10.1067/mge.2002.125367. PMID 12085034
  181. Sohn WS, Kim DR, Lee JS, et al. A case of severe protein-losing enteropathy as a late complication of pelvic irradiation. Korean J Intern Med. 2004;19(4):271–275. doi:10.3904/kjim.2004.19.4.271. PMID 15683118
  182. Soubra AB, Nasser SM. Focal active colitis: diagnostic relevance and long-term clinical outcomes. Hum Pathol. 2026;171:106070. doi:10.1016/j.humpath.2026.106070. PMID 41655859
  183. Speelman P, Kabir I, Islam M. Distribution and spread of colonic lesions in shigellosis: a colonoscopic study. J Infect Dis. 1984;150(6):899–903. doi:10.1093/infdis/150.6.899. PMID 6501931
  184. Star KV, Ho VT, Wang HH, Odze RD. Histologic features in colon biopsies can discriminate mycophenolate from GVHD-induced colitis. Am J Surg Pathol. 2013;37(9):1319–1328. doi:10.1097/PAS.0b013e31829ab1ef. PMID 24076772
  185. Stirrat T, Bejugam D, Alukal J, Kanth P. Colitis cystica profunda: a systematic review. Eur J Gastroenterol Hepatol. 2026;38(9):1001–1007. doi:10.1097/MEG.0000000000003150. PMID 41604561
  186. Su C, Brandt LJ, Sigal SH, et al. The immunohistological diagnosis of E. coli O157:H7 colitis: possible association with colonic ischemia. Am J Gastroenterol. 1998;93(7):1055–1059. doi:10.1111/j.1572-0241.1998.00328.x. PMID 9672329
  187. Subramanian V, Mannath J, Ragunath K, et al. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther. 2011;33(3):304–312. doi:10.1111/j.1365-2036.2010.04525.x. PMID 21128987
  188. Surawicz CM, Belic L. Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology. 1984;86(1):104–113. PMID 6689653
  189. Surawicz CM, Haggitt RC, Husseman M, McFarland LV. Mucosal biopsy diagnosis of colitis: acute self-limited colitis and idiopathic inflammatory bowel disease. Gastroenterology. 1994;107(3):755–763. doi:10.1016/0016-5085(94)90124-4. PMID 8076762
  190. Swanson BJ, Limketkai BN, Liu TC, et al. Sevelamer crystals in the gastrointestinal tract (GIT): a new entity associated with mucosal injury. Am J Surg Pathol. 2013;37(11):1686–1693. doi:10.1097/PAS.0b013e3182999d8d. PMID 24061514
  191. Tandon P, Malhi G, Abdali D, et al. Active margins, plexitis, and granulomas increase postoperative Crohn's recurrence: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(3):451–462. doi:10.1016/j.cgh.2020.08.014. PMID 32801016
  192. Teymouri A, Keshvari A, Khorasanizadeh F, et al. External validation of the modified Parks classification of cryptoglandular anal fistula to predict failure of healing: the protocol for a retrospective analysis. Int J Surg Protoc. 2025;29:118–121. doi:10.1097/SP9.0000000000000055. PMID 40860206
  193. Thomas T, Abrams KA, Robinson RJ, et al. Meta-analysis: cancer risk of low-grade dysplasia in chronic ulcerative colitis. Aliment Pharmacol Ther. 2007;25(6):657–668. doi:10.1111/j.1365-2036.2007.03241.x. PMID 17311598
  194. Thomson WH. The nature of haemorrhoids. Br J Surg. 1975;62(7):542–552. doi:10.1002/bjs.1800620710. PMID 1174785
  195. Tomuschat C, Mietzsch S, Dwertmann-Rico S, et al. The length of the transition zone in patients with rectosigmoid Hirschsprung disease. Children (Basel). 2022;9(2):152. doi:10.3390/children9020152. PMID 35204873
  196. Tsinganou E, Gebbers JO. Human intestinal spirochetosis: a review. Ger Med Sci. 2010;8:Doc01. doi:10.3205/000090. PMID 20200654
  197. Turner D, Ricciuto A, Lewis A, et al. STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD). Gastroenterology. 2021;160(5):1570–1583. doi:10.1053/j.gastro.2020.12.031. PMID 33359090
  198. Turner D, Ricciuto A, Yuval Bar-Asher S, et al. Updated treatment targets in inflammatory bowel disease (STRIDE-III): an initiative of the International Organization for the Study of IBD. Lancet Gastroenterol Hepatol. 2026. doi:10.1016/S2468-1253(26)00292-X. PMID 42896564
  199. Valenti S, Gallizzi R, De Vivo D, et al. Intestinal Behçet and Crohn's disease: two sides of the same coin. Pediatr Rheumatol Online J. 2017;15(1):33. doi:10.1186/s12969-017-0162-4. PMID 28427473
  200. Villanacci V, Reggiani-Bonetti L, Leoncini G, et al. Histopathology of non-IBD colitis. A practical approach from the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica. 2021;113(1):54–65. doi:10.32074/1591-951X-234. PMID 33686310 (cited as Villanacci et al. 2021b)
  201. Villanacci V, Reggiani-Bonetti L, Salviato T, et al. Histopathology of IBD colitis. A practical approach from the pathologists of the Italian Group for the study of the gastrointestinal tract (GIPAD). Pathologica. 2021;113(1):39–53. doi:10.32074/1591-951X-235. PMID 33686309 (cited as Villanacci et al. 2021a)
  202. Volk EE, Shapiro BD, Easley KA, Goldblum JR. The clinical significance of a biopsy-based diagnosis of focal active colitis: a clinicopathologic study of 31 cases. Mod Pathol. 1998;11(8):789–794. PMID 9720510
  203. Walker NI, Bennett RE, Axelsen RA. Melanosis coli: a consequence of anthraquinone-induced apoptosis of colonic epithelial cells. Am J Pathol. 1988;131(3):465–476. PMID 3381879
  204. Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33(1):179–201. doi:10.1016/s0031-3955(16)34975-6. PMID 3081865
  205. Wang J, Cortina G, Wu SV, et al. Mutant neurogenin-3 in congenital malabsorptive diarrhea. N Engl J Med. 2006;355(3):270–280. doi:10.1056/NEJMoa054288. PMID 16855267
  206. Wang Y, Wu Y, Guan W, et al. Meconium peritonitis due to fetal appendiceal perforation: two case reports and a brief review of the literature. BMC Pediatr. 2018;18(1):162. doi:10.1186/s12887-018-1133-8. PMID 29751786
  207. Wang YT, Zhu YX, Huang RY, et al. Pathological classification of chronic radiation-induced intestinal injury and its clinical implications. Gastroenterol Rep (Oxf). 2025;13:goaf072. doi:10.1093/gastro/goaf072. PMID 40656550
  208. Wangler MF, Gonzaga-Jauregui C, Gambin T, et al. Heterozygous de novo and inherited mutations in the smooth muscle actin (ACTG2) gene underlie megacystis-microcolon-intestinal hypoperistalsis syndrome. PLoS Genet. 2014;10(3):e1004258. doi:10.1371/journal.pgen.1004258. PMID 24676022
  209. Weidner AS, Panarelli NC, Geyer JT, et al. Idelalisib-associated colitis: histologic findings in 14 patients. Am J Surg Pathol. 2015;39(12):1661–1667. doi:10.1097/PAS.0000000000000522. PMID 26448188
  210. West AB, Kuan SF, Bennick M, et al. Glutaraldehyde colitis following endoscopy: clinical and pathological features and investigation of an outbreak. Gastroenterology. 1995;108(4):1250–1255. doi:10.1016/0016-5085(95)90227-9. PMID 7698592
  211. Westerhoff M. Histologic features of colonic infections. Pathologe. 2022;43(1):16–30. doi:10.1007/s00292-021-01015-7. PMID 34767063
  212. Whiteway J, Morson BC. Elastosis in diverticular disease of the sigmoid colon. Gut. 1985;26(3):258–266. doi:10.1136/gut.26.3.258. PMID 3972272
  213. Włodarczyk M, Włodarczyk J, Maryńczak K, et al. Role of adipose tissue hormones in pathogenesis of cryptoglandular anal fistula. Int J Mol Sci. 2024;25(3):1501. doi:10.3390/ijms25031501. PMID 38338780
  214. Wu H, Fuller MY, Pogoriler J. Granulomatous appendicitis in the pediatric population. Pediatr Dev Pathol. 2020;23(3):215–221. doi:10.1177/1093526619881545. PMID 31619135
  215. Xia R, Zhang X. Neutropenic enterocolitis: a clinico-pathological review. World J Gastrointest Pathophysiol. 2019;10(3):36–41. doi:10.4291/wjgp.v10.i3.36. PMID 31692935
  216. Xin W, Brown PI, Greenson JK. The clinical significance of focal active colitis in pediatric patients. Am J Surg Pathol. 2003;27(8):1134–1138. doi:10.1097/00000478-200308000-00011. PMID 12883246
  217. Yabanoglu H, Caliskan K, Ozgur Aytac H, et al. Unusual findings in appendectomy specimens of adults: retrospective analyses of 1466 patients and a review of literature. Iran Red Crescent Med J. 2014;16(2):e12931. doi:10.5812/ircmj.12931. PMID 24719727
  218. Zhang R, Lauwers GY, Choi WT. Increased risk of non-conventional and invisible dysplasias in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis. 2022;16(12):1825–1834. doi:10.1093/ecco-jcc/jjac090. PMID 35771958